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ABSTRACT
Toxoplasma gondii is an intracellular protozoan parasite that infects warm blooded
animals the world over. In the host, the parasite exists as either rapidly growing tachyzoites
or immunologically protected slowly dividing bradyzoites. While tachyzoites are generally
cleared by the host’s immune system, bradyzoites persist for life. If the immune system
becomes compromised, bradyzoites reconvert to tachyzoites and cause severe illness.
Bradyzoites develop in response to stressful stimuli, therefore discovering factors that
modulate bradyzoite conversion as well as determining how Toxoplasma’s stress response
pathways operate are essential to understanding parasite disease. In this work, the plant
alkaloid securinine as well as ten pyrrolidine derivatives were shown to have in vitro antiToxoplasma activity in the micromolar range. These compounds act in different capacities,
either restricting parasite’s invasion or by reducing the parasite’s rate of replication. One
of the hallmarks of the bradyzoite life stage is slowed replication. When tested, only
securinine induced bradyzoite formation at comparable levels to treatment with alkaline
media, suggesting that it initiates a stressful stimulus.
When in the bradyzoite stage, Toxoplasma induces a global translational repression
allowing for the remodeling of the transcriptome. However it remains unclear how certain
transcripts are maintained throughout the long term translational repression seen in
bradyzoites. Analysis of one such transcript, lactate dehydrogenase 1, showed a 40
nucleotide cis-acting element with its 5’UTR responsible for this activity. The formation
of 16 nucleotide regulatory RNA hairpin is necessary for inducing sustained translational
repression in bradyzoites, suggesting that it acts as a recognizable feature. Characterization
of the transcript reveals that its poly(A) tail does not shorten in bradyzoites, indicating that
v

it is likely targeted for long term storage instead of degraded under stress. Efforts were
made to capture and analyse the protein complement interacting with the cis-acting element
using RNA aptamer technologies, however they were unfruitful. Using extracellular
parasites, it was determined that a rapid induction of stress is insufficient to selectively
repress the transcript. This suggests that the reprogramming of the proteome may be
necessary for the sustained translational repression of lactate dehydrogenase 1 in
Toxoplasma bradyzoites.
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CHAPTER I – General introduction
Discovery of Toxoplasma gondii
Toxoplasma gondii is a single-celled protozoan parasite of the phylum Apicomplexa.
It is the only species within the genus Toxoplasma. T. gondii was first discovered
independently in an African rodent in Tunisia and in a rabbit in Brazil (Nicolle and
Manceaux, 1908; Splendore, 1908). It derives its name from the Greek “toξo” meaning
bow-like and the gundi, the animal from which it was first identified (Nicolle and
Manceaux, 1909). Since its discovery, T. gondii has been found to be a wide-spread
parasite capable of infecting virtually any nucleated cell in warm-blooded animals
including birds and mammals, earning it the title of the world’s most successful parasite
(Tenter et al., 2000; Turner et al., 2013).
Toxoplasma life cycle
Toxoplasma gondii is an intracellular parasite that spends most phases of its life cycle
inside the cells of its host. This life cycle can be subdivided into the sexual and asexual
phases (Figure 1.1).

In the sexual life cycle, the parasite differentiates through a

progression of cell types that allow for genetic crossing in its definitive host. In the asexual
life cycle, the parasite alternates between two stages and reproduces through a clonal
division.
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Figure 1.1 Sexual and asexual life cycles of Toxoplasma gondii.
Sexual reproduction occurs in the epithelium of the feline’s small intestine. Cats shed
oocysts into the environment which are then taken up by warm blooded animals. This
causes an acute infection by tachyzoites which differentiate into bradyzoites upon
induction of the immune response. Bradyzoites can be ingested through the consumption
of infected tissues. Adapted from Black and Boothroyd, 2000.
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1.2.1

Sexual life cycle
Members of the family Felidae act as the definitive host of Toxoplasma gondii.

Parasites are first taken up by the cat by ingesting either tissue cysts from an infected animal
through predation or sporulated oocysts from the environment (Dubey et al., 1998). Once
either of these two forms encounters the feline’s stomach, the cyst wall is dissolved and
infectious parasites are released which then infect the epithelial lining of the small intestine
(Dubey et al., 1998). Differentiation of the parasite into male and female gametocytes
proceeds and these combine to form oocysts (Dubey et al., 1998). Oocysts are then released
from the cat through its feces where sporulation occurs in the environment (Dubey et al.,
1998). The length of this process is complete in about 1 to 5 days depending on ambient
temperature (Dubey et al., 1998). This results in the formation of four sporozoites
contained within the sporulated oocyst (Dubey et al., 1998). Sporulated oocysts can
survive for years in the environment (Torrey and Yolken, 2013). If they happen to be
ingested by a feline, another round of sexual reproduction can occur, thus completing the
cycle (Dubey et al., 1998).
1.2.2

Asexual life cycle
Ingestion of tissue cysts or sporulated oocysts from the environment can also lead to

the commencement of asexual reproduction in warm blooded animals (Dubey et al., 1998).
Any host other than the cat is termed an intermediate host although asexual reproduction
also occurs in the feline definitive host (Dubey et al., 1998). Upon reaching the stomach,
gastric juices serve to digest the cyst wall and release infectious parasites (Dubey et al.,
1998). These invade the host’s tissues where they differentiate into rapidly growing
tachyzoites during an acute infection cycle (Dubey et al., 1998). During this phase of acute
3

infection, tachyzoites can spread throughout the host as well as be vertically transmitted to
a pregnant host’s offspring (Montoya and Liesenfeld, 2004). Infection by Toxoplasma
causes activation of the host’s immune system. In response to signals generated from the
immune response, tachyzoites differentiate into slow growing bradyzoites which are
immunologically protected (Skariah et al., 2010). Bradyzoites are encased in a cyst wall
and persist for the life of the host in a chronic infection (Dubey et al., 1998). Bradyzoites
can re-enter the Toxoplasma life cycle if an infected animal containing tissue cysts is eaten
through carnivorism (Dubey et al., 1998).
1.2.3

Distribution, prevalence and transmission in animals
It is estimated that at any given time, approximately 1% of domestic cats are shedding

oocysts into the environment at a rate of up to 55 million each a day per animal (Torrey
and Yolken, 2013). It has been estimated that on average, there may be as many as 9 to
434 oocysts per square foot of residential area in the United States of America shed by
domestic and feral cats alone (Torrey and Yolken, 2013). This value is assumed to be much
higher in areas where cats selectively defecate such as sand boxes and gardens (Torrey and
Yolken, 2013). Importantly, studies have shown that a single oocyst is capable of causing
infection in animals (Dubey et al., 1998).
Toxoplasma is transmitted to animals is through the consumption of sporulated
oocysts or infected meat. This most often occurs by eating directly off contaminated soil,
eating small insects that carry oocysts, drinking contaminated water, or carnivorism (Dubey
and Jones, 2008). They can also become infected by ingesting contaminated milk (Dubey
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and Jones, 2008; Tenter et al., 2000). Infection among small rodents is particularly
important as they are direct prey for cats.
Toxoplasma has been found to chronically infect animals on every continent
including Antarctica (Jensen et al., 2012; Dubey and Jones, 2008). Toxoplasma infections
are not limited to wild animals as the parasite has also been seen in companion animals and
other animals held in captivity such as farm and zoo animals (Dubey and Jones, 2008). The
infection of livestock is particularly of concern to human health because the ingestion of
contaminated undercooked meat or unpasteurized milk can pass the parasite along
(Montoya and Liesenfeld, 2004; Dubey and Jones, 2008; Tenter et al., 2000). Pigs, sheep,
goats, and chickens are more likely to be infected than cattle and raising these animals in a
free range environment increases the risk of infection because they are not protected from
oocysts in the environment (Dubey and Jones, 2008).
1.2.4

Distribution, prevalence and transmission among humans
Toxoplasma gondii is one of the most wide-spread human parasites with infections

noted on every continent. Around the world it is estimated that approximately one third of
people are infected with Toxoplasma and nearly 200 000 newborns are infected annually
(Montoya and Liesenfeld, 2004; Torgerson and Mastroiacovo, 2013). However, infection
rates can vary greatly from country to country, even between those that are geographically
close to one another. For example, seroprevalence in European countries vary from 7% in
the United Kingdom to 67% in Yugoslavia (Lafferty, 2006). In Canada and the United
States of America, studies have estimated that between 12-25% of people are seropositive
(Lafferty, 2006; Shuhaiber et al., 2003; Kruszon-Moran and McQuillan, 2005). Risks of
5

infection include cat ownership and raw meat consumption (Jones et al., 2009). Sanitary
conditions have also been shown to be important for controlling Toxoplasma infection. For
example in 1995, the world’s most serious Toxoplasma outbreak was recorded in Victoria,
British Columbia and was attributed to oocyst contamination of the water supply (Mullens,
1996).

While Toxoplasma infection is usually acquired orally, other methods of

transmission are also possible.

These include receiving an infected organ during

transplantation or congenital transmission from pregnant mother to fetus (Montoya and
Liesenfeld, 2004).
Multiple Toxoplasma genotypes have been found to infect people across the globe.
Phylogenetic studies have revealed that most Toxoplasma infections in North Americans
and Europeans are caused by three main clonal lineages commonly known as types I, II
and III (Howe and Sibley, 1995). Many other Toxoplasma genotypes exist as well. For
instance, isolates from South America appear to be much more genetically diverse (Khan
et al., 2006). The high prevalence of types I, II, and III is likely due to their highly
successful asexual clonal expansion amongst the population (Khan et al., 2006). There is
also a correlation between Toxoplasma type and severity of infection. Infections with type
II and III strains are less virulent and more common than infection with type I strains (Khan
et al., 2006).
Toxoplasmosis
Infection with T. gondii can cause the disease toxoplasmosis. Infection can be
divided into acute, latent, and recurrent phases. The acute phase of infection is caused by
rapidly growing tachyzoites and is generally considered to have mild to moderate
6

symptoms depending on a variety of parasite and host-related factors. The latent phase of
infection is associated with the presence of bradyzoites that persist for the life of host.
Symptoms are not easily discernible and historically, chronic infection has been considered
to be asymptomatic in humans.

Immunosuppression followed by the subsequent

conversion of bradyzoites into tachyzoites is responsible for recurrent toxoplasmosis. This
phase has the most severe effects in adults because the infection is already established
throughout the host and the immune system cannot combat the infection (Montoya and
Liesenfeld, 2004).
1.3.1

Acute toxoplasmosis
Acute toxoplasmosis occurs during the initial infection of the host with the parasite.

In immunocompetent hosts initial infection with T. gondii is generally benign, however
mild flu-like symptoms and / or swollen lymph nodes can occur (Montoya and Liesenfeld,
2004). Typically, tachyzoites, the causative agents of acute toxoplasmosis, are cleared by
the immunocompetent host’s immune system (Montoya and Liesenfeld, 2004). Therefore,
except in rare cases, these symptoms are usually quickly resolved and leave no lasting
effects (Montoya and Liesenfeld, 2004). Factors affecting the severity of symptoms
include parasite strain and virulence, the number of parasites taken in during initial
acquisition, as well as the sex, age, and immunological status of the host (Montoya and
Liesenfeld, 2004).
Although a rare occurrence in immunocompetent people, severe cases of acute T.
gondii infection can cause serious disease to the eye. Ocular toxoplasmosis can cause
temporary cloudy eyesight when reproducing tachyzoites obstruct the path of light in the
7

eye as well as permanent partial blindness when they destroy localized areas of the retina
(Mullens, 1996). While the cloudy vision can clear up once drugs are used to control the
initial infection, any destruction of retinal tissue results in permanent eyesight impairment
(Montoya and Liesenfeld, 2004).
If a woman becomes acutely infected for the first time during pregnancy, the parasite
can be vertically transmitted to the fetus through the placenta, causing congenital
toxoplasmosis. Generally, the earlier in gestation that transmission occurs, the more severe
effects congenital toxoplasmosis can have on fetal development (Montoya and Liesenfeld,
2004). The most severe symptoms include problems associated with eyesight such as
blindness and many debilitating effects on the brain including enlargement of the skull,
atrophy of the brain, the presence of brain lesions, and mental retardation (Montoya and
Liesenfeld, 2004). In the most severe circumstances, congenital toxoplasmosis can cause
spontaneous abortion or stillbirth, with this being a leading cause of stillbirth and abortive
births in sheep (Montoya and Liesenfeld, 2004; Innes et al., 2009).
In contrast to healthy individuals, previously unexposed patients who receive an
organ or hematopoietic stem cell transplant from a seropositive donor can suffer severe
consequences (Tenter et al., 2000). These include neurological problems and, most
severely, a multi organ response which can lead to sepsis, a mostly fatal outcome (Vaughan
and Wenzel, 2013).
1.3.2

Latent toxoplasmosis
Latent toxoplasmosis is the term associated the persistent infection of a host with

Toxoplasma bradyzoites (Montoya and Liesenfeld, 2004). Once this occurs, infection is
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incurable and lasts for life. Virtually any nucleated cell can be infected by the parasite and
bradyzoites have been found in many different tissues, including skeletal and cardiac
muscle, as well as eye and brain tissues (Montoya and Liesenfeld, 2004).

Latent

toxoplasmosis has been traditionally considered asymptomatic and because of this,
infection rates are under-diagnosed in the population (Montoya and Liesenfeld, 2004;
Tenter et al., 2000).
Interestingly, reports have emerged suggesting that latent toxoplasmosis can give rise
to long-term behavioural and phenotypic changes, thereby challenging the assumption of
asymptomatic infection (reviewed by Flegr, 2013).

For example, people who test

seropositive for Toxoplasma have decreased reaction times in standardized testing and
display a higher rate of work-related or traffic accidents than the average population (Flegr,
2013). Furthermore, personality and psychological testing has revealed that infected
individuals are more likely to characterize themselves as risk takers and are more prone to
psychological disorders including depression, schizophrenia, and suicidal behaviour (Flegr,
2013). Whilst latent toxoplasmosis appears to have nuanced effects on human behaviour,
the results can be striking in other animals. For example, chronically infected rats see an
abolishment of their innate avoidance of preditorial scents (Berdoy et al., 2000). Instead,
they display an attraction to the scent of feline urine, effectively increasing their predation
by the parasite’s definitive host in the wild and thus completing the parasite’s lifecycle
(House et al., 2011).
These characteristics and diseases may be associated with alterations in hormone and
neurotransmitter levels that occur upon long term Toxoplasma infection. For example,
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increased testosterone levels are seen in chronically infected men, and increases in γaminobutyric acid (GABA) and dopamine are seen in rodents (Hodková et al., 2007; Fuks
et al., 2012; Stibbs, 1985). Notably, these chemicals are linked to the psychiatric issues
described above and T. gondii possesses the ability to directly increase the levels of these
neurotransmitters as it encodes the complete pathway for converting glutamate to GABA
as well as two tyrosine hydroxylases that produce the dopamine precursor L-dopa (MacRae
et al., 2012; Gaskell et al., 2009). By altering these chemical levels, the parasite could be
thought to subtly increase the mortality rate of those infected, potentially increasing
Toxoplasma’s ability to come in contact with a new host.
1.3.3

Recurrent toxoplasmosis
Although recent research is illuminating the ways in which chronic toxoplasmosis

affects human health, by far the most common and serious pathologies of toxoplasmosis
are seen when encysted bradyzoites reconvert to tachyzoites in the host. Referred to as
recurrent toxoplasmosis, this process can affect any previously infected individual if they
become immunocompromised. The immune status of the host can become compromised
due to illnesses or pharmacological interventions, the most common of which include the
taking of immunosuppressant drugs following organ transplantation, undergoing
chemotherapy as a treatment for various cancers, or the development of acquired immune
deficiency syndrome (AIDS) due to HIV infection (Montoya and Liesenfeld, 2004; Tenter
et al., 2000).
Because recurrent toxoplasmosis relies on the reactivation of dormant bradyzoites
previously disseminated throughout the body, drastic pathologies can emerge following
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their conversion into tachyzoites. Common symptoms include ocular complications such
as retinitis and toxoplasmic encephalitis (Tenter et al., 2000). Encephalitis occurs when
reactivated tachyzoites reproduce and lyse infected neurons causing brain lesions and
necrotic foci in the host (Montoya and Liesenfeld, 2004). This damage to the central
nervous system can cause speech abnormalities, motor deficits, seizures, changes in mood,
psychosis, and is potentially fatal if left untreated (Montoya and Liesenfeld, 2004).
Toxoplasmic encephalitis occurs in up to 40% of AIDS patients worldwide and, at the turn
of the millennium, complications arising from Toxoplasma infection accounted for
approximately 10-30% of the fatal outcomes in seropositive HIV positive individuals
(Tenter et al., 2000). Other issues that can arise from the reactivation this opportunistic
pathogen are the development of skin lesions; toxoplasmic pneumonia; the swelling of
organs including, but not limited to, the heart, liver, and the gastrointestinal tract; and, a
disseminated toxoplasmosis leading to sepsis (Lowichik and Ruff, 1995; Tenter et al.,
2000).
Prevention and treatment
Currently, there exists only one Toxoplasma vaccine, a live attenuated parasite strain
that is defective in cyst formation (Kur et al., 2009). However, it is only approved for
veterinary use in sheep, has a limited shelf life, is prohibitively expensive, and has the
potential to revert to a more virulent phenotype (Kur et al., 2009; Liu et al., 2012).
Although many attempts have been made, there are no approved vaccines for use in humans
and therefore efforts to prevent human infection rely on education, public health initiatives,
and careful hygienic practices (Kur et al., 2009; Montoya and Liesenfeld, 2004; Verma and
Khanna, 2013).
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1.4.1

Approved drug regimens
Toxoplasmosis is usually considered asymptomatic in immune-competent

individuals and therefore treatment of Toxoplasma infection is limited only to those
showing signs of acute infection, newly infected pregnant mothers, or preventative
treatment for seropositive individuals at high risk of recurrent toxoplasmosis (Montoya and
Liesenfeld, 2004).

Anti-toxoplasmosis drug regimens consist exclusively of the

administration of multi-drug cocktails (Montoya and Liesenfeld, 2004).

The most

commonly used is the combination of sulfadiazine and pyrimethamine; alternatively,
sulfamethoxazole and trimethoprim may also be used (Montoya and Liesenfeld, 2004).
These drugs inhibit the dihydropteroate synthase (DHPS) activity of the bifunctional
hydroxymethyldihydropterin pyrophosphokinase-DHPS enzyme and the dihydrofolate
reductase (DHFR) activity of the bifunctional enzyme DHFR-thymidylate synthase,
respectively (Aspinall et al., 2002). Together, these drug combinations act synergistically
to inhibit de novo synthesis of folinic acid in Toxoplasma (Aspinall et al., 2002; Meneceur
et al., 2008). While the DHPS molecular target of sulfonamides is absent in humans, a
DHFR orthologue does exist and therefore, to minimize toxicity to the host, folinic acid is
always given in conjunction with pyrimethamine or trimethoprim (Warhurst, 1986;
Montoya and Liesenfeld, 2004). Notably, while all animals rely on dietary folates for
nucleotide synthesis, Toxoplasma is unable to use preformed folates for its metabolic needs,
making folinic acid supplementation an effective way to minimize host toxicity (Warhurst,
1986; Aspinall et al., 2002; Montoya and Liesenfeld, 2004).
Although supplementation with folinic acid is standard practise, the use of
pyrimethamine in animals has the potential to cause neural tube defects and other issues in
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the early phases of fetal development (Montoya and Liesenfeld, 2004; Peters et al., 2007).
Within the first two trimesters, the macrolide spiramycin is alternatively used because it
achieves high concentrations in the placenta, thereby reducing the potential for fetal
transmission (Montoya and Liesenfeld, 2004; Halonen and Weiss, 2013).

Another

common treatment issue arises in individuals who are intolerant or allergic to sulfonamides.
When this occurs, either the protein synthesis inhibitor clindamycin or the cytochrome b
inhibitor atovaquone is given in conjunction with pyrimethamine and folinic acid
(Meneceur et al., 2008; Montoya and Liesenfeld, 2004; Halonen and Weiss, 2013).
Although the currently used drug regimens are generally effective, concerns have
arisen regarding the spread of drug insensitivity and resistance. For example, reports have
documented the resistance of clinical isolates to sulfonamides from animal and human
samples collected in the United Kingdom and France (Aspinall et al., 2002; Meneceur et
al., 2008). Furthermore, a large variation in susceptibility to pyrimethamine as well as
atovaquone has also been demonstrated between clinical isolates (Meneceur et al., 2008).
While outright resistance towards pyrimethamine has not yet been observed in Toxoplasma
gondii isolates, this phenomenon is widely spread in Plasmodium falciparum, the causative
agent of malaria and an apicomplexan parasite (Fohl and Roos, 2003). Two mutations
within the DHFR-TS gene are required to induce resistance in P. falciparum, and
sequencing from multiple T. gondii clinical isolates shows that DHFR-TS is already
polymorphic, suggesting potential for the development of pyrimethamine resistance also
exists in Toxoplasma (Fohl and Roos, 2003; Aspinall et al., 2002; Meneceur et al., 2008;
toxodb.org v.12.0).

13

1.4.2

Novel drug discovery
Since currently used drug regimens have severe side effects and have variable

efficacies, the discovery of alternative compounds displaying anti-Toxoplasma activity
acting against different molecular targets is desirable. Some of the efforts take advantage
of the differences between the biology of Toxoplasma and the human host. While these
have yet to be translated to a clinical setting, many compounds show high efficacies in vitro
or in a mouse model of infection. For example, the herbicide fluridone specifically inhibits
the synthesis of the plant hormone abscisic acid by the apicoplast, a parasite-specific
organelle of red algal origins (Nagamune et al., 2008; van Dooren and Striepen, 2013).
Furthermore, it has been shown to decrease parasite burden in a mouse model and is well
tolerated by mammalian cells since, while the production of this hormone is essential for
the completion of the parasite’s lifecycle, the pathway is absent in mammalian and avian
hosts (Nagamune et al., 2008).
Some drug discovery efforts have taken advantage of the similarities between the
apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii. For example the
currently used anti-malarial drug artemisinin has shown effectiveness in vitro and in mouse
models at inhibiting Toxoplasma growth (Hencken et al., 2010; Schultz et al., 2014).
Artemisinin, the active compound in the traditional Chinese herb qinghao, is particularly
interesting because its synthetic derivatives are currently the only compounds that are
effective at clearing Toxoplasma bradyzoites (Hencken et al., 2010; Schultz et al., 2014).
Many more large scale drug screening efforts have been directed towards P. falciparum in
part because malaria causes many more fatalities, thus increasing the interest in the
development of novel chemotherapeutics. Importantly, these efforts have yielded a library
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of approximately twenty thousand compounds that show anti-malarial activity in vitro, 400
of which are freely available (Spangenberg et al., 2013). Screening of these compounds
discovered several novel agents with different chemical backbones that display high
selectivity against Toxoplasma, suggesting that building upon the work of malaria drug
research may eventually yield novel anti-Toxoplasma agents (Boyom et al., 2014).
Another common vein of drug discovery rests upon the repurposing of drugs
currently used on humans for non-related diseases since these are generally already known
to be well tolerated and therefore may have fewer regulatory hurdles to overcome. Of
particular interest is the activity of drugs acting on the central nervous system, since they
are known to cross the blood-brain barrier and because the majority of complications from
recurrent toxoplasmosis occur in the brain. For example, one study has shown that the
antipsychotic haloperidol, which acts in opposition to dopamine, and the mood stabilizer
valproic acid, which increases GABA activity and reuptake, inhibit Toxoplasma growth in
vitro at concentrations below their bio-availabilities in vivo (Jones-Brando et al., 2003;
Kornhuber et al., 1999). While noting the ability of the parasite to synthesize these
neurotransmitters (MacRae et al., 2012; Gaskell et al., 2009), these examples may suggest
that altering the availability of these neurotransmitters may modulate Toxoplasma growth.
Lytic cycle
The most serious outcomes of toxoplasmosis are etiologically caused by the
destruction of host cells which is itself caused by tachyzoites undergoing multiple
replicative cycles. In an immunocompromised host, tachyzoites are free to rapidly divide
and invade new cells and do so through a repeating process called the lytic cycle (Black
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and Boothroyd, 2000). The lytic cycle can be subdivided into three major parts: the
attachment and invasion of an uninfected cell by an extracellular parasite, followed by
multiple rounds of intracellular growth and replication of tachyzoites, and completed by
the lysis of the host cell with subsequent parasite egress. The newly freed tachyzoites then
migrate towards new host cells and the cycle begins anew (illustrated in Figure 1.2).
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Figure 1.2 Lytic cycle of Toxoplasma gondii.
Extracellular parasites first attach and invade an uninfected host cell. The intracellular
parasite undergoes multiple replicative rounds. Once the host cell’s size limit is reached,
the tachyzoites escape from the lysed host and the extracellular parasites migrate towards
and invade a new host cell. Adapted from Gubbels, 2014.
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1.5.1

Attachment and invasion
T. gondii is an obligate intracellular parasite and as such, when it finds itself in the

extracellular environment, it must attach to the host cell’s membrane and subsequently
invade it in order to survive. The initial attachment of the host by the parasite is mediated
through the recognition of specific host cell factors, namely host cell surface glycoproteins
(Black and Boothroyd, 2000; Robinson et al., 2004; Friedrich et al., 2010). One of the
main mediators of attachment is the family of surface antigens, SAGs. The most prominent
member, SAG1, is a marker of the tachyzoite stage and has been shown to interact
specifically with glucosamine, found on the cell surface (Robinson et al., 2004). The SAG
family members are not the only host cell-binding mediators as SAG1 knockout mutants as
well as bradyzoites, which do not express SAG1, still attach and invade host cells
(Robinson et al., 2004).
More recently, it has been shown that sialic acid plays a major role in the maintenance
of the parasite-host interaction. After initial contact is formed with the host cell, the parasite
reorients its apical end towards the host cell and secretes the contents of its microneme, an
apical secretory organelle which contains the MIC family of adhesins (Soldati-Favre,
2008). The MIC1-4-6 complex and, in an independent complex, MIC13 are anchored to
the parasite’s membrane and are responsible for binding sialic acid, one of the most
abundant oligosaccharides that are incorporated onto cell surface glycoproteins and
glycolipids (Blumenschein et al., 2007; Friedrich et al., 2010).

Interestingly, the

widespread usage of sialylated conjugates on the cell surface throughout the animal
kingdom and in various tissues may be a reason why Toxoplasma has such a large tropism
(Schauer, 2004). For example, in addition to invading any nucleated cell in any warm
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blooded animal, T. gondii also successfully invades host cells in which the parasite cannot
survive like those of mosquitoes and fish (Buckley, 1973; Omata et al., 2005).
Immediately after the microneme ejects MIC proteins into the parasite’s membrane,
another apical secretory organelle, the rhoptry, injects its content of rhoptry neck proteins
(RON)s into the membrane of the host cell (Soldati-Favre, 2008). The microneme-derived
and parasite-anchored AMA1 interacts with the host cell-anchored RON2, forming a stable
link between parasite and host (Lamarque et al., 2011; Tyler and Boothroyd, 2011). The
RON2-4-5-8 complex serves to anchor the parasite to the host cell and, together with the
AMA1 protein, serve to act as the moving junction. Interestingly, this demonstrates that
Toxoplasma provides its own cell surface receptor in RON2 and is another indication as to
why the parasite can invade a multitude of cell types (Besteiro et al., 2011). Contrary to
other intracellular pathogens where the host cell internalizes them, T. gondii actively
invades its host. The cytoplasmic portion of AMA1, as well that of another adhesin MIC2,
interact with the parasite’s aldolase (Jewett and Sibley, 2003; Sheiner et al., 2010). In
apicomplexan parasites, in addition to serving a metabolic role, aldolase also serves as the
bridge between adhesins and the parasite’s actin cytoskeleton (Jewett and Sibley, 2003).
Through an active process dependent on Toxoplasma’s actin-myosin motor system
(Jewett and Sibley, 2003), the parasite causes an invagination of the host’s membrane and
progressively passes further into the host until it is completely internalized within the
parasitophorous vacuolar membrane.

This membrane delimits the nonfusogenic

parasitophorous vacuole and is composed of host cell lipids and a mix of parasite and
selected host cell membrane proteins (Sinai, 2008). Toxoplasma secretes proteins from its
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rhoptries (ROP)s and its dense granules (GRA)s that integrate within the parasitophorous
vacuole to control its fate within the host cell. By reorganising the host’s intermediate
filament and microtublar networks, the parasitophorous vacuole migrates towards the
nucleus where it stably associates with the endoplasmic reticulum through the action of
GRA3 and with mitochondria through a mechanism that may or may not involve the ROP2
family (Laliberté and Carruthers, 2008; Kim et al., 2008; Sinai and Joiner, 2001; Pernas
and Boothroyd, 2010).
1.5.2

Growth and replication
As an intracellular parasite, Toxoplasma must coopt the normal functioning of its

host cell for its own benefit, converting it from potentially hostile environment to one that
promotes the parasite’s growth and replication. The parasite accomplishes this through a
variety of mechanisms. For example, a decrease in host cyclin B1 causes it to arrest at the
G2/M interface while both the extrinsic and intrinsic apoptosis pathways are inhibited due
to increased expression of a variety of anti-apoptotic proteins (Brunet et al., 2008; Carmen
and Sinai, 2007). These are important because, as an intracellular parasite, T. gondii would
not be able to survive in a cell undergoing apoptosis and would undoubtedly encounter
difficulties within an actively dividing host cell. To accomplish these feats, Toxoplasma
drastically reprograms the host cell at the transcriptional level by modulating a number of
transcription factors upon infection. For example, the polymorphic kinases ROP16 and
ROP18, as well as the dense granule proteins GRA2 and GRA15 have been shown to
modulate the activities of NF-κB and the STAT family of transcription factors in a strain
specific manner (Du et al., 2014; Butcher et al., 2011; Jensen et al., 2013). Alleles of these
genes from virulent type I parasites tend to activate STATs and inhibit NF-κB while type
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II parasites do the reverse (Du et al., 2014; Butcher et al., 2011; Jensen et al., 2013).
Notably, the downstream targets of these transcription factors are varied and include cell
cycle and anti-apoptotic genes (Du et al., 2014; Butcher et al., 2011). Importantly, not just
protein coding transcripts are modified. Reports have shown that T. gondii specifically
induces the expression of certain host miRNAs, some of which are upregulated through the
activation of STAT3 and have anti-apoptotic properties (Zeiner et al., 2010; Cai et al.,
2013). Taken together, this suggests that Toxoplasma has ideally evolved to remodel the
host environment to be conducive for parasite survival and growth.
In addition to modulating the host cell environment, the parasite has developed
methods to siphon its nutritional requirements from the host cell. By promoting the
degradation of its regulatory partner through an unknown effector, Toxoplasma causes an
increase in host hypoxia-inducible-factor-1 (Wiley et al., 2010). Downstream targets of
this transcription factor include growth factors and genes that promote increased glucose
metabolism and iron uptake (Laliberté and Carruthers, 2008). Toxoplasma is auxotrophic
for the amino acids tryptophan, arginine, and serine, purines, cholesterol, certain lipids, and
small molecules such as choline and polyamines (Laliberté and Carruthers, 2008). The
host’s endo-lysosomal pathway, in conjunction with the modified microtubular network
and the activity of GRA7, is used to deliver a constant supply of lipids and cholesterol
needed for growth (Coppens et al., 2006). In addition, the parasite is able to gather small
molecules such as sugars, amino acids, nucleotides, and ions by diffusion through the
porous parasitophorous vacuole membrane (Laliberté and Carruthers, 2008). Together,
these processes satisfy not only the parasite’s nutritional needs, but also allow growth and
the rapid, efficient replication that is characteristic of tachyzoites.
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Parasite virulence is directly tied to the rapidity with which tachyzoites can complete
their cell cycle and successfully replicate (Radke et al., 2001). While all Toxoplasma
strains spend approximately 60% of the cell cycle in G1 and 30% in S phase at a genomic
content of 1.8N, virulent type I strains have an increased replication rate, completing the
entire cycle in 5-6 hours while slower growing type II tachyzoites take approximately 9
hours (Radke et al., 2001). Since the highest proportion of time is spent in G1, it suggests
that the main driving force behind the increase in virulence is the ability for the tachyzoite
to grow. Interestingly, as alluded to above, the type I allele of ROP18 correlates with
increased virulence (Taylor et al., 2006). When this allele is transformed into a type II
strain, the tachyzoites proceed through the cell cycle at an increased rate and become more
virulent in mice, thus reinforcing the necessity of remodelling the host environment for
optimal growth (Taylor et al., 2006).
Toxoplasma gondii displays a streamlined cell cycle compared to most eukaryotic
model organisms. For example, the G2 phase is absent and mitotic spindle assembly occurs
in late S phase while the parasite only has a genomic content of 1.8N, suggesting a lack of
clear delineation between S and M phases (Radke et al., 2001; Gubbels et al., 2008).
Furthermore, mitosis occurs in its entirety without the dissolution of the nuclear membrane
and with only limited chromosomal condensation (Gubbels et al., 2008).

Parasite

duplication occurs through a process of internal budding, known as endodyogeny. This
produces two immature daughter cells, each delineated by the inner membrane complex,
within the mother. The inner membrane complex is a membrane and cytoskeletal network
that serves as a scaffold for the recruitment of the nucleus and a complete organellar
complement (Ouologuem and Roos, 2014).

Shortly after receiving these, the inner
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membrane complex pinches closed and the daughters emerge from the mother, leaving
behind a residual body whose materials are recycled within the parasitophorous vacuole
(Gubbels et al., 2008). The entire process from the commencement of mitosis until the
completion of cytokinesis occurs within a matter of 35-40 minutes (Radke et al., 2001).
1.5.3

Parasite egress
In all cases, the most serious consequences of Toxoplasma gondii infection are

caused by the destruction of infected cells due to the escape of tachyzoites. Several signals
can cause egress and produce viable extracellular parasites. These can be extrinsic factors,
such as mechanical disruption of the host cell due to physical strain or from an immune
response (Blackman and Carruthers, 2013), or through parasite-driven factors. After
repeated rounds of multiplication, the parasitophorous vacuole fills with parasites. The
plant hormone abscisic acid is produced by the parasite apicoplast, serving as a quorum
sensing molecule to signal the release of intracellular calcium stores (Nagamune et al.,
2008; McCoy et al., 2012). The release of calcium activates the calcium dependent protein
kinase 3 which induces microneme secretion (McCoy et al., 2012).

The micronemes

secrete a perforin-like protein that breaks the parasitophorous vacuole membrane (Kafsack
et al., 2009). The lysis of the parasitophorous vacuole increases the concentration of
intracellular calcium in the host, activating the host protease calpain 1 which in turn
degrades the host’s cytoskeleton, facilitating parasite egress (Chandramohanadas et al.,
2009; Blackman and Carruthers, 2013). The parasites then liberate themselves from the
weakened host cell and in total, this process takes between one and ten minutes (Caldas et
al., 2007). Once extracellular, they are free to attach, invade and colonize a new host cell
to complete the lytic cycle.
23

Bradyzoites
Bradyzoites are the most important developmental phase of the parasite asexual
lifecycle. Without this stage, depending on parasite virulence and dosage, a tachyzoite
infection would either be rapidly cleared by the immune system or would illicit an
overwhelming inflammatory response in the host, ultimately leading to a rapid death.
Instead, bradyzoites provide an alternate path, serving to act as a non-immunogenic state
where the establishment of an incurable chronic infection for the life of host occurs.
Furthermore, they reportedly alter host behaviour in ways that increase host mortality,
thereby increasing the odds that they will be ingested by a predator or scavenger and
transmit the infection to a new host (House et al., 2011; Flegr, 2013). Bradyzoites have
developed a variety of adaptations that aid them in persisting long term within the host cell.
One of these includes modifying the parasitophorous vacuole into an elastic, glycoproteinrich, protective cyst wall whose integrity is crucial for tissue cyst maintenance in vivo
(Zhang et al., 2001; Tomita et al., 2013). Other classic features include a stalling of parasite
growth and replication as well as a reduction in their metabolic needs.
1.6.1

Changes to growth and metabolism
The modulation of parasite growth is an important step in the establishment of

chronic disease. If uncontrolled growth occurs, the host is unable to stem the infection and
ultimately succumbs. This is particularly demonstrated by type I parasites, who grow
rapidly, are deficient in bradyzoite development, and are considered much more virulent in
vivo than type II parasites (Radke et al., 2001; Soête et al., 1994; Sibley and Boothroyd,
1992). In contrast, parasites that successfully convert to bradyzoites exit the cell cycle in
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the G1 phase and remain non proliferative, existing solely with a 1N genomic content
(Radke et al., 2003).
Accompanying this decrease in growth and replication is a fundamental shift in
metabolism. Bradyzoites likely lack the ability to complete the tricarboxylic acid cycle and
their unique mitochondrion loses membrane potential indicating an absence of oxidative
phosphorylation (Denton et al., 1996; Toursel et al., 2000). Furthermore, along with an
upregulation of the enzymes needed for gluconeogenesis, bradyzoites are marked by the
appearance of cytoplasmic amylopectin storage granules whose presence has been
hypothesized to serve as an energy reservoir that allows them to survive the transition from
one host to another (Fleige et al., 2008; Coppin et al., 2003). Together, these metabolic
characteristics underline the importance of glycolysis in bradyzoites, where glycolytic
throughput is much greater in the functionally anaerobic bradyzoites than in tachyzoites
(Denton et al., 1996).
Interestingly, most of the enzymes involved in the glycolytic pathway are duplicated
in the Toxoplasma genome and at least some of these show differential stage expression,
enzymatic properties, and / or cellular functions between one another, suggesting
specialized adaptations between tachyzoite and bradyzoite life stages has occurred (Fleige
et al., 2007; Manger et al., 1998, Dzierszinski et al., 1999; Dzierszinski et al., 2001; Yang
and Parmley, 1997; Dando et al., 2001). For example, the bradyzoite-specific lactate
dehydrogenase (LDH) 2, which converts pyruvate to lactate and regenerates the essential
coenzyme NAD+, is much more suited to the bradyzoite environment than the tachyzoitespecific LDH1 even though they share 71% identity (Yang and Parmley, 1997). LDH2 is
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able to offer a much larger throughput of NAD+ regeneration because it is insensitive to
pyruvate concentration, whereas LDH1 displays substrate inhibition (Dando et al., 2001).
The inverse is true in the case of Toxoplasma enolases (ENO)s, where the tachyzoitespecific ENO2 displays a higher specific activity than the bradyzoite ENO1 (Dzierszinski
et al., 2001). Intriguingly, the Toxoplasma ENOs both display nuclear localization and
more recently they have been shown to act as stage-specific transcription factors or
transcriptional regulators, underlining that stage-specific adaptations are not just limited to
enzymatic functionality (Ferguson et al., 2002; Mouveaux et al., 2014).
1.6.2

Stage-specific transcriptional gene regulation
Differential gene regulation between life stages is an essential feature of any

organism that needs to adapt to a changing environment. In its infancy, studies directed
toward bradyzoite-specific gene transcriptional upregulation in Toxoplasma had only
revealed a handful of model genes, such as the heat shock protein bradyzoite antigen 1
(BAG1), and the metabolic enzymes LDH2 and ENO1 (Bohne et al., 1997; Yang and
Parmley, 1997; Dzierszinski et al., 2001). In fact, along with verifying the absence of the
tachyzoite-specific LDH1, ENO2, and SAG1 proteins, seeing the protein products of these
genes had emerged as canonical markers of successful induction of the bradyzoite stage
(Ferguson, 2004). The development and application of microarray and SAGE technologies
to the Toxoplasma transcriptome revealed many more stage-specifically regulated
transcripts (Cleary et al., 2002; Radke et al., 2005). These studies showed that upon
bradyzoite induction, a remodeling of the transcriptome occurs within the broadly defined
families of surface antigens, metabolic enzymes, cell cycle regulators, and proteins targeted
to secretory organelles (Cleary et al., 2002; Radke et al., 2005). However, it was unknown
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if bradyzoite-induced genes were upregulated transcriptionally or through post
transcriptional mechanisms, such as through a systematic increase in their mRNA half-lives
(Cleary et al., 2002; Radke et al., 2005). This question was categorically answered when
it was shown that the promoters of canonical bradyzoite-induced genes contained cis-acting
elements that were capable of inducing bradyzoite-specific developmental regulation when
inserted in the promoters of otherwise constitutively expressed genes (Behnke et al., 2008).
Furthermore, these cis-acting elements were able to selectively bind unknown nuclear
proteins, suggesting they interacted with unknown transcription factors (Behnke et al.,
2008).
Perhaps surprisingly, despite the completion of the Toxoplasma genome project and
the known importance of so called “just-in-time” transcriptional regulation to
apicomplexan cell biology, initial efforts to identify transcription factors had proved largely
unfruitful (Bozdech, 2003; Meissner and Soldati, 2005). It wasn’t until relatively recently,
when sequence-based homology searches directed against predicted DNA-binding motifs
in the Plasmodium genome were performed that a large number of plant-like AP2
transcription factors were suggested to be present and active in apicomplexan parasites
(Balaji et al., 2005). Interestingly, when studied in Toxoplasma, not only were many of the
newly identified AP2 transcription factors found to be regulated in a cell cycle dependent
manner, yet more were specifically upregulated in bradyzoites (Behnke et al., 2010).
Furthermore, these transcription factors were suggested to bind different promoter
regulatory cis-acting elements, suggesting that these factors mediate the transcription of
genes throughout progression and withdrawal from the cell cycle (Behnke et al., 2010).
More recently, it has been shown that different bradyzoite-induced AP2 family members
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can selectively induce or repress the transcription of the same subset of canonical
bradyzoite transcripts, underlining their importance in stress response and developmental
transcriptional regulation (Walker et al., 2013; Radke et al., 2013).
1.6.3

Bradyzoite differentiation in vivo
Conversion to the bradyzoite stage offers a means to the parasite to persist in the host

indefinitely, and this ability appears to be strain-specific. While the type I lineage of
parasites is more virulent and usually fatal in mouse models, type II parasites cause a much
less severe disease and readily persist as bradyzoite-containing cysts (Robben et al., 2004).
The difference between these outcomes is primarily mediated through modulation of the
host’s inflammatory response, which itself is mediated through the interaction between the
parasite and macrophages, sentinel cells that are a key component of the innate immune
system.

Upon host cell egress, type II tachyzoites infect macrophages where they

specifically induce the classical inflammatory activation pathway through the activity of
the secreted dense granule protein GRA15 (Jensen et al., 2011; Rosowski et al., 2011).
Through an unknown mechanism, GRA15 induces the phosphorylation of the IκB kinase
which in turn phosphorylates the NF-κB inhibitory protein IκB, causing its ubiquitination
and subsequent degradation (Rosowski et al., 2011). The newly freed NF-κB transcription
factor then translocates to the nucleus where it initiates the transcription of proinflammatory genes such as the cytokines tumour necrosis factor α and interleukin-12
(Rosowski et al., 2011; Robben et al., 2004). These cytokines promote Th1 cell activation
and the production of interferon γ (IFNγ) in a variety of cell types, which in turn promotes
NF-κB activation, creating a positive feedback loop that induces a robust inflammatory
response (Schroder et al., 2004).
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IFNγ has long been known to be a key mediator of bradyzoite differentiation and its
presence is essential to survival in a mouse model of type II infection (Jones et al., 1986;
Suzuki et al., 1988; Suzuki et al., 1991). Among the many downstream targets with antiparasitic activities that are upregulated by IFNγ are inducible nitric oxide synthase (iNOS)
and indoeamine 2,3 dioxygenase (Schroder et al., 2004). While the latter depletes the
intracellular environment of tryptophan, iNOS produces the reactive nitrogen intermediate
nitric oxide (NO) from arginine (Schroder et al., 2004). Toxoplasma is auxotrophic for
both of these amino acids and while their depletion could be cause for cellular stress, it is
the production of NO that is essential for long term host survival and mediates bradyzoite
differentiation (Laliberté and Carruthers, 2008; Scharton-Kersten et al., 1997; Bohne et al.,
1994). Molecular targets of NO include enzymes of the Krebs cycle, such as succinate
dehydrogenase, and the essential heme groups of the cytochromes involved in complexes
I-IV of the mitochondrial respiratory chain (Dai et al., 2013).

Notably, succinate

dehydrogenase activity is not detectable in bradyzoites and the drug atovaquone, which
specifically inhibits cytochrome b in complex III of the respiratory chain, causes bradyzoite
differentiation (Denton et al., 1996; Tomavo and Boothroyd, 1995). Together with the
observations that NO acts upon the parasite’s unique mitochondrion and that loss of
mitochondrial potential is associated with the bradyzoite differentiated state, a model
becomes apparent where type II parasites initiate the macrophage-induced production of
NO to promote their own differentiation and persistence (Bohne et al., 1994; Toursel et al.,
2000).
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1.6.4

Bradyzoite differentiation in vitro
Studying the interconversion between tachyzoite and bradyzoite is a challenging area

of research, particularly in vivo. The combination of low parasite abundance and the
complexities added by a live host background make the need for an in vitro model of
Toxoplasma infection and differentiation apparent.

Over the last few decades, a

standardization of Toxoplasma in vitro culture and differentiation methods has emerged.
For example, parasites are routinely cultured in confluent human foreskin fibroblasts
(HFF)s because Toxoplasma more easily infects monolayers than suspension cells and they
can replicate many times in this long and narrow cell type, yielding a high number of
parasites with little host cell contamination after host cell lysis (Roos et al., 1994). Also,
benefiting from the parasite-specific selectable marker hypoxanthine-xanthine-guanine
phosphoribosyltransferase (HXGPRT), it is possible to study stage-specific gene
expression in an in vitro system (Bohne and Roos, 1997).
Induction of bradyzoite differentiation in tissue culture systems was unreliable and
poorly understood in its infancy. While addition of IFNγ or sodium nitroprusside, a
chemical NO donor, to tissue culture systems induced bradyzoite formation, they only did
so at moderate rates (Bohne et al., 1993; Bohne et al., 1994). However, it had also been
shown that certain Toxoplasma lineages could spontaneously convert from tachyzoite to
bradyzoite in vitro even in the absence of immunologic factors, suggesting that the
conversion process may be activated by other signals in addition to NO (Dardé et al., 1989).
Shortly thereafter, it was revealed that a variety of chemical and physical stimuli could
induce bradyzoite development nearly completely, making it possible to reliably study the
bradyzoite stage in vitro for the first time (Soête et al., 1994). These conditions included
30

prolonged heat shock at 43°C, increased pH of culture media with concurrent CO2
reduction to atmospheric levels, or addition of the oxidative stress agent sodium arsenite
(Soête et al., 1994). Other studies have identified pyrrole- and pyrrolidine-containing
chemicals that induce differentiation through poorly characterized mechanisms (Radke et
al., 2006; Conde de Felipe et al., 2008). A systematic analysis has examined the relative
proficiency of these alternate methods of inducing bradyzoite conversion (Behnke et al.,
2008). Although the trisubstituted pyrrole, termed compound 1, appeared to be the most
efficient, increasing the pH of the media with concurrent induction of pyrimidine starvation
through the reduction of CO2 levels has emerged as the most common method for initiating
bradyzoite differentiation in vitro (Behnke et al., 2008; Bohne and Roos, 1997).
More recently, studies have focused on determining how Toxoplasma copes with a
variety of cellular stresses and how these drive the differentiation of tachyzoites towards
bradyzoites. By submitting parasites to a barrage of cellular stresses, it has been suggested
that in response to nearly any stress, Toxoplasma initiates a process of translational control
(Sullivan et al., 2004; Narasimhan et al., 2008; Joyce et al., 2010; Konrad et al., 2011;
Konrad et al., 2013a; Joyce et al., 2013; Konrad et al., 2013b). While under the effects of
this generalized translational control mechanism, stress-responsive transcripts are
prioritized for translation and this has been suggested to be the driving force behind the
tachyzoite to bradyzoite conversion (Joyce et al., 2013).
Post-transcriptional gene regulation in gene expression
Gene expression is the summation of transcriptional and post-transcriptional events
that occur to a particular transcript, as well as the collection of post-translational regulatory
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events. Transcriptional gene regulation relies on inducing, suppressing, or otherwise
modifying the amount of DNA transcription at a particular genomic locus. While this
process is widely used to control gene expression throughout different tissues,
developmental stages, and / or under different environmental conditions, transcriptional
regulation is a relatively slow process and is insufficient to rapidly and precisely modulate
gene expression when compared with the potential finesse that post-transcriptional gene
regulation (PTGR) offers (Moore, 2005; Hall et al., 2005; Mair et al., 2006). While PTGR
may more commonly be considered to consist of methods for regulating mRNA translation,
it is a more general umbrella term encompassing a variety of mechanisms that control the
expression of gene products by operating at the transcript level. Importantly, all PTGR
mechanisms rely on the interaction between cis-acting elements encoded within the
transcript and the trans-acting factors that bind and recognize them (Moore, 2005).
Together, the mRNA and the collection of RNA-binding proteins (RBP)s form the
messenger ribonucleic particle (mRNP), a dynamic complex that changes as the transcript
is shuttled from one location to the next in the cell (Moore, 2005). The components of the
mRNP at any given time dictate which biological processes the transcript will undergo at
any given time (Moore, 2005). Therefore, it is important to note that decisions made early
in the mRNA’s biogenesis directly affect its participation in downstream regulatory events
by influencing the content of its cis-acting elements and its subsequent ability to recruit
certain RBPs (Moore, 2005; Darnell, 2013). Below follows a description of mRNA
maturation and cap-dependent translation to serve as a reference point from which to build
on downstream regulatory events.
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1.7.1

mRNA maturation and nuclear PTGR mechanisms
Transcript maturation and the mechanisms of nuclear PTGR are intimately linked,

since each step in the maturation process leaves a trace on the transcript either in the form
of altered nucleotide composition and / or through deposition of RBPs at specific locations.
The first step in maturation is the co-transcriptional introduction of one of the most
universally recognizable cis-acting elements, the 5’ 7-methylguanosine cap (Topisirovic et
al., 2011). The 5’ cap is added by a 5’ to 5’ linkage to the 20-30 nucleotide long nascent
transcript through the sequential actions of the enzymes nucleotide triphosphatase,
guanylyltransferase, and N7-methyltransferase (Topisirovic et al., 2011). The 5’ cap serves
as protection from the many 5’ to 3’ exonucleases in the cell and as a key recognition point
for a variety of cap-binding proteins including the nuclear cap-binding complex (nCBC;
Topisirovic et al., 2011; Moore, 2005; Carmody and Wente, 2009).
The next major maturation event, occurring within thirty seconds of transcription, is
the addition of the 3’ poly(A) tail to the pre-mRNA (Darnell, 2013). To gain a poly(A) tail,
the cleavage and polyadenylation specificity factor first binds the encoded polyadenylation
signal and, after inducing an endonucleolytic cut, recruits nuclear poly(A) polymerase
(Gruber et al., 2014). In metazoans, this template-independent polymerase generates a tail
of between 200 to 250 adenosines which is then coated by nuclear poly(A)-binding protein
(PABP; Gruber et al., 2014). In transcripts containing multiple polyadenylation sites, the
usage of alternative polyadenylation sites plays an important role in modulating transcript
translatability and stability by mediating the inclusion or exclusion of cis-acting elements,
including potential microRNA-binding sites, within its 3’ untranslated region (UTR;
Gruber et al., 2014; Darnell, 2013). This PTGR mechanism likely occurs in many T. gondii
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transcripts. For example, the DHFR-TS 3’UTR varies in length from approximately 250 to
900 nucleotides depending on which of fourteen polyadenlyation sites is used (Matrajt et
al., 2004).
The final step to generate a mature transcript is the splicing out of introns. While
some splicing can occur while the nascent pre-mRNA is still being transcribed, the majority
occurs after RNA polymerase II has finished transcribing and polyadenylation is complete
(Darnell, 2013). Splicing of an intron involves the participation of the 5’ donor and 3’
acceptor sites, and an adenosnine branch point residue located upstream of a
polypyrimidine tract within the intron (Suvorova and White, 2014). The components of
the spliceosome are recruited through interaction with nCBC and sequentially mediate
cleavage at the 5’ donor site, lariat formation through the transesterification of the 5’ donor
site guanosine to the branch point adenosine, and the cleavage of the 3’ acceptor site with
concurrent linkage of 5’ and 3’ exons (Topisirovic et al., 2011; Darnell, 2013; Suvorova
and White, 2014). A successful splicing event yields a correct linkage between the 5’ and
3’ splice sites and the deposition of the exon junction complex (EJC) approximately 20 to
30 nucleotides upstream of each exon-exon junction (Moore, 2005; Carmody and Wente,
2009). The alternative use of splice sites is a mechanism that can be used to generate
multiple protein isoforms through the use of a single genomic locus by including or
excluding selected exons and / or introns into a mature transcript (Hassan et al., 2012).
However, alternative splicing can also be used to selectively post-transcriptionally
downregulate gene expression. For example, if an EJC is deposited onto the 3’UTR of a
transcript, it serves as a marker of an improperly spliced transcript and will signal its demise
through nonsense mediated decay in the cytoplasm (Moore, 2005). Interestingly, while
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Toxoplasma contains functional splicing machinery and over 75% of predicted genes
contain introns, few studies have examined alternative splicing as a means of PTGR
(Suvorova et al., 2013; Suvorova and White, 2014). Despite this, sporadic reports have
shown that some transcripts, including the widely used selectable marker HXGPRT are
alternatively spliced (Hasan et al., 2012; White et al., 2000).
The final step of nuclear PTGR is the export of the mature transcript to the cytoplasm
through the nuclear pore complex. In most cases, this requires the recruitment of the
transcription-export complex which, in metazoans, is indirectly recruited through the 5’ cap
and EJC deposited on spliced transcripts (Carmody and Wente, 2009). Alternatively, if a
transcript is improperly processed, it is degraded by the nuclear exosome (Carmody and
Wente, 2009). Shuttling of the mature mRNP occurs through the nuclear pore complex
likely through a 5’ to 3’ threading process and the emergent transcript can be directly
recruited to the translational machinery, even before it has entirely entered the cytoplasm
(Moore, 2005; Carmody and Wente, 2009).
1.7.2

Cap-dependent translation
The export of the mRNP from the nucleus into the cytoplasm signals a dramatic

remodeling of protein complement associated with the transcript. For example, after an
initial round of translation, the nCBC and the nuclear PABP are exchanged for their
cytoplasmic equivalents, priming the transcript for translation (Moore, 2005).

Cap-

dependent translation is the most common mode by which eukaryotic organisms initiate
protein production (Figure 1.3; reviewed in Sonenberg and Hinnebusch, 2009). Under
optimal conditions, cap-dependent translation begins with the recognition of the 5’ cap by
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a collection of eukaryotic initiation factors (eIF)s termed the eIF4F complex, which is
composed of the cap binding protein eIF4E, the DEAD-box helicase eIF4A, the eIF3interacting eIF4B, and the eIF4G scaffold (Sonenberg and Hinnebusch, 2009). Notably,
eIF4E is one of the most highly regulated proteins involved in translation and many
organisms produce multiple isoforms that can have specialized roles in certain tissues, in
developmental phases, or in stress response (Topisirovic et al., 2011; Martínez-Silva et al.,
2012). Furthermore, in certain cases, different eIF4E and eIF4G isoforms can combine to
form specialized eIF4F complexes that show transcript specificity by either favouring short
and unstructured 5’UTRs or promoting the translation of transcripts containing longer,
structured 5’UTRs (Mayberry et al., 2011; Martínez-Silva et al., 2012). Intriguingly,
Toxoplasma encodes at least two eIF4E isoforms and multiple proteins that contain
canonical eIF4G domains, however these remain uninvestigated (Xia et al., 2008).
Upon binding of the 5’ cap by eIF4F, the mRNA circularizes through the interaction
between eIF4G and PABP in the closed loop model of eukaryotic translation (Figure 1.3;
Sonenberg and Hinnebusch, 2009). This facilitates the recruitment of the pre-initiation
complex which is composed of the small 40S ribosomal subunit, eIFs 1, 1A, 3, 5, and the
ternary complex (Sonenberg and Hinnebusch, 2009). The ternary complex contains the
initiator transfer RNA, Met-tRNAi, and eIF2-GTP, which is responsible for recruiting MettRNAi to the pre-initiation complex (Sonenberg and Hinnebusch, 2009). After the preinitiation complex is recruited to the mRNA, it commences processively scanning the
5’UTR until perfect complementarity is achieved between the AUG start codon and the
anti-codon contained within the Met-tRNAi (Hinnebusch, 2011). In particularly long or
highly structured 5’UTRs, scanning is facilitated through the ATP-dependent helicase
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activity eIF4A and other helicases (Hinnebusch, 2011). Most start codons are flanked by
an adenosine three nucleotides upstream and a guanosine four nucleotides downstream of
the translational start site and if these conditions are not met a downstream AUG can be
selected as the preferred start codon in a process known as leaky scanning (Kozak, 1987;
Hinnebusch, 2011). This sequence preference is conserved in T. gondii and thought to be
important for mediating contacts between these residues and other eIFs (Seeber, 1997;
Hinnebusch, 2011). Recognition of the start codon triggers the irreversible eIF2-mediated
hydrolysis of GTP, the release of eIFs, and recruitment of the large 60S ribosomal subunit
(Sonenberg and Hinnebusch, 2009). Translation of the mRNA then proceeds through
successive rounds of translational elongation until reaching the stop codon, a termination
signal that signals for the dissociation of the ribosome.
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Figure 1.3 Eukaryotic cap-dependent translational initiation and its regulation.
An assembled eIF4F complex binds the mRNA 5’cap causing its circularization. The
pre-initiation complex is then recruited and scanning of the 5’UTR is conducted until
start codon recognition. eIF2 mediated GTP hydrolysis occurs, inducing the recruitment
of the 60S large ribosomal subunit and departure of most eIFs.

Regulation of

translational initiation occurs by phosphorylation events mediated by the TOR and eIF2α
kinases. Adapted from Sonenberg and Hinnebusch, 2007.
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Translational control and translational repression
The selective control of translation is an important regulatory mechanism for
controlling gene expression. General modes of translational control operate under stressful
conditions and permit the widespread translational repression of most transcripts while
promoting the translation of a limited number of stress-responsive transcripts. In contrast,
transcript-specific translational control selectively withdraws transcripts from the
translational pool and can be commonly seen on a case by case basis operating under
optimal growth conditions, stressful conditions, or throughout developmental phases.
However it is important to note that none of the general or transcript-specific translational
repression mechanisms are mutually exclusive.
1.8.1

Translational control mediated by target of rapamycin
In principle, the many steps of eukaryotic translation are subject to regulation,

however, the most common regulatory events control the rate-limiting steps of translational
initiation (Gastens and Fischer, 2002; Sonenberg and Hinnebusch, 2009). A key regulatory
mechanism in higher eukaryotes rests upon modulating the ability of eIF4F complex to
bind the 5’ cap, which is accomplished by the kinase target of rapamycin (TOR; Figure 1.3;
Sonenberg and Hinnebusch, 2009). In metazoans, under optimal conditions that include
the presence of mitogens and growth factors, TOR is activated by the kinase AKT which
itself is activated through PI3K (Hay and Sonenberg, 2004). TOR is responsible for either
directly or indirectly phosphorylating many components of the eIF4F complex (Hay and
Sonenberg, 2004). Through the downstream effector ribosomal protein S6 kinase, TOR
contributes to the phosphorylation of eIF4B which serves to increase the recruitment the
small ribosomal unit to the pre-initiation complex and to promote the helicase activity of
39

eIF4A, allowing for increased 5’UTR scanning (Hay and Sonenberg, 2009; Baird and Wek,
2012). Furthermore, while the phosphorylation of eIF4G has unknown consequences, that
of eIF4E-binding proteins (4E-BP)s decrease their affinity for the cap-binding eIF4E,
thereby allowing the latter to participate in the eIF4F complex (Hay and Sonenberg, 2004;
Sonenberg and Hinnebusch, 2009). In contrast, upon amino acid starvation TOR is
inactivated, reducing cap-dependent translation and causing a generalized translational
repression (Hay and Sonenberg, 2004; Sonenberg and Hinnebusch, 2009; Baird and Wek,
2012).
Interestingly, certain mRNA subsets appear to be preferentially repressed while
others are more favourably translated under TOR inactivation (Hay and Sonenberg, 2004;
Baird and Wek, 2012). The loss of functional eIF4B decreases eIF4A helicase processivity,
reducing the ability of the pre-initiation complex to scan through and melt strong secondary
structures in transcripts containing long and structured 5’UTRs (Baird and Wek, 2012).
TOR inactivation also results in the sequestration of eIF4E by hypophosphorylated 4E-BPs
and causes a global inhibition of 5’ cap recognition and translational repression (Figure 1.3;
Sonenberg and Hinnebusch, 2009; Baird and Wek, 2012). However, transcripts whose 5’
most nucleotides consist of an oligopyrimidine tract are particularly prone to TORmediated translational repression. Notably, interactions between eIF4E and the transcript
are formed through both the 7-methylguanosine cap and the first nucleotide of the transcript
and it has been suggested that eIF4E has a comparatively reduced affinity for mRNAs with
5’ terminal oligopyrimidine tracts (Topisirovic et al., 2010; Thoreen et al., 2012).
Consequently, even a mild reduction in 4E-BP phosphorylation levels can trigger a
dramatic translational reduction for these transcripts (Thoreen et al., 2012).
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In contrast, stress-induced translational activation is seen in a subset of mRNAs that
contain an internal ribosomal entry site (IRES) within their 5’UTR (Sonenberg and
Hinnebusch, 2009; Martínez-Salas et al., 2013). IRESes are cis-acting elements that are
diverse in both structure and sequence composition and are found in a variety of metazoan
transcripts whose gene products are important for mediating the stress response, such as
transcription factors (Martínez-Salas et al., 2013; Sonenberg and Hinnebusch, 2009).
When under cellular stress, context-specific IRES trans-acting factors are recruited to their
cognate IRESes and serve to stabilize and / or remodel them to promote the direct
recruitment of the translational machinery (Martínez-Salas et al., 2013). This mechanism
allows these transcripts to bypass the generalized cap-dependent translational repression
that occurs under stresses such as amino acid starvation. Interestingly, TOR has also been
shown to be responsive to amino acid starvation in Toxoplasma (Ghosh et al., 2011).
However, while it has been shown to be a key regulator in the stress-induced autophagic
loss of T. gondii’s unique mitochondrion, its influence on the two eIF4Es and role in
translational control remain unexplored (Ghosh et al., 2011; Xia et al., 2008).
1.8.2

Translational control mediated by eIF2α phosphorylation
Another stress-induced generalized translational control mechanism rests upon

limiting the amount of ternary complex available for pre-initiation complex assembly
(Sonenberg and Hinnebusch, 2009). After eIF2 hydrolyses GTP and dissociates from the
pre-initiation complex, it must have its GDP exchanged for a GTP through the action of the
nucleotide exchange factor eIF2B before being able to participate in another round of
translational initiation (Figure 1.3; Sonenberg and Hinnebusch, 2009). Various stressful
stimuli induce the phosphorylation of the eIF2α subunit and this increases its affinity for
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eIF2B, thereby turning it into a competitive inhibitor of the nucleotide exchange factor
(Sonenberg and Hinnebusch, 2009). In turn, this reduces the turnover of eIF2-GDP,
limiting the pool of ternary complex available for cap-dependent translational initiation and
causes a generalized translational repression (Sonenberg and Hinnebusch, 2009).
Phosphorylation of eIF2α occurs at position Ser51 in yeast and humans and can be
performed by one of four mammalian eIF2α kinases, depending on the particular cellular
stress (Sonenberg and Hinnebusch, 2009). The eIF2α kinases HRI, PKR, PERK, and
GCN2 are activated by low haem concentration or oxidative stress, the presence of long
double-stranded viral RNA, accumulation of unfolded proteins in the ER lumen, and amino
acid starvation, respectively (Sonenberg and Hinnebusch, 2009; Yamasaki and Anderson,
2008; Anderson and Kedersha, 2008). This mechanism is also conserved in T. gondii, with
stressful stimuli inducing phosphorylation of the cognate Ser71 through the activity of
stress-responsive eIF2α kinases (Sullivan et al., 2004). T. gondii encodes four eIF2α
kinases termed TgIF2K-A through -D (Narasimhan et al., 2008). TgIF2K-A is a homolog
of PERK and is activated during conditions causing ER stress (Narasimhan et al., 2008).
Like HRI, TgIF2K-B is activated upon oxidative stress and likely other forms of
cytoplasmic stress (Narasimhan et al., 2008). Two GCN2-like paralogues are expressed;
TgIF2K-C mediates the intracellular stress response under amino acid starvation while
TgIF2K-D acts solely during the extracellular phase of the lytic cycle (Konrad et al., 2013b;
Konrad et al., 2011; Joyce et al., 2010).
While eIF2α phosphorylation is a powerful general repressor of translation, a subset
of transcripts that contain one or a series of small open reading frames upstream of the main
start codon (uORF)s actually see their translation increased under these conditions
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(Sonenberg and Hinnebusch, 2009; Baird and Wek, 2012). Most commonly, uORFcontaining transcripts encode stress-responsive proteins such as transcription factors and
have their translation suppressed under optimal growth conditions (Sonenberg and
Hinnebusch, 2009; Baird and Wek, 2012). Under normal growth conditions, uORFs
mediate the suppression of the main protein by one of two mechanisms depending on their
number and positioning within the 5’UTR (Baird and Wek, 2012). In the first mechanism,
an out of frame uORF overlaps the main start codon (Baird and Wek, 2012). The ribosome
translates the small peptide and dissociates, having bypassed the main start codon (Baird
and Wek, 2012). In the second mechanism, a series of uORFs positioned within the 5’UTR
is used to suppress translation of the main ORF by successively promoting dissociation of
the ribosome as it passes each stop codon (Baird and Wek, 2012). In contrast, under
conditions of stress, uORF-containing transcripts benefit from the reduced amount of
ternary complex available to promote their translation (Baird and Wek, 2012). After
translating the first uORF, the small ribosomal subunit can either dissociate or resume
scanning the 5’UTR in the absence of ternary complex (Baird and Wek, 2012). Since
ternary complex is in low abundance, the scanning small ribosomal is more likely to scan
through proximal inhibitory start codons and re-initiate translation at downstream start
codons, thereby promoting translation of the main protein in these systems (Baird and Wek,
2012).
As in higher eukaryotes, generalized translational repression mediated through eIF2α
phosphorylation induces the preferential translation of a subset of stress responsive
transcripts in Toxoplasma and, if kept in a phosphorylated state either through inhibiting
its dephosphorylation or by maintaining various stressful conditions, bradyzoite
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development ensues (Yamasaki and Anderson, 2008; Joyce et al., 2013; Konrad et al.,
2013a; Sullivan et al., 2004; Narasimhan et al., 2008). Included among the subset of
preferentially translated mRNAs are bradyzoite surface antigens, heat shock proteins, and
a subset of uORF-containing AP2 transcription factors (Joyce et al., 2013). This underlines
that the stress-dependent modulation of cap-dependent translation is key to the bradyzoite
transition process by offering an interesting link between stress-induced translational
control and the extensive stage-specific transcriptional regulation known to be important
for bradyzoite development. Further research in this field will likely yield intriguing
results.
1.8.3

Transcript-specific translational repression
General translational control mechanisms can account for large changes to gene

expression in response to cellular stresses.

However, many transcripts are post-

transcriptionally regulated under optimal or stressful conditions or throughout
developmental phases through the use of specific regulatory RBPs. Although the partners
involved vary on a case by case basis, all transcript-specific regulatory mechanisms rely on
the interaction between cis-acting elements generally encoded within the 5’- or 3’UTR of
the transcript and trans-acting factors which either bind the RNA directly or through an
intermediate. At any given time, the collection and placement of trans-acting factors along
the mRNP dictate the localization, stability, and translational competency of the transcript
(Moore, 2005).
Targeting an estimated 60% of the transcriptome in humans, the microRNA
(miRNA) system is one the most widely used mechanisms to target transcripts for
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withdrawal from the translational pool within the cell (Friedman et al., 2009; Carthew and
Sontheimer, 2009). miRNAs are derived from RNA polymerase II-derived transcripts or
from spliced out intronic sequences (Carthew and Sontheimer, 2009). miRNA precursors,
which form RNA hairpins, are processed first in the nucleus by the double-stranded
ribonuclease Drosha and, after nuclear export, by the related cytoplasmic nuclease Dicer,
generating a 22 nucleotide RNA duplex with 3’ dinucleotide overhangs (Carthew and
Sontheimer, 2009). This RNA duplex is then loaded onto the ribonuclease Argonaute
(AGO), which preferentially incorporates whichever one of the two strands has weaker 5’
end base pairing (Carthew and Sontheimer, 2009). The loaded miRNA is used by AGO as
a guide to target transcripts destined for PTGR (Carthew and Sontheimer, 2009). Targeting
is mediated through the use of the miRNA’s seed sequence, consisting of nucleotides 2-8,
which binds through Watson-Crick base pairing to a generally 3’UTR located cis-acting
element on target transcript (Carthew and Sontheimer, 2009). Interestingly, approximately
40% of human transcripts have differential polyadenylation site selection which can
mediate the inclusion or exclusion of miRNA binding sites within the 3’UTR, offering a
direct link between nuclear PTGR and downstream gene regulatory events (Darnell, 2013).
Generally, the binding of AGO to a transcript has an inhibitory effect on its
translation through one of two mechanisms. If the miRNA-target interaction consists of
perfect base pairing and if the AGO isoform is catalytically active, the target transcript is
cleaved, inducing its degradation through the actions of cellular exonucleases (Carthew and
Sontheimer, 2009).

However, if the miRNA-target interaction contains base pair

mismatches outside of the seed sequence or if the AGO isoform is catalytically inactive,
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cleavage does not occur and the transcript is generally withdrawn from the translational
pool (Carthew and Sontheimer, 2009).
While the importance of miRNA-directed PTGR is well documented in plants and
metazoans, its importance in protozoan parasites as an endogenous regulatory mechanism
is only just beginning to emerge. It has recently been shown that Toxoplasma produces
many small regulatory RNAs with the characteristics of miRNAs, some of which are strainspecifically regulated, suggesting that a large number of genes are likely targeted to be
post-transcriptionally regulated (Braun et al., 2010). Also, a functional RNA silencing
machinery is expressed, however it is somewhat modified compared to most widely
characterized systems (Braun et al., 2010; Musiyenko et al., 2012). While perfect miRNAtarget matches can be cleaved by AGO, imperfect matches are also cleaved through the
actions of a Tudor nuclease, which is recruited to AGO through a methylation-dependent
mechanism (Musiyenko et al., 2012).
Many more cases of transcript-specific translational repression occur through the
direct interactions between cis-acting elements and RBPs. These act to withdraw the
transcript from the translational pool while serving as key factors in the remodeling of the
mRNP complex. One of the most commonly studied families of cis-acting elements that
mediate translational control in mammalian cells are AU-rich elements (ARE)s which
consist of overlapping AUUUA motifs (Brooks and Blackshear, 2013). Typically located
within 3’UTRs, AREs have been shown to bound by a variety of translational repressors
such as tristeraprolin (TTP) which generally induces the degradation of the transcript
(Brooks and Blackshear, 2013; Arribas-Layton et al., 2013). AREs are also capable of
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binding other factors such as the T cell internal antigen-1 (TIA1), which is an RBP involved
in the translational repression and storage of transcripts under stress (Cruz-Gallardo et al.,
2013). Furthermore, TIA1 also binds 5’oligo pyrimidine tracts, which represents a major
category of repressed transcripts upon stress-induced TOR-inactivation (Cruz-Gallardo et
al., 2013; Thoreen et al., 2012).
A large amount of research on transcript-specific translational repression has been
conducted on oocytes and the early embryogenesis stages of development. During these
stages, transcription is non-functional and all protein translation derives from stored
maternal transcripts, therefore offering an opportunity to study translational control in a
biological system without the background signal potentially generated from ongoing
transcription (Vardy and Orr-Weaver, 2007; Barckmann and Simonelig, 2013).

In

Drosophila, a key upstream regulator in the developmental gene expression cascade is the
RBP SMAUG, which binds a structural cis-acting element in the 3’UTR of its target
transcript NANOS (Vardy and Orr-Weaver, 2007; Crucs et al., 2000). This element consists
of bipartite RNA hairpins with terminal CNGGN loop motifs extending from a central stem
and underlines that RNA structure plays an important role in its function (Crucs et al., 2000;
Barckmann and Simonelig, 2013). In order to confer translational repression, SMAUG
recruits the 4E-BP CUP which competes with eIF4G in order to inhibit translational
initiation and deadenylation (Nelson et al., 2004; Vardy and Orr-Weaver, 2007).
Interestingly, the NANOS protein itself is also involved in the translational repression of
transcripts containing the nanos response element (NRE), a UC-rich element consisting of
two central UUGU motifs (Vardy and Orr-Weaver, 2007; Zamore et al., 1997).
HUNCHBACK contains a NRE within its 3’UTR and is bound by PUMILIO, a PUF family
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protein which is responsible for recruiting the other members of the NRE complex,
NANOS and BRAIN TUMOR (Vardy and Orr-Weaver, 2007). In turn, the NRE complex
recruits the deadenylation complex and d4EHP, an inhibitory cap-binding protein with high
homology to eIF4E that lacks the capacity to interact with eIF4G (Vardy and Orr-Weaver,
2007).
PUF family members have been shown to play roles as translational repressors
involved in the controlling of developmental stage progression in a variety of organisms
throughout the evolutionary tree including apicomplexan parasites (Gomes-Santos et al.,
2011). In Plasmodium female gametocytes, the PUF2 protein binds a large number of
translationally repressed transcripts, including those encoding the major ookinete surface
antigens P25 and P28, through a PUF-binding element which consists of a UGUX3-5UA
motif located in either the 5’ or 3’UTR of the target transcript (Miao et al., 2013; Braks et
al., 2008). Translational repression of these transcripts is relieved upon conversion to
zygotes, where transcription is restricted after gamete fertilization (Mair et al., 2006).
Interestingly, PUF2-mediated translational repression also acts in other stages of the
parasite’s life cycle.

Disruption of PUF2 in the salivary gland sporozoite stage of

development causes the premature translation of repressed transcripts, including
transcription factors (Miao et al., 2013). In turn, large scale alterations in the parasite’s
transcriptome occur resulting in the premature conversion to the mammalian liver stage of
the parasite while still in the mosquito (Miao et al., 2013). These changes point to
Plasmodium PUF2 serving as a master regulator of developmental progression by working
as a stage-specific translational repressor (Miao et al., 2013). Intriguingly, the Toxoplasma
PUF2 homolog, PUF1, is capable of binding Plasmodium PUF-binding elements in vitro,
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is upregulated in bradyzoites, and preferentially translated under stressful conditions,
raising the interesting possibility of it serving a similar function in mediating Toxoplasma
development (Liu et al., 2014; Joyce et al., 2013).
Fate of translationally repressed mRNAs
The translational machinery and repressor proteins remain in competition throughout
the life of the transcript since, under the right conditions, repressed transcripts can re-enter
the translational pool (Anderson and Kedersha, 2008). However, by limiting access to the
translational machinery, a translational repressor can remodel the mRNP components by
revealing novel sites on the transcript for RBP interactions and by directly promoting the
association of other RBPs involved in mediating a transcript’s turnover, long-term
maintenance, and / or sub-cellular localization (Vardy and Orr-Weaver, 2007; ArribasLayton et al., 2013; Hooper and Hilliker, 2013). Although the processes of translational
repression can be separated from its downstream fate, withdrawal from translation typically
induces the physical movement of the transcript into sub-cellular foci where they are
processed either for degradation, short-term storage, or long-term storage and maintenance
(Anderson and Kedersha, 2008).
1.9.1

Processing bodies and mRNA degradation
In many cases, RBPs that induce translational repression also promote the association

of machinery involved in the transcript’s degradation. For example, the translational
repressors TTP and PUF proteins have been shown to interact with the machinery involved
in the removal of the poly(A) tail and 5’cap (Godwin et al., 2013; Arribas-Layton et al.,
2013). Typically mRNA decay occurs in a series of steps, the first of which is the
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degradation of its poly(A) tail through the actions of the 3’ to 5’ poly(A) specific
ribonuclease or a functional equivalent (Godwin et al., 2013). Notably, this step is
reversible and while the shortening of the poly(A) inhibits the association of PABP with
eIF4G, its lengthening by a cytoplasmic poly(A) polymerase is key to re-initiation of
translation (Sonenberg and Hinnebusch, 2009; Godwin et al., 2013). Maintaining a short
poly(A) tail is a key method by which transcripts are kept in a state of translational
quiescence and the balance of tail shortening versus tail lengthening helps dictate the
translational competence throughout development (Godwin et al., 2013). Deadenylation
greatly enhances the second step in mRNA decay, the removal of the 5’ cap from the
transcript (Arribas-Layton et al., 2013). The decapping complex, consisting of DCP1 and
DCP2, catalyses the removal of a 7-methyl-GDP from the transcript, leaving a
monophosphate 5’ terminal nucleotide (Arribas-Layton et al., 2013). The decapping
machinery can be specifically recruited to transcripts through the use of RBP adaptors such
as TTP, PUF proteins, and the yeast DEAD box helicase DHH1 (Arribas-Layton et al.,
2013).
Aside from serving as recognizable components to promote translation, the 5’cap and
poly(A) tail also play an important role in protecting the transcript from the ribonucleases
present in the cell (Topisirovic et al., 2011; Nagarajan et al., 2013; Chlebowski et al., 2013).
Removal of these elements subjects the transcript to 3’ to 5’ degradation as it is threaded
into the exosome as well as to the 5’ to 3’ exonuclease activity of XRN1. These
exonucleases also act in other pathways with the exosome being responsible for degrading
transcripts through nonsense mediated decay and removing the 5’ fragment of AGO-
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cleaved transcripts while the XRN1 exonuclease degrades the 3’ fragment (Chlebowski et
al., 2013; Nagarajan et al., 2013).
In most eukaryotes, the mRNA degradation machinery is preferentially localized in
cytoplasmic foci called processing bodies (P-bodies; Anderson and Kedersha, 2008). In
metazoans, P-bodies contain a key scaffolding protein, GW182, while the decapping and
deadenylase machinery are characteristic components of P-bodies in all organisms (Moser
and Fritzler, 2010; Eulalio et al., 2007; Anderson and Kedersha, 2008). They also contain
translational repressor proteins such as PUF proteins, TTP, DHH1, and AGO while
excluding PABP and translational initiation factors (Anderson and Kedersha, 2008;
Godwin et al., 2013; Hooper and Hilliker, 2013). While P-bodies can be present under
normal growth conditions, they have been shown to increase in aggregation under stressful
conditions (Anderson and Kedersha, 2008). Interestingly, it has been suggested that the
stress-induced increase in P-body formation is a result rather than a mechanism of increased
transcript decay, as degradation proceeds unimpeded if P-body assembly is inhibited
(Anderson and Kedersha, 2008; Eulalio et al., 2007).
1.9.2

Stress granules and short term storage of transcripts
Stress granules (SGs) are cytoplasmic foci that form rapidly in response to eIF2α

phosphorylation and consist of transcripts stalled in the process of translational initiation
(Anderson and Kedersha, 2008).

While SGs and P-bodies share many components

including translational repressors like TIA1, TTP, AGO, DHH1, and SMAUG as well as
mRNA, SGs are uniquely characterized by the inclusion of PABP, various eIFs and the
small 40S ribosomal subunit consistent with its role in aggregating stalled translational
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machinery (Anderson and Kedersha, 2008). Furthermore, in contrast to P-bodies and
consistent with SGs containing primarily stalled initiation transcripts, mRNAs within SGs
are polyadenylated (Stoecklin and Kedersha, 2013).
In contrast to most other large cytoplasmic mRNP granules, the aggregation of SGs
is fairly well defined (Moser and Fritzler, 2010; Anderson and Kedersha, 2008). The
decrease in available ternary complex in response to eIF2α phosphorylation drastically
reduces the rate of translational initiation, while translational elongation and termination
proceeds unimpeded (Anderson and Kedersha, 2008). This causes the run off of translating
ribosomes and the accumulation of stalled initiation complexes (Anderson and Kedersha,
2008). The removal of the translational machinery from the transcript at this step may
allow for increased RBP interactions causing transcript-specific translational repression
(Arribas-Layton et al., 2013). Subsequently, mRNP aggregation and nucleation occurs,
likely through the actions of prion-like domains in certain RBPs, such as those seen in TIA1
and some RNA helicases (Anderson and Kedersha, 2008; Voronina et al., 2011). This
aggregation then intensifies as more RBP-mRNA and protein-protein interactions occur
(Anderson and Kedersha, 2008). Notably, the interactions mediating SG assembly are
thought to be fairly weak and SGs have been said to have a liquid-like structural fluidity,
with RBP components such as TIA1, TTP, and PABP rapidly shuttling in and out of SGs
(Voronina et al., 2011, Stoecklin and Kedersha, 2013; Moser and Fritzler, 2010; Anderson
and Kedersha, 2008). Furthermore, inhibition of translational elongation depletes SGs
formation, suggesting that the dynamic SG components are in equilibrium with the
translational machinery (Anderson and Kedersha, 2008).
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While the identity of many SG-associated RBPs is known, the identity of transcripts
that accumulate in SGs upon stress is less well established. However, studies have shown
that inclusion of transcripts within SGs is selective and mediated by cis-acting elements
(Anderson and Kedersha, 2008; Hooper and Hilliker, 2013). For example, housekeeping
transcripts are preferentially recruited to SGs while transcripts corresponding to stressresponsive genes get excluded (Anderson and Kedersha, 2008). Notably, while the latter
category consists of transcripts that are translationally permissive under stress, the former
members are translationally repressed. This has led to the theory that SGs are essential to
the relief of cellular stress by allowing stress-responsive transcripts to receive preferential
access to the limited amount of functional translational machinery (Kedersha and
Anderson, 2002; Yamasaki and Anderson, 2008).
The existence of stress-induced mRNA cyctoplasmic foci with the appearance and
characteristics of SGs has recently been found in T. gondii (Lirussi and Matrajt, 2011).
These granules appear exclusively during the extracellular phase of the parasite, are
phospho-eIF2α dependent, and contain both PABP and the Toxoplasma homolog of yeast
DHH1, but do not include AGO (Lirussi and Matrajt, 2011; Cherry and Ananvoranich,
2014). Notably, immunocytochemistry experiments have shown that both PABP and
DHH1 completely overlap the signal generated by a fluorescent oligo-dT probe (Lirussi
and Matrajt, 2011; Cherry and Ananvoranich, 2014). Another study has found granules in
extracellular parasites which are marked by the presence of the RBPs ALBA1 and ALBA2,
with both proteins also showing perfect overlap with polyadenylated mRNA (Gissot et al.,
2013).

However, these granules have a distinct perinuclear localization and co-

immunoprecipitation studies using a mix of intracellular and extracellular tachyzoites have
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shown that ALBA1 is associated with AGO as well as a host of translational machinery
(Gissot et al., 2013). Furthermore, ALBA1 has been implicated in the translational
activation of transcripts (Gissot et al., 2013). While different experimental conditions and
/ or the dynamics of the partners involved may account for these discrepancies, further
research into the composition and dynamics of stress-induced polyadenylated mRNAcontaining granules is needed.
Interestingly, the formation of mRNA-containing granules has been shown to be
important for Toxoplasma to successfully transition from the extracellular to the
intracellular environment (Lirussi and Matrajt, 2011). Extracellular tachyzoites that were
inhibited from forming mRNA-containing granules displayed reduced invasion and growth
(Lirussi and Matrajt, 2011). It was suggested that these granules served to promote the
sequestration of “intracellular” transcripts during the extracellular period, therefore giving
preference to “extracellular”-responsive transcripts and preparing for intracellular growth,
in turn increasing the fitness of the parasites (Lirussi and Matrajt, 2011). This suggests a
short-term salvage strategy is used by the parasite to selectively withdraw transcripts from
the translation pool under stressful conditions and maintain them for use in a later
developmental phase and is consistent with the hypothesized role of canonical stress
granules (Lirussi and Matrajt, 2011; Kedersha and Anderson, 2002; Yamasaki and
Anderson, 2008; Moore, 2005).
1.9.3

Germ granules and long term storage of transcripts
It has been suggested that in Toxoplasma, stress-induced generalized translational

repression provokes the degradation of translationally repressed transcripts through mRNA
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decay mechanisms (Joyce et al., 2013). While this is likely the case in the vast majority of
repressed transcripts, it raises the question as to what happens to those transcripts that lack
translational competency and yet are maintained at appreciable levels in bradyzoites, which
can lie dormant for decades before initiating stage conversion to tachyzoites.

This

observation is suggestive of a developmentally-controlled mechanism that selectively
reduces the mRNA turnover of certain transcripts while inhibiting their translation.
A common system for studying the long-term maintenance of transcripts and how
this relates to developmental cycles in eukaryotes is the oocyte and its transition to the early
zygote after fertilization (Vardy and Orr-Weaver, 2007; Barckmann and Simonlelig, 2013).
Oocytes contain a variety of specialized mRNA-containing granules, some of which are
able to stably store transcripts over the period of days to years depending on the organism
(Voronina et al., 2011; Hooper and Hilliker, 2013; Schisa, 2012). Importantly, these
transcripts appear to be recruited in a transcript-specific manner mediated by the interaction
between specific cis-acting elements and trans-acting factors (Vornonina et al., 2011;
Schisa, 2012). For example, in Drosophila, the RBP BRUNO binds the Bruno response
element in the 3’UTR of the OSKAR transcript and recruits CUP, causing its translational
repression and recruitment to germ granules, which have been implicated in long-term
mRNA storage (Vornonina et al., 2011; Barckmann and Simonelig, 2013).
Importantly, while germ granules, P-bodies, and SGs have been shown to share many
components, they are distinct entities. In contrast to SGs, germ granules do not contain
translational initiation components (Voronina et al., 2011). While germ granules may seem
more similar to P-bodies, the former contain a greater amount of transcript-specific
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translational repression machinery and does not lead to the decay of transcripts (Voronina
et al., 2011; Barkmann and Simonelig, 2013). It has therefore been suggested that germ
granules may be a functional hybrid or specialized form of SGs and / or P-bodies (Voronina
et al., 2011). Supporting this hypothesis is the fact that shared components can have
different functions in these granules. For example, while the homolog of DHH1 in
Drosophila aids in the recruitment of decay machinery in P-bodies, it is an essential
component for the stability of transcripts in germ granules and its loss leads to sterility
(Voronina et al., 2011). Also, in mouse oocytes it has been shown that GCN2 kinase is
upregulated which causes an increase in eIF2α phosphorylation that is only alleviated after
zygote formation (Alves et al., 2009). Notably, this occurs concurrently to the disruption
of germ granules and an increase in general translation (Alves et al., 2009). Taken together,
these results offer a link between generalized translational repression, germ granule
formation, and the long-term storage and maintenance of transcripts as well as between
germ granule dissolution, translational activation, and developmental progression in higher
eukaryotes.
In Plasmodium, similar mRNA-containing granules have been shown to form in
female gametocytes (Mair et al., 2006; Mair et al., 2010). It is important to note that in the
Plasmodium lifecycle, gametocytes reside in mammalian red blood cells and must wait
until they are taken up by the mosquito in order to initiate fertilization and progression into
zygotes. eIF2α is maintained in a phosphorylated state by the kinase IK4 in gametocytes
and transcripts, including the zygote-specific surface antigens P25 and P28, are maintained
in a state of translational quiescence (Zhang et al., 2012; Hall et al., 2005). Importantly,
these transcripts localize to mRNA granules contingent on a 47 nucleotide U-rich cis-acting
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element that can be located in either the 5’- or 3’UTR (Mair et al., 2006; Hall et al., 2005;
Braks et al., 2008). More recently, these elements have been shown to be bound by the
translational repressor PUF2 in vitro and notably, a PUF2 deletion mutant displayed
increased P25 and P28 steady state transcript and protein levels, suggesting that this
interaction is essential for their translational repression in vivo (Miao et al., 2013). The
maintenance of these mRNA granules depends on the Plasmodium DHH1 orthologue,
DOZI (Mair et al., 2010). Similar to metazoan germ granules, disruption of DOZI causes
the loss of stored transcripts, including P25 and P28, and the inability to develop into
zygotes after fertilization (hence the name Development Of Zygote Inhibited; Voronina et
al., 2011; Mair et al., 2010). Although a co-immunoprecipitation study failed to find an
association between PUF2 and DOZI in female gametocytes, these data would correlate
with a model very similar to that of sexual development in higher eukaryotes and led the
authors to suggest that the mRNA granules in Plasmodium female gametocytes act
specifically to store translationally repressed transcripts in anticipation of stage conversion,
similar to what is seen for maternal transcripts in the germ line of metazoans (Mair et al.,
2010).
Interestingly, it appears that this mechanism is not limited to sexual reproduction in
apicomplexan parasites. The transmission of Plasmodium from mosquitoes is also marked
by a long delay where sporozoites must wait in the mosquito salivary glands until they are
delivered to the mammalian host, where they can then enter the next developmental phase
in the mammalian liver. Salivary gland sporozoites are under a state of global translational
repression mediated by IK2-induced eIF2α phosphorylation and this stage is characterized
by polyadenylated mRNA and PABP-containing granules that are needed in order to
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maintain their developmental state (Zhang et al., 2010). Furthermore, deletion of PUF2 in
salivary gland sporozoites, which normally displays granular localization, causes the
release of translationally repressed transcripts, including those encoding transcription
factors, and premature differentiation into liver-stage parasites (Gomes-Santos et al., 2011;
Müller et al., 2011). The potential involvement of DOZI in sporozoite storage granules
remains unexplored, however its involvement may be limited since it is transcriptionally
down regulated during this stage (Müller et al., 2011).
These data are consistent with the notion that in apicomplexan parasites, select
translationally repressed transcripts are shuttled to storage granules by RBPs based on their
recognizable cis-acting elements and maintained until the commencement of the next
developmental phase. In contrast to the “just-in-time” model of transcriptional regulation,
this “store-and-go” mode of PTGR may be more favourable in certain circumstances since
it allows for more rapid translation with less energy input upon developmental transition
(Mair et al., 2006).
To date, the existence of bradyzoite-specific mRNA-containing storage granules
have not been discovered in Toxoplasma and a comprehensive list of translationally
quiescent transcripts has been impossible to generate because, although the identification
of most transcriptionally regulated transcripts are known through EST, SAGE, and
microarray experiments, a study identifying the bradyzoite proteome, which could be used
to generate such a list, has not been performed (Manger et al., 1998; Radke et al., 2005;
Cleary et al., 2002). Instead, sporadic reports throughout the literature have demonstrated
that while certain genes have their transcripts expressed at appreciable levels in both stages,
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their cognate protein is undetectable in bradyzoites. Examples include the RNA-binding
DNA repair enzyme TgDRE and the canonical tachyzoite marker LDH1 (Dendouga et al.,
2002; Yang and Parmley, 1997).

Furthermore, a transcriptional pulse-chase assay

identified a number of transcripts whose overall mRNA abundance is maintained in
bradyzoites despite reduced transcriptional activity suggesting that they are preferentially
stored (Cleary et al., 2005). These include transcripts that encode transcriptional and
translational machinery as well as the canonical tachyzoite marker SAG1 (Cleary et al.,
2005). Like LDH1, the SAG1 protein is widely used as an immunological marker to
identify the tachyzoite stage and is not present in mature bradyzoites (Ferguson, 2004).
These findings, taken together with the role of stage-dependent translational repression
suggest that, as seen in Plasmodium, a stage-specific mechanism exists in bradyzoites to
selectively store and maintain transcripts in anticipation of tachyzoite stage conversion.
Objectives
Successful tachyzoite and bradyzoite interconversion is crucial for the parasite’s
survival and for its ability to be transmitted to a new host. As such, understanding how
Toxoplasma copes during a stressful insult is an essential part of understanding its
fundamental biology. This works aims to further the investigation into the stress response
mechanism. In Chapter 2, a demonstrated anti-parasitic agent, securinine, was investigated
in an in vitro model of Toxoplasma infection. Its influence on parasite replication and
bradyzoite differentiation is outlined. Using the translationally repressed LDH1 as a model,
Chapter 3 describes the identification and characterization of a small RNA cis-acting
regulatory element that is responsible for mediating transcript-specific translational
repression in bradyzoites. Finally, Chapter 4 outlines efforts made towards identifying the
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trans-acting factors associated with the LDH1 transcript while it is undergoing translational
repression as well as generally characterizing the mechanism.
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CHAPTER II – Toxoplasma gondii: Inhibitory activity and encystation effect of
securinine and pyrrolidine derivatives on Toxoplasma growth
Introduction
Toxoplasma gondii is a widespread opportunistic pathogen of both veterinary and
human importance. In the otherwise healthy individual, the immune system keeps the
parasite in the asymptomatic dormant bradyzoite state. However, upon immune system
suppression the conversion of bradyzoites to the rapidly growing tachyzoites cause a
recurrence of acute infection which may lead to toxoplasmic encephalitis (Montoya and
Liesenfeld, 2004). The current treatment for acute toxoplasmosis calls for a combined
approach using pyrimethamine and sulfadiazine, both folate inhibitors.

In certain

circumstances, clindamycin, a protein synthesis inhibitor, may also be indicated. However,
the currently available drugs have a variety of side effects including intolerance (Montoya
and Liesenfeld, 2004). Also, resistance to some of the classical drugs of treatment has been
reported in T. gondii (Aspinall et al., 2002), as well as other apicomplexans, most notably
pyrimethamine resistant Plasmodium falciparum (Mita et al., 2009).

It is therefore

important to discover novel drugs that act upon a multitude of parasite-specific targets.
Many studies have been launched to investigate currently used drugs for their
possible uses as anti-parasitic agents. Jones-Brando et al. (2003) showed that a number of
drugs acting on the central nervous system (CNS), such as the anti-psychotics haloperidol
and olanzapine, exhibit anti-Toxoplasma activity.

Cortez et al. (2008) showed that

simvastatin, an anti-hypercholesterolemic statin, inhibits the growth of T. gondii in
macrophages in vitro. Other efforts have turned towards the active ingredients found in
traditional Chinese medicines for drug discovery (Jiang et al., 2008; Ke et al., 1990).
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One compound that has shown promise is securinine, an alkaloid produced by
Securinega suffruticosa. As reviewed by Raj and Luczkiewicz (2008), the plant is one of
the 50 basic medical plants in traditional Chinese phytotherapy and was used in the
treatment of various ailments ranging from rheumatic disease, quadriplegia, paralysis
following infectious disease, and impotence. Also, in Russia, where it was initially isolated
and used for its GABA antagonistic activity as a CNS stimulant, securinine was referred to
as a drug in the 10th Russian Pharmacopoeia-1968, although its drug registry later expired.
A previous report has shown that this compound also shows an inhibitory effect against P.
falciparum (Weenen et al., 1990). More recently, Rana et al. (2010) reported that securinine
can preferentially kill cancer cells while protecting normal cells and acts via the p73dependent apoptotic pathway.
In this study we have analysed the effects of securinine on the proliferation of T.
gondii in vitro. Moreover, 10 pyrrolidine compounds, which were synthesized from trans4-hydroxy-L-proline to complete the asymmetric total synthesis of (–)-securinine
(Dhudshia et al., 2009), have been selected for the study. Assessing their inhibitory effect,
we show that securinine and the pyrrolidine derivatives have unique properties in inhibiting
T. gondii proliferation in comparison to pyrimethamine, the classical anti-toxoplasmosis
drug.
Materials and methods
2.2.1

Host cell and parasite cultures
All experiments were carried out using human foreskin fibroblasts (HFF) that were

cultured using DMEM medium with L-glutamine and high glucose (Invitrogen, Canada),
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supplemented with 10% Cosmic calf serum (Hyclone, Logan, Utah), 0.5x antibiotic–
antimycotic (Invitrogen, Canada) in 5% CO2. Tachyzoites of T. gondii strains RHΔHX
(NIH AIDS Research and Reference Reagent Program-2857), a commonly used laboratory
strain lacking the gene hypoxanthine-xanthine-guanine phosphoribosyl transferase (Donald
et al., 1996), and 2F (ATCC-50839) were propagated in HFF grown in MEM medium with
L-glutamine (Invitrogen, Canada), supplemented with 1% dialyzed fetal bovine serum
(Hyclone) and 0.5x antibiotic–antimycotic.
2.2.2

Inhibition and cytotoxicity assays
Securinine and 10 pyrrolidine derivatives (Figure 2.1) were dissolved in DMSO to

obtain a final concentration of 1 mM. Various concentrations of these compounds (0.1–100
µM followed by 1–1000 µM if the compound showed anti-Toxoplasma activity but no host
cell cytotoxicity in the first range tested) were tested for inhibitory effects on T. gondii
proliferation using 96-well plates. Fifty freshly released 2F tachyzoites, which express βgalactosidase (McFadden et al., 1997), were inoculated onto 6/8 wells in each column. On
day 3, the β-gal substrate, chlorophenol red–β-D-galactopyranoside, was added and the
plate was incubated overnight. On the fourth day, cytotoxicity effects of tested compound
were measured in the remaining 2/8 wells per column using the MTT (3-[4,5dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) colorimetric assay as previously
described (Tominaga et al., 1999). Colour reactions in all wells were read in a Victor3
microplate reader (PerkinElmer). Experiments were performed in triplicate. DMSO
(solvent for the stock solution) was also tested for its inhibitory effect and cytotoxicity (data
not shown).

After normalizing for experimental variations and expressing data in

percentage positivity to control for individual experimental variations (Gubbels et al.,
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2003), all inhibitory concentrations (IC50) and toxic doses (TD50) were determined using
the Reed–Muench formula (Reed and Muench, 1938) and the therapeutic index (TI) was
calculated with the formula TI = TD50/IC50 (Table 2.1). Calculated partition coefficient
(clogP) and partition coefficient (logP) values were obtained using ChemDraw version
11.0 software (Cambridgesoft, Cambridge, MA).
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Group A
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Group B

4
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31
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11
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Reference
Compounds
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Figure 2.1 Securinine and 10 pyrrolidine precursors generated via the retrosynthesis of
(–)-securinine.
The pyrroldinine precursors (Dhudshia et al., 2009) are divided into groups by their antiToxoplasma activity.

The structurally unrelated pyrimethamine, the classical anti-

toxoplasmosis agent, is included for reference.
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2.2.3

Tachyzoite growth rate assessment
Both confluent HFF monolayers grown on cover-slips and freshly lysed RHΔHX

tachyzoites were harvested and incubated for one hour in the tested compound at their
respective IC50 (DMSO used as control). After the initial one hour incubation, the parasites
were allowed to infect the cover-slips and grow for either 24 or 36 h for the determination
of growth inhibition. The cover-slips were subjected to 3% paraformaldehyde fixation and
then Hoechst stained (final concentration 10 µM). For each compound, 100 vacuoles were
counted from three independent trials. Average vacuole size was determined using the
weighted average and doubling time was determined using algorithm provided by
http://www.doubling-time.com/compute.php.
2.2.4

Invasion assay
Confluent HFF monolayers were grown on cover-slips and an equal number of

extracellular tachyzoites (approximately 7.5 x 104) were incubated with parasite culture
media in the presence of selected compounds at their respective IC50 for 1 h. The parasites
were then used to infect the HFFs and allowed to grow for 24 h, after which they were fixed
and stained with Hoechst. Fifty randomly chosen microscopic fields of view were then
examined and the density of parasitophorus vacuoles per field of view was determined.
Each experiment was performed in triplicate.
2.2.5

Extracellular viability assay
Freshly lysed RHΔHX tachyzoites were pelleted and resuspended in parasite

culturing media containing the compound of interest at their respective IC50 (DMSO for
control) for 1, 2, 3, or 24 h. At each time point, tachyzoites were stained with propidium
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iodide (final concentration 1 µg/ml; Sigma Aldrich) and placed on a slide. Ten random
fields of view were chosen for each tested compound and tachyzoite viability was assessed
by propidium iodide staining.
2.2.6

Determination of parasite differentiation
To evaluate the ability of the test compounds to induce parasite differentiation,

freshly lysed RHΔHX tachyzoites were used to infect confluent HFF monolayers grown on
cover-slips in the presence or absence of tested compounds for 3 days. At least three
independent experiments were performed for each compound. Cover-slips were fixed in
3% paraformaldehyde then permeabilized with 0.25% Triton-X in PBS for 10 min and then
incubated with 5% BSA in PBS for 1 h. Cover-slips were subsequently incubated with
Dolichos biflorus lectin conjugated with FITC (Sigma Aldrich) in order to probe for the
presence of the cyst wall glycoprotein, a marker of parasite differentiation (Zhang et al.,
2001). Hoechst stain was used for localizing the nuclei of parasite and HFF. As control
conditions for the detection of differentiation and cyst wall formation, the parasite was
grown under alkali conditions (RMPI medium containing 25 mM HEPES, pH 8.3, 5%
dialyzed fetal bovine serum) and atmospheric CO2. Slides were mounted and examined
with a Leica DMIRB microscope. All images were taken with a cooled Q-Imaging CCD
camera using the Northern Eclipse software. One hundred vacuoles from each independent
experiment were examined for the presence of cyst wall glycoprotein among vacuoles
formed.
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Results and discussion
2.3.1

Cytotoxic and inhibitory effect of securinine and pyrrolidine derivatives
Ideally an anti-microbial compound should have minimal toxicity towards the host

while showing high selectivity and toxicity toward microorganisms. Therefore, we first
evaluated the cytotoxic effects of securinine and pyrrolidine derivatives on HFFs in
comparison to pyrimethamine. Using MTT assays, tested compounds showed varied
cytotoxic doses (TD50) ranging from 32 to 291 µM (Table 2.1). Securinine was less
cytotoxic (TD50 = 81 µM) compared to pyrimethamine, the reference compound (TD50 =
44 µM). Compounds 1 and 8 were the most cytotoxic with TD50 of 32 and 34 µM,
respectively, while the other compounds exhibited equal or less cytotoxicity than
pyrimethamine. Compound 21 showed the least cytotoxicity with TD50 of 291 µM with a
high standard deviation.
Using β-gal expressing 2F tachyzoites, we evaluated the anti-Toxoplasma property
of securinine and pyrrolidine derivatives. Securinine exhibited an inhibitory effect against
T. gondii proliferation with an IC50 of 9.8 µM (Table 2.1). Most of the synthetic pyrrolidine
precursors of securinine had good activity against T. gondii with IC50s in the micromolar
range. Based on their inhibitory effect, these pyrrolidine derivatives can be categorized
into four groups. Group A contains compounds 1, 3 and 8 with similar IC50 values ranging
between 3 and 6 µM. Group B includes compounds 4, 5, and 31 showing IC50 values ~30
µM. Group C, comprised of compounds 11 and 21, show IC50 values of ~60 μM. The
fourth group, Group D, made up of compounds 41 and 51, which have negative logP values,
did not show any inhibitory effect on parasite proliferation at the tested concentrations (IC50
> 100 µM). Since logP values are an indicator of physicochemical properties and reflect
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how well a compound will distribute across cell membranes (the higher logP value, the
more hydrophobic the compound; Patrick, 2009), their lack of inhibitory effect on T. gondii
proliferation could be explained by their inability to cross the host cell membrane. Notably,
the most effective compounds in inhibiting T. gondii proliferation, Group A, have the
highest calculated logP values (clogP ~5) and the lowest IC50 (~5 µM). Group C has logP
values less than 1 with IC50 > 100 µM and is the least biologically effective. The data thus
suggest that the pyrrolidine derivatives showing the most biological activity are those that
are most able to diffuse across the cell membrane.
Among the pyrrolidine compounds tested here, we found that the higher the logP
value, the lower IC50 value. However, this biological and physicochemical relationship
cannot be extended to explain the biological effect of securinine (logP = 0.54). This is
possibly due to its different structural features. Securinine, with a tricyclic structure, does
not retain the pyrrolidine structure, although it is derived from the same trans-4-hydroxyL-proline precursor (Dhudshia et al., 2009). We thus postulated that securinine inhibits the
parasite proliferation using a different mode and / or target than pyrrolidine derivatives.
To evaluate whether tested compounds show promising therapeutic properties, we
used the therapeutic index as an indicator to compare securinine and pyrrolidine derivatives
to pyrimethamine (TI of 100). All compounds tested here showed much lower therapeutic
indices than pyrimethamine (Table 2.1), suggesting that further chemical modifications
onto the structure of securinine and pyrrolidine analogs tested here are required to achieve
equivalent or better anti-toxoplasmosis activity. Securinine and Group A (compounds 1, 3
and 8) showed the best therapeutic indices (TI = ~9). Compounds 4 and 5 are stereoisomers
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and show the same TI of 3. Group C (compounds 11 and 21) showed some inhibitory effect
with variable cytotoxicity. Although these compounds are not yet suitable for a commercial
development, it is crucial to gain a better understanding of their mode of action. The
information will aid future rational drug design of anti-toxoplasmosis agents. We therefore
chose to further examine securinine as well as Group A compounds as they displayed the
highest anti-Toxoplasma activity.
Table 2.1 T. gondii inhibitory concentrations (IC50) and HFF toxic doses (TD50) of
securinine and pyrrolidine derivatives in comparison to those of pyrimethamine.
Compound
Securinine
1
3
4
5
8
11
21
31
41c
51c
Pyrimethamine

logP
0.54
5.4695b
4.8175b
2.92155b
2.92155b
4.66115b
0.48
0.45
2.64
-0.03
-0.21
2.69

IC50a
9.8 ± 1.6
3.9 ± 1.2
5.6 ± 1.6
27.4 ± 17
26.6 ± 12.2
3.9 ± 0.6
63.3 ± 8.4
60.4 ± 22.7
27.0 ± 18.5
0.4 ± 0.1

TD50a
81 ± 20
32 ± 14
54 ± 17
80 ± 2
83 ± 3
34 ± 11
84 ± 4
291 ± 268
49 ± 4
44 ± 2

TI
8
8
10
3
3
9
1
2
100

a

Values ± standard deviation.

b

Calculated logP.

c

compounds not biologically active at tested concentrations (0.1 – 100 μM).

2.3.2

Inhibitory effect of securinine and pyrrolidine derivatives on the parasite lytic cycle
During infection leading to toxoplasmosis, T. gondii tachyzoites progress through the

lytic cycle, comprised of three distinct phases: invasion of host cells, intracellular
replication, and destruction of host cells (Black and Boothroyd, 2000). The destruction of
host cells coincides with the egress of tachyzoites which remain extracellular until they
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successfully invade new host cells and begin another cycle. We therefore examined various
steps of the lytic cycle to further understand the mechanisms by which securinine and
Group A compounds affect intracellular growth.
We first examined the effects these compounds had on intracellular replication by
treating them with the compounds at their respective IC50 or DMSO as control. The
parasites were allowed to proceed for either 24 or 36 h post-infection after which they were
fixed and stained with Hoechst to allow for examination of the intracellular growth rates.
DMSO treated tachyzoites were able to replicate and give parasitophorus vacuoles
containing 2, 4, 8, or 16 parasites at 24 h post-infection (Table 2.2). Most vacuoles (63%)
contained eight parasites at 24 h post-infection, whereas at 36 h the majority (50%)
vacuoles contained 32. This indicated a doubling time of approximately 6 h. This is similar
to that observed in RHΔHX parasites grown without DMSO (Radke et al., 2001). We
therefore concluded that the solvent of choice had little effect on intracellular growth rates
and proceeded to see the effects of Group A compounds.
Pyrimethamine, securinine and Group A compounds had an inhibitory effect on
intracellular growth as can be seen by the decrease in the average vacuole size of these
compounds when compared to DMSO treatment (Table 2.2).

Compounds 1 and 8

suppressed intracellular growth the most, with the majority of vacuoles containing only two
parasites at 24 h. At 36 h, the majority of vacuoles contained eight parasites for all
compounds tested with the exception of pyrimethamine, a difference of two replicative
cycles from the DMSO control. Although all compounds showed a decrease in average
vacuole size, some were unable to decrease growth rate (as shown by doubling time) of the
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parasites. Securinine and compound 8 proved to be the most effective, increasing the
doubling time by twofold, whereas compound 3 and pyrimethamine only moderately
affected the growth rate. Interestingly, compound 1 showed little effect on doubling time
perhaps indicating that its anti-Toxoplasma effects rely primarily on an earlier step in the
lytic cycle, possibly influencing host cell invasion.
Table 2.2 Inhibition of T. gondii growth by securinine and pyrrolidine derivatives.
Compound

DMSO
Securinine
Compound 1
Compound 3
Compound 8
Pyrimethamine

a

Time
(h)
24
36
24
36
24
36
24
36
24
36
24
36

Number of parasites per vacuole (%)a
2
5
2
31
13
55
11
37
13
51
17
23
2

4
24
4
53
27
43
20
56
24
48
31
56
11

8
63
12
16
37
2
39
7
38
2
46
21
34

16
8
22

32

64

50

10

23
26

3

21

4

6
45

8

1

Average
vacuole
size
7
27
4
8
3
10
4
9
3
6
4
13

Doubling
time (h)
6
12
7
9
12
8

Averages of three trials.

We therefore examined whether extracellular tachyzoites pretreated with either
DMSO, securinine, compound 1 or pyrimethamine would impair invasion of host cells. An
equal number of extracellular tachyzoites were incubated in parasite culture media in the
presence of selected compounds at their respective IC50 for 1 h, and then used to infect HFF
monolayers. The number of parasitophorus vacuoles per microscopic field of view was
determined in order to give an indication of the parasite’s ability to infect host cells. When
treated with compound 1, the average vacuole density (0.35 ± 0.23 vacuoles per field of
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view; VPF) decreased drastically by 70% when compared to the DMSO control (1.2 ± 0.28
VPF), indicating that treatment with compound 1 impaired invasion. A moderate decrease
of about 40% was also observed in securinine (0.73 ± 0.13 VPF) and pyrimethamine (0.73
± 0.29 VPF) treatments.
A decrease in the number of vacuoles detected may either be due to a decrease in the
ability of the parasite to invade a host cell, or due to a loss of viability of extracellular
parasites during the 1 h incubation with the tested compound. We therefore examined the
effects of the above compounds on the viability of extracellular tachyzoites. Freshly
released extracellular tachyzoites were incubated in culture media in the presence of tested
compounds for various durations. Their viability was determined microscopically using
propidium iodide staining. Viable parasites are able to exclude the dye, while impaired or
dead parasites accumulate the fluorescent dye.

As shown in Table 2.3, tachyzoites

incubated with the tested compounds show similar viability as those treated with DMSO.
We concluded that securinine, compound 1 and pyrimethamine were incapable of
eliminating extracellular parasites under the tested conditions. A previous report by Camps
and Boothroyd (2001) found that pyrrolidine dithiocarbamate (PDTC), a pyrrolidinecontaining compound, was able to selectively kill extracellular T. gondii tachyzoites.
However, their results suggested that the cidal activity relied on a pro-oxidant pathway, not
related to the pyrrolidine ring. Our results support this and suggest that the primary role of
the pyrrolidine ring in the extracellular cidal activity of PDTC may simply be to increase
its hydrophobic nature, thereby facilitating crossing of the T. gondii membrane.

96

Table 2.3 Extracellular tachyzoite viability after compound treatment.

Time (h)
0
1
2
3
24

2.3.3

DMSO
91
92
83
80
35

Viability (%)
Sec
C1
82
81
86
89
77
88
78
84
37
34

Py
77
82
78
82
30

Effect of securinine and pyrrolidine derivatives on parasite differentiation
The rate of replication of intracellular parasites may be indicative of the

developmental stage of the parasite. While residing within warm-blooded animals, actively
replicating tachyzoites switch into slow growing encysted bradyzoites in response to the
immune system attack during disease progression.

Since the treatment of infected

monolayers with securinine and some Group A compounds slowed the rate of parasite
replication, we further investigated whether these compounds can induce T. gondii
differentiation. Tachyzoites were allowed to invade HFF without any pre-treatment. The
infected monolayers were then cultured in the presence of securinine or pyrrolidine
derivatives at their respective IC50 for 3 days under normal culturing conditions (1% serum,
pH 7, 5% CO2). To detect presence of a cyst wall structure, we stained infected monolayers
with FITC-labelled Dolichos biflorus lectin, which has high affinity to cyst wall
glycoproteins. As shown in Figure 3.2A, treatment with DMSO did not cause the formation
of encysted parasites (upper panel). Securinine treatment induced the formation of cyst
structures (Figure 3.2A, middle panel) similar to those observed by induction under alkali
conditions (pH 8.3, atmospheric CO2; Figure 3.2A, lower panel). We thus compared the
ability to induce differentiation by securinine to that of alkaline conditions. We detected
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that approximately the same amount of RHΔHX strain parasites can be induced to form
encysted bradyzoites under both conditions (Figure 3.2B). Interestingly, none of the Group
A compounds tested, including compound 8, which greatly decreased parasite doubling
time, induced the formation of encysted parasites under tested conditions.
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A

Hz

Dol-FITC

Phase

DMSO

Securinine

pH=8.3

B
70%

60%
50%
40%
30%
20%
10%
0%
DMSO pH=8.3

Sec

C1

C3

C8

Py

Figure 2.2 Securinine causes bradyzoite differentiation in vitro.
RHΔHX tachyzoites were incubated for 3 days with selected compounds or in alkaline
media. They were then stained with Hoechst (Hz) and with a cyst-specific FITCconjugated lectin (Dol-FITC) and microscopically examined for bradyzoite formation.
(A) Visual comparison of tachyzoites treated with DMSO, securinine or alkaline media
for 3 days. Scale bar equals 10 μm. (B) Differentiation rates of RHΔHX parasites
incubated for 3 days in selected compounds. Sec, securinine; C1, compound 1; C3,
compound 3; C8, compound 8; Py, pyrimethamine.
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Conclusion
We have shown that securinine, a widely used alkaloid in traditional Chinese
medicines, is useful as an anti-Toxoplasma agent that induces bradyzoite formation in vitro.
Interestingly, Rana et al. (2010) have recently shown that securinine is also able to
selectively kill p53 deficient colon cancer cells. As an agent able to act upon the CNS (Raj
and Luczkiewicz, 2008), securinine may have potential in cancer patients who have been
previously infected with T. gondii.

Upon immune suppression from chemotherapy

treatment, bradyzoites residing in the CNS may convert to tachyzoites, leading to
toxoplasmic encephalitis (Montoya and Liesenfeld, 2004). The addition of securinine to
the chemotherapy mix may assist in both fighting the cancer and maintaining T. gondii in
the dormant bradyzoite state.
In addition to securinine, we also examined 10 synthetic precursors from the
synthesis of (–)-securinine. Although these pyrrolidine derivatives show varying potential
as anti-Toxoplasma agents, they do offer important information in the development of
future anti-toxoplasmosis compounds. Their activity seems to correlate best to their
hydrophobicity. However, Group A compounds inhibit T. gondii proliferation at different
steps of lytic cycle. Compound 1 reduces T. gondii proliferation by limiting its invasion of
host cells. Compounds 3 and 8 slow down the intracellular growth rate of T. gondii without
inducing bradyzoite differentiation. These compounds show promise as a starting point
from which to work forward in the development of novel invasion and growth inhibitors of
T. gondii.

100

Works cited
Aspinall TV, Joynson DH, Guy E, Hyde JE, Sims PF. (2002). The molecular basis of
sulfonamide resistance in Toxoplasma gondii and implications for the clinical management
of toxoplasmosis. The Journal of Infectious Diseases. 185(11): 1637-43.
Black MW, Boothroyd JC. (2000). Lytic cycle of Toxoplasma gondii. Microbiology and
Molecular Biology Reviews. 64(3): 607-23.
Camps M, Boothroyd JC. (2001). Toxoplasma gondii: selective killing of extracellular
parasites by oxidation using pyrrolidine dithiocarbamate. Experimental Parasitology.
98(4): 206-14.
Cortez E, Stumbo AC, Oliveira M, Barbosa HS, Carvalho L. (2008). Statins inhibit
Toxoplasma gondii multiplication in macrophages in vitro. International Journal of
Antimicrobial Agents. 33(2): 185-6.
Dhudshia B, Cooper BF, Macdonald CL, Thadani AN. (2009). The asymmetric total
synthesis of (–)-securinine. Chemical Communications (Cambridge, England) 4: 463-5.
Donald RG, Carter D, Ullman B, Roos DS. (1996). Insertional tagging, cloning and
expression

of

the

Toxoplasma

gondii

hypoxanthine-xanthine-guanine

phosphoribosyltransferase gene: use as a selectable marker for stable transformation. The
Journal of Biological Chemistry. 271(24): 14010-9.
Gubbels MJ, Li C, Striepen B. (2003). High-throughput growth assay for Toxoplasma
gondii using yellow fluorescent protein. Antimicrobial Agents and Chemotherapy. 47(1):
309-16.
Jiang JH, Jin CM, Kim YC, Kim HS, Park WC, Park H. (2008). Antitoxoplasmosis effects
of oleuropein isolated from Fraxinus rhychophylla. Biological & Pharmaceutical Bulletin.
31(12): 2273-6.

101

Jones-Brando L, Torrey EF, Yolken R. (2003). Drugs used in the treatment of
schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii.
Schizophrenia Research. 62(3): 237-44.
Ke OY, Krug EC, Marr JJ, Berens RL. (1990). Inhibition of growth of Toxoplasma gondii
by qinghaosu and derivatives. Antimicrobial Agents and Chemotherapy. 34(10): 1961-5.
McFadden DC, Seeber F, Boothroyd JC. (1997). Use of Toxoplasma gondii expressing
beta-galactosidase for colorimetric assessment of drug activity in vitro. Antimicrobial
Agents and Chemotherapy. 41(9): 1849-53.
Mita T, Tanabe K, Kita K. (2009). Spread and evolution of Plasmodium falciparum drug
resistance. Parasitology International. 58(3): 201-9.
Montoya JG, Liesenfeld O. (2004). Toxoplasmosis. Lancet. 363(9425): 1965-76.
Patrick GL. (2009). An Introduction to Medicinal Chemistry, fourth ed. Oxford University
Press, New York.
Radke JR, Striepen B, Guerini MN, Jerome ME, Roos DS, White MW. (2001). Defining
the cell cycle for the tachyzoite stage of Toxoplasma gondii. Molecular and Biochemical
Parasitology. 115(2): 165-75.
Raj D, Luczkiewicz M. (2008). Securinega suffruticosa. Fitoterapia. 79(6): 419-27.
Rana S, Gupta K, Gomez J, Matsuyama S, Chakrabarti A, Agarwal ML, Agarwal A,
Agarwal MK, Wald DN. (2010). Securinine induces p73-dependent apoptosis
preferentially in p53-deficient colon cancer cells. FASEB Journal. 24(6): 2126-34.
Reed LJ, Muench H. (1938). A simple method of estimating fifty percent endpoints. The
American Journal of Hygiene. 27(3): 493-9.
Tominaga H, Ishiyama M, Ohseto F, Sasamoto K, Hamamoto T, Suzuki K, Watanabe M.
(1999). A water-soluble tetrazolium salt useful for colorimetric cell viability assay.
Analytical Communications. 36(2): 47-50.
102

Weenen H, Nkunya MH, Bray DH, Mwasumbi LB, Kinabo LS, Kilimali VA, Wijnberg
JB. (1990). Antimalarial compounds containing an alpha, betaunsaturatedcarbonyl moiety
from Tanzanian medicinal plants. Planta Medica. 56(4): 371-3.
Zhang YW, Halonen SK, Ma YF, Wittner M, Weiss LM. (2001). Initial characterization of
CST1, a Toxoplasma gondii cyst wall glycoprotein. Infection and Immunity. 69(1): 501-7.

103

CHAPTER III – Sustained translational repression of lactate dehydrogenase 1 in
Toxoplasma gondii bradyzoites is conferred by a small regulatory RNA hairpin
Introduction
Toxoplasma gondii is an obligate intracellular parasite of the phylum Apicomplexa.
It infects warm blooded animals with world-wide distribution and is estimated to infect up
to a third of people (Pappas et al., 2009; Lafferty, 2006). In intermediate hosts, T. gondii
exists as one of two haploid stages, the rapidly growing tachyzoite or the dormant
bradyzoite. Tachyzoites are generally eliminated by the host’s immune system or drug
therapy. Under stressful conditions caused by the induction of the immune response,
tachyzoites convert into encysted bradyzoites (Skariah et al., 2010). The presence of
encysted bradyzoites is responsible for a chronic infection and is generally non-responsive
to the immune system and drug treatments (Moreno and Li, 2008). If a chronically infected
host becomes immunocompromised, bradyzoites can reconvert to tachyzoites and cause
serious illness (Montoya and Liesenfeld, 2004).
Gene expression is highly regulated throughout the different stages of the
Toxoplasma life cycle. Determining the mechanisms by which genes are differentially
regulated between tachyzoites and bradyzoites will aid in gaining a better understanding of
the conversion process. Previous work on transcriptional regulation in Toxoplasma has
shown that a variety of genes are controlled through stage-specific promoters (Saksouk et
al., 2005; Behnke et al., 2008). Research aimed at understanding post-transcriptional
regulation has suggested that controlling the translational competency of transcripts is
equally important for regulating gene expression, particularly in bradyzoites.

The

mechanisms controlling translational competency under stressful conditions are crucial for
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modulating the survival of parasites within the host and the prognosis of toxoplasmosis
(Konrad et al., 2013).
Previous studies have demonstrated that a global translational repression (TR) is
induced in Toxoplasma in response to stressful conditions. These conditions include being
in the extracellular environment and being subjected to environmental changes that induce
differentiation into bradyzoites, examples of which include amino acid starvation and
accumulation of unfolded proteins (Joyce et al., 2010; Narasimhan et al., 2008; Konrad et
al., 2013; Joyce et al., 2013). The global TR also persists throughout the bradyzoite stage
and has been thought to aid in the preferential translation of stress-response proteins
(Narasimhan et al., 2008; Joyce et al., 2013; Sullivan et al., 2004). Regulation of the global
TR response in Toxoplasma relies on the phosphorylation of eukaryotic initiation factor 2
(eIF2) by eIF2 kinases A-D (Narasimhan et al., 2008; Konrad et al., 2013; Konrad et al.,
2011). Phosphorylation by eIF2 kinases also occurs in other organisms under stressful
conditions (Sonenberg and Hinnebusch, 2009). Phosphorylated eIF2 has a greater affinity
for its nucleotide exchange factor eIF2B, limiting the ability of eIF2B to maintain a pool
of functional eIF2 (Sonenberg and Hinnebusch, 2009). This in turn causes a general
decrease in protein translation by reducing translational initiation (Sonenberg and
Hinnebusch, 2009).
Successful implementation of the global TR response is necessary for the parasite to
cope with changes to its environment by allowing the remodeling of its transcriptome. This
occurs through two complementary mechanisms. First, a subset of mRNAs is preferentially
translated (Joyce et al., 2013). These transcripts correspond primarily to stress-response
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proteins and transcription factors which probably induce the transcription of a variety of
stress-responsive downstream targets (Joyce et al., 2013). This subset of translationally
permissive transcripts has been suggested to be preferentially translated due to the presence
of upstream open reading frames within their 5’ untranslated regions (UTRs; Joyce et al.,
2013). The second mode by which the transcriptome is remodeled is by removing
unneeded transcripts from the translation pool. Many repressed transcripts are probably
degraded through standard mRNA decay and turnover (Joyce et al., 2013). Interestingly,
in bradyzoites some translationally silent transcripts such as lactate dehydrogenase 1
(LDH1) are maintained (Yang and Parmley, 1997), indicating that another mechanism is
acting to selectively withdraw transcripts from the active translation pool and maintain
them in a sustained TR throughout stress. This mechanism would allow translationally
permissive transcripts access to the limited supply of functional translation machinery
(Yamasaki and Anderson, 2008).
It is currently unknown how repressed transcripts are directed for sustained TR in
Toxoplasma bradyzoites. The process of storing quiescent transcripts that are needed for
the transition between developmental phases is highly conserved across species (Kronja
and Orr-Weaver, 2011). In animals for example, transcription is inhibited during late
meiosis throughout the initial stages of embryogenesis (Kronja and Orr-Weaver, 2011).
Production of new proteins necessary for driving the cell cycle is tightly controlled and
relies on the translational activation of previously stored maternal transcripts (Kronja and
Orr-Weaver, 2011). In Plasmodium female gametocytes, sustained TR plays a critical role
in the maintenance of genes necessary for the transition to zygote. This activity is achieved
by the presence of recognizable RNA sequences within these transcripts that are bound by
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TR-promoting proteins (Mair et al., 2006; Miao et al., 2013). The widespread conservation
of this regulatory system suggests that any transcripts that undergo sustained TR in
Toxoplasma bradyzoites, such as LDH1, are necessary for the reconversion to tachyzoites
upon relief of stress.
Other well characterized examples of transcript-specific TR-inducing mechanisms
include the targeting of transcripts through the miRNA pathway and through the binding
of a variety of regulatory cis-acting elements by corresponding RNA binding proteins that
act to inhibit translation (Sonenberg and Hinnebusch, 2009). Since there is a large
heterogeneity in cis-acting elements and RNA binding proteins, they likely function
through different mechanisms to achieve a similar result.

However, all of these

mechanisms share in common the ability to distinguish transcripts through the
identification of recognizable cis-acting elements, indicating that an RNA-centric view
must be taken to study sustained TR. In this study, we sought to determine if cis-acting
elements could be responsible for the specific targeting of a transcript for sustained TR in
Toxoplasma bradyzoites.
The gene encoding LDH1 is unique and suitable for this study because it is one of the
only experimentally verified post-transcriptionally regulated genes in bradyzoites (Yang
and Parmley, 1997). While the LDH1 protein is present only in tachyzoites, its mRNA is
present in both tachyzoites and bradyzoites at similar levels (Yang and Parmley, 1997),
strongly suggesting a sustained TR mechanism is at play. Furthermore, it has been shown
that this regulation is mediated through the sequences flanking the LDH1 coding sequence
(Yang and Parmley, 1997). We hypothesized that the regulation of LDH1 is mediated
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through a regulatory cis-acting element located in one or both its UTRs that is capable of
specifically conferring sustained TR. In this study, we examined the flanking sequences of
LDH1 and found a 40 nucleotide element located within its 151 nucleotide 5’UTR. This
cis-acting element, termed the K45–85 element, is capable of conferring sustained TR in a
heterologous context to transcripts that normally do not exhibit stage-specific regulation.
Furthermore, this element requires the formation of a small regulatory RNA hairpin for its
activity. These results offer insight into the wider capability of Toxoplasma to selectively
distinguish transcripts and target them for sustained TR under stressful conditions.
Materials and methods
3.2.1

Host cell and parasite culturing conditions
Human foreskin fibroblasts (ATCC: SCRC-1041) were grown to confluency in

DMEM medium (Invitrogen, Ontario, Canada) supplemented with 10% cosmic calf serum
(Hyclone, Utah, USA) and 0.5x antibiotic-antimycotic (Invitrogen) at 5% CO2. Confluent
monolayers were infected with the type II T. gondii strain PLKΔHX (NIH AIDS program,
Division of AIDS, NIAID, cat#2860; Roos et al., 1994; Pfefferkorn and Borotz, 1994)
which were grown for 24 h or 5 days under tachyzoite or bradyzoite culturing conditions
respectively. Tachyzoites were grown in MEM medium (Invitrogen) supplemented with
1% dialysed fetal bovine serum (Hyclone) and 0.5x antibiotic-antimycotic at 5% CO2.
Bradyzoites were grown at ambient CO2 levels in alkaline RPMI medium (Invitrogen)
supplemented with 5% dialysed fetal bovine serum and buffered with 50 mM HEPES (pH
8.2). Freshly lysed parasites were transformed by electroporation with purified plasmids
using a previously established protocol (Roos et al., 1994). Transformed parasites were
selected with tachyzoite culture medium containing 20 µg∙ml-1 mycophenolic acid and 50
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µg∙ml-1 xanthine. Stable transgenic clonal lines were obtained by isolating single plaques
following serial dilution of transformed cultures in 96-well plates.
3.2.2

Plasmid construction

3.2.2.1 Whole UTR constructs
All plasmids created in this study are modified from pTUBmycGFP_HX (Hettmann
et al., 2000). This construct, termed pCTRL for this study, contains the α-tubulin TUB8
promoter and 5’UTR upstream of the GFP coding sequence followed by the SAG1 3’UTR
(Table 3.1). LDH1 (TGME49_032350) upstream (600 bp containing the promoter and
5’UTR) and downstream (780 bp containing the 3’UTR) flanking regions were obtained
by PCR. See Appendix A for a list of oligonucleotides. Constructs containing the flanking
regions were created by digesting the relevant PCR fragments and pCTRL with either KpnI
and HindIII or PacI and BamHI to form compatible ends and to remove TUB8- or SAG1related sequences from the vector followed by gel purification and ligation. The construct
consisting of GFP flanked by both upstream and downstream LDH1 regions was termed
p53L1 because it contains of the 5’ and 3’UTRs of LDH1 (Table 3.1). Similarly in p5L1,
GFP is flanked 5’ by LDH1 while in pT3L1 GFP is flanked with LDH1 sequences 3’ while
maintaining the TUB8 promoter and 5’UTR (Table 3.1).
The pT5L1 construct was created by digesting p53L1 with EcoRI and PstI to excise
the fragment consisting of the LDH1 5’UTR to the distal end of the GFP coding sequence.
This was ligated into EcoRI / PstI digested pCTRL. This construct therefore is a fusion of
the TUB8 and LDH1 5’UTRs where the TUB8 promoter was used to drive the
transcriptional unit (Table 3.1).
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Table 3.1 Outline of sequences flanking selected GFP reporter constructs.
CTRL
P53L1
P5L1
PT3L1
PT5L1
PT5L1:ΔXX-XXa
PT5L1:K45-85
PGRA:CTRL
PGRA:K45-85
1

a

Promoter
TUB8
LDH1
LDH1
TUB8
TUB8
TUB8
TUB8
GRA1
GRA1

5'UTR
TUB8
LDH1
LDH1
TUB8
TUB8-LDH1
TUB8-LDH1(truncated)
TUB8-LDH1(segment)
GRA1
GRA1-LDH1(segment)

3'UTR
SAG1
LDH1
SAG1
LDH1
SAG1
SAG1
SAG1
SAG1
SAG1

XX represents nucleotides deleted from LDH1 5’UTR.

3.2.2.2 5’ UTR fragment constructs
Deletion mapping of the LDH1 5’UTR was done using pT5L1 as a template.
Oligonucleotides (Appendix A) were designed to anneal within the LDH1 5’UTR back to
back (omitting the segment to be deleted) and to introduce an AfeI restriction site at the
deletion site for screening purposes.

PCR amplification was performed as per the

manufacturer’s instructions (Phusion High Fidelity, Thermo Scientific, Ontario, Canada)
followed by phosphorylation and ligation of PCR products.
Constructs designed to test for the effectiveness of selected 5’UTR cis-acting
elements were termed pT5L1:K106–151 and pT5L1:K45–85 because they keep the
fragment consisting of nucleotides 106-151 or 45-85 and 133-151 respectively and were
made from the pT5L1 background (Table 3.1). Briefly, pT5L1:K106–151 was made by
deleting nucleotides 2-105 of the LDH1 5’UTR in pT5L1 while pT5L1:K45–85 was made
by deleting nucleotides 86-132 from pT5L1:Δ2-44 using the process described above. See
Appendix A for oligonucleotide combinations.
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Constructs where the TUB8 promoter and 5’UTR were replaced with corresponding
GRA1 (TGME49_070250) fragments were termed GRA:K45–85 and GRA:CTRL where
K45–85 and CTRL correspond to above acronyms (Table 3.1). Briefly, 610 bp of the
upstream region of GRA1 was selectively amplified from PLKΔHX genomic DNA by PCR
using oligonucleotides “gra1_upstrm_fw” and “gra1_upstrm_rv” (Appendix A). This
region has been shown to be effective for driving expression (Messina et al., 1995).
pT5L1:K45–85 and pCTRL vectors and the GRA1 PCR fragment were digested with KpnI
and EcoRI to excise TUB8-related sequences and generate compatible ends followed by
ligation.
3.2.3

pT5L1:K45–85 mutational analysis
The LDH1-derived sequences from the pT5L1 5’UTR were assessed for predicted

secondary structures using the Mfold webserver located at http://mfold.rna.albany.edu/
(Zuker, 2003). Oligonucleotides were designed back to back against predicted stems in
order to introduce mutations that either disrupt or restore predicted hairpins as well as to
introduce restriction endonuclease sites to allow for plasmid screening (See Appendix A
for oligonucleotide list). Plasmids were created in a similar fashion as described above
using pT5L1-K45:85 as a template.
3.2.4

Western blot analysis
One million parasites of freshly released tachyzoites or bradyzoite-infected

monolayers were harvested and lysed in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). Protein samples were resolved on a
10% SDS/PAGE gel. After transfer to a nitrocellulose membrane, blots were blocked in
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5% milk for 1 h and probed with α-LDH1 (1:2000; a gift from Dr. Parmley, Palo Alto, CA,
USA), α-BAG1 (1:250; a gift from Dr. Weiss, Albert Einstein College, NY, USA), α-GFP
(1:2500; Rockland, PA, USA) or α-TUB (12G10, 1:1000; DSHB, IA, USA). Blots were
then probed with horseradish-peroxidase-conjugated α-rabbit (1:20 000), α-mouse (1:10
000) or α-goat (1:10 000) secondary antibodies as appropriate. Chemiluminescent signals
were visualized on an Alpha-Imager system. Densitometry measurements were obtained
from at least three independent blots using the ImageJ software (version 1.42q). A blot was
performed using a serially diluted tachyzoite sample and probed with α-TUB to assess the
linear range for densitometric analysis (data not shown). A one tailed Student t test
assuming unequal variances was performed using the data analysis package available
through Microsoft Excel 2007.
3.2.5

Quantitative RT-PCR
RNA was isolated from freshly released tachyzoites or bradyzoite-infected

monolayers using the guanidium isothiocyate-based method according to the
manufacturer’s instructions (BioBasic, Ontario, Canada). Isolated RNA (approximately 15
µg) was resuspended in DEPC-treated H2O and 20 mM ribonucleoside vanadyl complexes
(NEB, Ontario, Canada) and treated with 1 unit of DNase for 30 minutes at 37°C. Treated
RNA samples were then run on a 1 % agarose gel to ensure integrity and complete genomic
DNA digestion. The reverse transcriptase reaction was completed as per manufacturer’s
instructions (M-MLV; BioBasic, Ontario, Canada) with the exception of dNTPs being
present in the reaction mixture at 2 mM. A negative control reaction excluding reverse
transcriptase was also performed (NoRT). Real-time RT-PCR was conducted on the
StepOne

Plus

system

(ABI,

Ontario,

Canada)

using SyBR

green

reagents
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(KapaBiosystems, Ontario, Canada) as per manufacturer’s instructions. All tachyzoite and
bradyzoite samples were run in technical triplicates and LDH1, GFP, and BAG1 signals
were normalized using the Δ(ΔCt) method against GAPDH. NoRT reactions were run in
conjunction to ensure lack of carry-over DNA contamination.

The complete

oligonucleotide list is given in Appendix A. Relative mRNA amounts were determined
from three independent biological replicates and a two tailed Student t test assuming
unequal variances was performed using the data analysis package available through
Microsoft Excel 2007.
3.2.6

Fluorescence microscopy
Human foreskin fibroblasts grown to confluency on coverslips were infected with

clonal transgenic parasites and allowed to grow under either tachyzoite or bradyzoite
culturing conditions for the allotted time. The infected monolayer was then fixed in 3%
paraformaldehyde. After DNA staining with 10 µM Hoechst (Invitrogen), coverslips were
mounted on slides and infected monolayers were visualized with a Leica DMIRB inverted
microscope. All images were taken with a cooled Q-Imaging CCD camera using the
Northern Eclipse software (Image Scanning Technology, Ontario, Canada). Images were
processed for publication using Adobe Photoshop software (version 7.0).
3.2.7

Relative GFP fluorescence measurement and analysis
GFP-expressing parasites were measured for their relative fluorescent intensity

(RFI), determined by the formula RFI = (Iv/Ib) – 1 where Iv and Ib are the average intensity
readings for vacuoles and the background respectively as determined by the Northern
Eclipse measurement function. This formula allows for the GFP fluorescent signal to be
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expressed as a function of the endogenous background signal, thereby minimizing any
interference due to local background fluorescence variations. At least 100 vacuoles in each
life stage were measured for each clone. Between three and seven clones were analyzed
for each construct with no fewer than 300 counts per life stage per construct. For each
clone, the distribution of tachyzoite measurements was normalized to have a mean count
of 100% expression while the corresponding bradyzoite counts were expressed as a
function of cognate tachyzoite readings. For each construct, the descriptive statistics
function available in the Microsoft Excel 2007 Data Analysis pack was used to calculate
the population means of tachyzoite and bradyzoite samples (xTz and xBz, respectively) as
well as their variances (σTz2 and σBz2, respectively). In order to assess the percent change
between tachyzoite and bradyzoite samples, the margin of error of the difference between
the two means (xTz - xBz) was assessed at a confidence interval of 99.9% using a two tailed
z test. The standard deviation of this distribution was calculated using the formula σTz-Bz =
√[(σTz2/nTz) + (σBz2/nBz)] where nTz and nBz represent the tachyzoite and bradyzoite sample
size, respectively. To assess the statistical significance of a decrease of xBz in relation to
xTz, a one tailed z test was performed with α = 0.001.
Results
3.3.1

LDH1 is translationally repressed in bradyzoites
The post-transcriptional regulation of LDH1 is likely performed though a sustained

TR mechanism, defined here as the sustained inhibition of translation and the maintenance
of the transcript throughout the bradyzoite stage. To address whether the sequences
flanking the LDH1 coding sequence were able to confer bona fide TR, we adopted a system
in which a green fluorescent protein (GFP) reporter was flanked upstream and downstream
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by LDH1-derived sequences which encompass its promoter, 5’UTR, and 3’UTR. This
transgenic parasite strain was named P53L1 (Table 3.1, Figure 3.1A). We compared the
expression profile of this parasite to a control GFP reporter flanked by non-related
sequences (CTRL; Table 3.1, Figure 3.1A; Hettmann et al., 2000). A previous study has
shown that a CAT reporter flanked upstream by tubulin-related sequences and downstream
by SAG1 did not display stage-specific regulation (Bohne et al., 1997).
The transgenic parasite strains were analysed for their reporter expression in
tachyzoites and bradyzoites. While the CTRL showed a small non-statistically significant
decrease, GFP protein expression was markedly reduced in bradyzoites to 28% ± 22% that
of tachyzoites in P53L1 (Figure 3.1B). The reduction of GFP mirrors the large decrease
seen in endogenous LDH1 (94% ± 5%; Figure 3.1B) and is in accordance with observations
from Yang and Parmley that a CAT reporter flanked on either side by LDH1-derived
genomic segments yielded a decrease of 70% signal in bradyzoites (Yang and Parmley,
1997). This may reflect the maximal achievable reduction in reporter expression when
flanked by LDH1-derived genomic sequences. Notably, although efforts were made to load
each lane in the western blot with the same number of parasites, a consistent decrease in
tubulin (TUB) signal was observed in bradyzoites (Figure 3.1B). While it could be argued
that this may represent an effect of general TR due to eIF2α phosphorylation, the specific
LDH1 and GFP decreases seen when normalized to TUB suggest rather that variation in
TUB signal is probably due to variation in accurate parasite loading.
The steady state levels of LDH1 and GFP mRNA were also analysed in the parental
PLKΔHX and transgenic lines. While PLKΔHX bradyzoites showed a 35% decrease in
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LDH1 mRNA, it was not significant (P ≥ 0.01; Figure 3.1C). In the tested reporter
constructs, GFP transcripts were maintained in tachyzoites and bradyzoites at similar levels
(± 10%; Figure 3.1C). Notably, all bradyzoite samples were shown to express BAG1
mRNA and protein, a marker of the bradyzoite stage (Figure 3.1B,C) thus confirming in
vitro stage conversion.

Taken together, these results confirm that LDH1 is post-

transcriptionally regulated through a sustained TR mechanism.
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Figure 3.1 Post-transcriptional regulation of LDH1 and GFP reporter constructs.
(A) Graphical representation of P53L1 and CTRL reporter constructs. (B) Western blot
and densitometry analysis of LDH1 and GFP protein expression in tachyzoites and
bradyzoites. Relative LDH1 and GFP expression levels as measured by densitometry
were normalized against α-TUB levels and converted relative to tachyzoite values.
Values were obtained from at least three independent experiments. BAG1 was probed
as verification of successful bradyzoite differentiation. (C) Relative quantification of
mRNA expression of LDH1, GFP and BAG1 in tachyzoites and bradyzoites of selected
clones. Expression levels were obtained via the Δ(ΔCt) method and normalized against
the internal control, GAPDH. Values were obtained from at least three independent
experiments. Bars reflect normalized mean ± standard deviation. Dark bars, tachyzoites;
light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 0.01.
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3.3.2

LDH1 sustained translational repression is mediated through its 5’UTR
To assess whether the upstream or downstream flanking region of LDH1 is

responsible for conferring TR, we constructed two additional transgenic strains named
P5L1 and PT3L1 (Table 3.1) with the goal of determining which flanking region was
responsible for conferring post-transcriptional regulatory effects. These strains, along with
P53L1 and CTRL, were evaluated by fluorescent microscopy and their relative GFP
expression was quantified as a function of normalized GFP fluorescent signal (Figure 3.2A,
B). In both CTRL and PT3L1 parasites, a similar bradyzoite-specific increase in GFP
fluorescent intensity was observed (19% ± 10% and 19% ± 9%, respectively; P = 0.999).
Furthermore, GFP transcript levels remained unchanged between tachyzoites and
bradyzoites (Figure 3.2C). This indicated that neither the 3’UTRs of LDH1 nor SAG1
contribute any regulatory effects to their transcript and are unlikely to contain any cis-acting
elements either promoting or inhibiting translation.
The apparent bradyzoite-specific increase in GFP fluorescent intensity was
unexpected as western blot densitometry showed that GFP protein levels did not increase
in bradyzoites (Figure 3.1B). This apparent increase was likely due to the difference in
vacuole morphology seen in Toxoplasma tachyzoites and bradyzoites. A tighter clustering
of individual parasites within bradyzoite vacuoles resulted in a moderately higher
fluorescent signal due to the stacking of parasites over one another; this does not occur in
tachyzoites (compare tachyzoite and bradyzoite vacuole morphology in Figure 3.2A). This
moderate bradyzoite-specific increase of GFP fluorescence was taken into account and used
as a baseline of zero repression for all comparison because the morphology of tachyzoite
and bradyzoite vacuoles among all the tested clonal strains remained constant. GFP signals
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were quantified to allow for a robust statistical analysis among the different strains. The
analysis was performed for individual vacuoles within the population, reflecting the
heterogeneity of possible gene regulation and growth. Furthermore, this method permits
the rapid collection of a large dataset for each clonal line tested (at least three clonal lines
per construct were quantified for each parasite strain mentioned throughout this study).
In contrast to CTRL and PT3L1, both P53L1 and P5L1 which are GFP constructs
flanked upstream by LDH1 sequences (Table 3.1) displayed a decrease of 31% ± 6% and
45% ± 4%, respectively, in fluorescent signal (P = 0.999) while mRNA levels did not
significantly change between the two stages (Figure 3.2A-C). These data demonstrated
that the sustained TR seen in LDH1 is due to its 5’ flanking sequence. Since TR is a posttranscriptional regulatory process, the activity is likely restricted to the LDH1 5’UTR. To
ensure the same level of transcriptional control between TUB8 and LDH1 5’ flanking
sequences, we generated the PT5L1 construct where the LDH1 5’UTR was fused between
the TUB8 5’UTR and GFP coding sequence used in CTRL (Table 3.1, Figure 3.3A). By
doing so, it allowed for the control of any regulatory activities that might have been caused
by upstream sequences other than the LDH1 5’UTR. Our results showed that the TUB8
promoter is stronger than that of LDH1 (Figure 3.2A) and therefore, using the TUB8
promoter to drive GFP expression in PT5L1, had the added benefit of generating parasites
with a brighter fluorescent signal, making the parasites more amenable for visualization.
Most importantly, by fusing the two 5’UTRs, it allowed for the direct and non-ambiguous
determination whether the LDH1 5’UTR was able to induce sustained TR. Analysis of
GFP fluorescence in PT5L1 revealed a bradyzoite-specific decrease of 53% ± 3% (P =
0.999) while mRNA levels remained stable (Figures 3.2A-C and 3.3A), indicating TR was
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occurring in PT5L1. This conclusively demonstrated that the LDH1 5’UTR confers a TRpromoting activity to its transcript. Interestingly, these results also showed that this activity
was capable of overriding the constitutive expression profile possibly attributable to the
TUB8 5’UTR. Since this regulation was likely due to the presence of a cis-acting element
located within the LDH1 5’UTR, we therefore attempted to locate and identify a minimal
element.
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Figure 3.2 LDH1 5’UTR is responsible for conferring TR.
(A) Fluorescent images of representative GFP-containing transgenic parasite strains
under tachyzoite and bradyzoite conditions. Scale bar represents 5 μm. (B) Relative
GFP fluorescence (RFU) of transformed parasites under tachyzoite and bradyzoite
conditions. Bars show normalized average readings ± standard error (N ≥ 700) obtained
from at least three independent clones per construct. (C) Relative quantification of
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones. Expression
levels were obtained via the Δ(ΔCt) method and normalized against the internal control,
GAPDH. Values were obtained from at least three independent experiments. Bars reflect
normalized mean ± standard deviation. Dark bars, tachyzoites; light bars, bradyzoites;
asterisk, bradyzoite-specific decrease where P ≤ 0.001.
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3.3.3

The LDH1 5’UTR contains a cis-acting element capable of inducing sustained TR
In order to identify and localize minimal and essential cis-acting element(s),

segments of approximately either 20 nucleotides or 40 nucleotides were deleted in a
stepwise fashion along the LDH1 5’UTR of the plasmid used to make PT5L1 (Figure 3.3A).
This construct was chosen as a template for deletion studies for three reasons. First, as
previously mentioned, the transcriptional unit is driven by the TUB8 promoter which is
stronger than the LDH1 promoter, generating brighter GFP-containing parasites and
making them more amenable to fluorescent visualization (compare GFP intensities in
Figure 3.2A). Second, in a fusion 5’UTR, the structural and sequence context near the
transcriptional start site is unlikely to change while examining the effects of deletions
within the LDH1 portion. Importantly, 5’UTRs are prone to being regulated by RNA
structures (Kozak, 1991). For example, highly structured 5’UTRs can inhibit ribosome
scanning while even moderate structural elements near the transcriptional start site can
hinder the recruitment of the 40S ribosomal subunit (Kozak, 1991). Because altering the
nucleotide sequence can cause local changes in secondary structure (Zuker, 2003), using
PT5L1 as a template for deletional analysis of the LDH1 5’UTR ensures that the TUB8
portion of the 5’UTR can insulate against these and other potential unintended regulatory
consequences. The final advantage of using the TUB8-LDH1 fusion 5’UTR is that it would
allow for the rapid determination of a deletion’s effect on regulation. Maximal repression
would generate a fluorescent signal similar to the reduction of 53% seen in full length
PT5L1 (Figure 3.2C). In contrast, since the difference between PT5L1 and CTRL is merely
the insertion of the LDH1 5’UTR, a deletion that caused the loss of its regulatory activity
would result in a fluorescent profile more akin to that of CTRL.
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Six deletion constructs were created from the parental PT5L1 (Figure 3.3A). These
were named according to which LDH1-derived residues were deleted with nucleotide +1
being the transcriptional start site of LDH1 as predicted by the T. gondii genomics database
(http://toxoDB.org version 6.0). Deletion of nucleotides 2-24 maintained a moderate
bradyzoite-specific decrease in GFP fluorescence of 21% ± 10% (P = 0.999; Figure 3.3B).
In contrast, deletion of nucleotides 26-65 and 47-65 disrupted TR, as seen by their relative
GFP fluorescent profile resembling that of CTRL. Elimination of residues 66-105 also
moderately alleviated TR (20% ± 10%, P = 0.999; Figure 3.3B). Taken together, this
suggests that deletion of residues 26-65 cause a loss of TR, with nucleotides 47-65
constituting a possible minimal cis-acting element. Notably, the abrogation of regions
flanking this element (i.e. Δ2-24 and Δ66-105) appeared to reduce its efficacy in conferring
post-transcriptional regulation.

Upon elimination of nucleotides 86-105, bradyzoites

expressed GFP at approximately 43% ± 6 % (P = 0.999) the amount observed in tachyzoites
(Figure 3.3B). This is similar to the level seen in the parental PT5L1, strongly suggesting
that these residues do not contribute to any post-transcriptional regulatory effect in the
LDH1 5’UTR.

In contrast, a 5’UTR lacking residues 106-132 displayed a loss of

translational repression, suggesting the presence of a second cis-acting element within the
LDH1 5’UTR. The terminal nucleotides (133-151) of the LDH1 5’UTR were not analysed
through deletion so as not to alter the nucleotide context surrounding the Kozak sequence
because this may have impacted translation in an unpredictable manner. Importantly, when
relative GFP transcript amounts were evaluated for each of the above mentioned deletion
constructs, no significant change in mRNA abundance was seen between tachyzoites and
bradyzoites (P ≥ 0.01; Figure 3.3C).
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Figure 3.3 Deletion analysis of the LDH1 5’UTR reveals a minimal and essential cisacting element.
(A) Graphical representation of deletions along the LDH1 5’UTR of PT5L1. TUB8 and
GFP sequences are in purple and green, respectively, while LDH1 sequences are orange.
(B) Relative GFP fluorescence (RFU) of reporter 5’UTR deletion constructs under
tachyzoite and bradyzoite conditions. Bars show normalized average readings ± standard
error (N ≥ 300) obtained from at least three clones per construct.

(C) Relative

quantification of mRNA expression of GFP in tachyzoites and bradyzoites of selected
clones. Expression levels were obtained via the Δ(ΔCt) method and normalized against
the internal control, GAPDH. Values were obtained from at least three independent
experiments. Bars reflect normalized mean ± standard deviation. Dark bars, tachyzoites;
light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤ 0.001.
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To validate these elements as self-contained bona fide cis-acting elements that are
capable of conferring TR, we constructed plasmids that retained these elements in the
CTRL background and named the transgenic parasites lines PT5L1:K106–151 and
PT5L1:K45–85 (Table 3.1, Figure 3.4A). In both of these constructs we also included
nucleotides 133-151 so as not to interfere with the nucleotide context surrounding the
Kozak sequence as outlined above. In the latter construct, although the minimal cis-acting
element was outlined by 47-65 through deletional analysis, we opted to use residues 45-85
because the K45–85 region of the LDH1 5’UTR was predicted to have a modest amount of
secondary structure (discussed further below; Figures 3.4A and 3.5A). The transformed
parasites were then analysed for relative GFP expression in bradyzoites. The putative
element contained within nucleotides 106-151 did not cause bradyzoite-specific
downregulation of GFP expression (Figure 3.4B), thus indicating that this region alone is
not sufficient to confer TR. This may have been because the element was not in the proper
context, could not adopt the proper conformation, or it may need to work cooperatively
with other regions of the LDH1 5’UTR in order to function. Since this element was not
self-sufficient it was not further investigated. As previously mentioned, the terminal
nucleotides of the LDH1 5’UTR (from 133-151) were not screened by deletional analysis
in the above PT5L1 model (Figure 3.3A). However, by including these nucleotides with
the putative 106-132 element, we inferred that this region likely does not contribute
regulatory effects. When assessed for GFP expression, PT5L1:K45–85 displayed a 41% ±
6% (P = 0.999) bradyzoite-specific reduction in fluorescence which was similar to that seen
in the parental PT5L1 (Figures 3.2B and 3.4B) while no significant change in GFP mRNA
was seen (P ≥ 0.01; Figure 3.4C). Taken together, this strongly suggested that these
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residues, termed the K45–85 element, constitute a self-contained cis-acting element
capable of causing TR in the CTRL background.
To verify the ability of the K45–85 element to induce sustained TR in exogenous
transcripts, another constitutively expressed gene, GRA1, was introduced into the upstream
flanking region. The GRA1 gene is highly expressed in both tachyzoites and bradyzoites
and a previous report has shown that this region is sufficient to constitutively express a
protein at high abundance in T. gondii (Messina et al., 1995). A pair of constructs were
created replacing TUB8 sequences by the promoter and 5’UTR from GRA1 and named
PGRA:CTRL and PGRA:K45–85 (Table 3.1). A decrease of 29% ± 6% (P = 0.999) in
bradyzoite fluorescence was seen by PGRA:K45–85 while no significant difference was
seen in PGRA:CTRL (P ≥ 0.01; Figure 3.4D). Also, GFP mRNA levels remained
statistically unchanged between tachyzoites and bradyzoites (Figure 3.4E). These findings
confirm that the K45–85 element is a functional TR-inducing cis-acting element.
Furthermore, inclusion of this element overrides the constitutive expression seen when
either the TUB8 or GRA1 upstream flanking regions alone are present, suggesting that the
strong sustained TR seen is signaled through the K45–85 element.
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Figure 3.4 Nucleotides 45-85 can induce TR in an exogenous system.
(A) LDH1 5’UTR sequence. Sequences kept for PT5L1:K106–151 are underlined, while
sequences included in PT5L1:K45–85 are capitalized.

(B), (D) Relative GFP

fluorescence (RFU) of selected LDH1 5’UTR elements under tachyzoite and bradyzoite
conditions. All bars show normalized average readings ± standard error (N ≥ 300)
obtained from at least three clones per construct. (C), (E) Relative quantification of
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones. Expression
levels were obtained via the Δ(ΔCt) method and normalized against the internal control,
GAPDH. Values were obtained from at least three independent experiments. Bars reflect
normalized mean ± standard deviation. Dark bars, tachyzoites; light bars, bradyzoites;
asterisk, bradyzoite-specific decrease where P ≤ 0.001.
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3.3.4

Mutational analysis of K45–85 element reveals a small regulatory RNA hairpin
Since the K45–85 element is a strong regulatory element, we hypothesized it would

be highly conserved in Toxoplasma. In order to probe the transcriptome for similarly
regulated transcripts, we generated a MEME motif (Bailey et al., 2009) using the LDH1
5’UTR variants selected so as to account for conservation of loss of TR activity (Figure
3.3B). This motif was then used for a MAST search (Bailey et al., 2009) against the
annotated non-redundant UTRs of the Toxoplasma type II transcriptome as generated by
toxodb.org using EST-based evidence. This method identified 12 genes (excluding LDH1)
with unacceptably high expected values (data not shown). It was therefore concluded that
this cis-acting element was either not detectable in the transcriptome without further
refinement for other TR genes or it is unlikely to be conserved at the sequence level.
It had been noted during the analysis of the LDH1 5’UTR that deletions targeting
areas immediately flanking the minimal cis-acting element located between nucleotides 4765 caused a moderate loss of TR (Figure 3.3B). Importantly, since RNA folding is in part
a thermodynamic process (Zuker, 2003), alterations in the sequence composition at one
location can cause changes in structure that influence the folding of adjacent regions. It
was therefore hypothesized that observations showing that deletion of sequences located
immediately upstream or downstream of the minimal cis-acting element caused a moderate
impairment of TR may have indicated that its activity relied on the adoption of a particular
structural conformation (Figure 3.3B). We therefore examined whether the K45–85

128

element owed its strong TR-inducing activity to the formation of a specific regulatory
secondary structure.
The secondary structures that mRNAs can adopt are varied and have been implicated
in a variety of regulatory functions. The formation of strong structures to the order of –50
kcal∙mol-1 in the 5’UTR can inhibit scanning of the 40S ribosomal subunit (Kozak, 1991)
which could explain the ability of the K45–85 element to confer sustained TR in the tested
fusion 5’UTRs. To see if such a mechanism could be responsible, the potential for the
LDH1 5’UTR (151 nucleotides + 44 nucleotides of coding sequence downstream) to form
inhibitory structures was assessed using the RNA secondary structure prediction software
Mfold (Zuker, 2003). We selected the predicted structure with the lowest free energy as it
should represent the most stable structure (Figure 3.5A). While the level of secondary
structure obtained appeared to be insufficient to inhibit ribosomal scanning, the presence
of two RNA hairpins was found in the location corresponding to the K45–85 element
(Figure 3.4A).

Notably these two hairpins, termed Hp1 and Hp2 respectively, are

maintained when analysing the K45–85 element in the context of PT5L1:K45–85 (Figure
3.5B). Interestingly, it has previously been established that RNA hairpins can serve various
regulatory functions (Svoboda and Di Cara, 2006). We therefore examined whether the
formation of these hairpins was important for mRNA regulation and further tested the
ability of these predicted structural elements to regulate GFP expression in bradyzoites.
To assess the effects of Hp1 formation on TR, destabilizing mutations within the
PT5L1:K45–85 construct were designed to disrupt base pairing between the stems of Hp1
(see Materials and Methods for details). Parasites containing this construct were termed
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Hp1D (Figure 3.5C). Corresponding rescue mutations were designed to restore base
pairing of the stems and this construct was termed Hp1R (Figure 3.5C). In selecting
mutations, care was used to maintain a predicted C:A base pair between residues 55 and 66
(see arrowhead, Figure 3.5A,B) and to ensure the formation of a hairpin with a similar
calculated free energy, and therefore similar stability, as the parental PT5L1:K45–85.
Disruption of Hp1 caused a loss of TR while the restorative mutations (Hp1R) partially
rescued TR as evidenced by a bradyzoite-specific decrease of 25% ± 7% in GFP
fluorescence (P = 0.999; Figure 3.5D). Furthermore, no significant changes were observed
in GFP transcript levels (P ≥ 0.01; Figure 3.5E). Taken together, these data suggest that a
hairpin involving the base pairing of nucleotides 53-57 with 64-68 is crucial for regulation.
Previous reports have suggested that non Watson-Crick base pairing may serve an essential
role for the recognition of certain RNA hairpins (Hermann and Westhof, 1999), raising the
possibility that the predicted C:A pair may serve as a defining feature of this regulatory
element. To test this possibility, the Hp1R-UA construct was made in which the pair in
question was mutated to form a standard Watson-Crick U:A base pair (Figure 3.5C).
Interestingly, the mutation caused a complete loss of bradyzoite-specific GFP regulation
and led to a profile akin to that seen in the original CTRL construct with an increase of 17%
± 8% (P = 0.999; Figures 3.2B and 3.5D) while mRNA abundance was maintained at
similar levels in tachyzoites and bradyzoites (P ≥ 0.01; Figure 3.5E).
The potential involvement of Hp2 was also investigated. Parasites with disruptive
and restorative mutations targeted against Hp2, termed Hp2D and Hp2R respectively, were
generated as described above (Figure 3.5C). Both types of mutations designed against Hp2
resulted in similar bradyzoite-specific decreases in GFP expression (26% ± 5% and 24% ±
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5% respectively, P = 0.999; Figure 3.5D) while no change in mRNA abundance was seen
(Figure 3.5E), suggesting that mutations to the distal part of the K45–85 element cause only
a partial loss of TR. Since no difference was observed between Hp2D and Hp2R, it seems
likely that only the formation of Hp1 is necessary for inducing TR.
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Figure 3.5 Mutational analysis of K45–85 element reveals essential structural
component.
(A) Secondary structure of LDH1 5’UTR was predicted using the MFOLD webserver
(Zuker, 2003). Forty-four nucleotides of the plasmid-derived sequence downstream of
the LDH1 5’UTR were included in the predicted fold. (B) Predicted secondary structure
of K45–85 element in PT5L1:K45–85. Two predicted hairpin structures are noted (Hp1
and Hp2). (C) Multiple sequence alignment of PT5L1:K45–85 and mutated constructs.
The shaded area represents the K45–85 element. Sequences predicted to base pair in
Hp1 and Hp2 are underlined and mutated residues are capitalized. (D) Relative GFP
fluorescence (RFU) of hairpin disrupting and restorative constructs under tachyzoite and
bradyzoite conditions. All bars show normalized average readings ± standard error (N ≥
300) obtained from at least three clones per construct. (E) Relative quantification of
mRNA expression of GFP in tachyzoites and bradyzoites of selected clones. Expression
levels were obtained via the Δ(ΔCt) method and normalized against the internal control,
GAPDH. Values were obtained from at least three independent experiments. Bars reflect
normalized mean ± standard deviation. Dark bars, tachyzoites; light bars, bradyzoites;
asterisk, bradyzoite-specific decrease where P ≤ 0.001.
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Discussion
3.4.1

Structural requirements of Hp1 suggest a recognition site for a trans-acting factor
that is capable of targeting the LDH1 transcript for sustained TR
The predicted secondary structure of the LDH1 5’UTR and mutational analysis of

Hp1 suggested that an essential regulatory RNA hairpin is formed from position 53-68.
Furthermore, base pairing between residues 53-57 with 64-68 as well as a non-canonical
C:A pairing between residues 55 and 66 appear essential to its activity (Figure 3.5).
Previous studies have shown that non-canonical base pairing between residues within the
stem of RNA hairpins may serve as important recognition points for ribonucleoprotein
assembly (Hermann and Westhof, 1999). As RNA hairpins have been known to serve as
potential nucleation sites for the assembly of regulatory ribonucleoproteins (Svoboda and
Di Cara, 2006), it is possible that Hp1 serves this function in LDH1 to allow the binding of
an unidentified TR-promoting trans-acting factor. Upon the binding of such a factor, the
transcript could be removed from the active translational pool. This is a common theme
often repeated in the literature.

For example, in mammals the post-transcriptional

regulation of ferritin and other genes involved in iron metabolism relies on a 5’UTR-located
conserved RNA hairpin termed the iron response element. In periods of iron depletion, the
iron response element is bound by the iron response protein, causing its withdrawal from
the translational pool (Muckenthaler et al., 1998).
The proposed unknown trans-acting factor involved in LDH1 TR could act similarly
where it may either be responsible for, or contribute to, the recruitment of other factors
necessary for protecting the transcript from degradation during the bradyzoite stage where
it could be stored until translational reactivation in tachyzoites.

Such transcript
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maintenance could be mediated through its recruitment to areas of cytoplasmic storage
known as stress granules (SGs).

In other organisms, SGs are well characterized

cytoplasmic bodies that form under the same stressful conditions that cause eIF2
phosphorylation (Yamasaki and Anderson, 2008). They selectively store transcripts
throughout stress and it has been suggested that this serves to withdraw them from the
limited functional translational machinery, thereby giving preference to the translation of
stress-response transcripts (Yamasaki and Anderson, 2008; Kedersha and Anderson, 2002).
Furthermore, these structures have been implicated in the maintenance of important
mRNAs during stressful conditions and allow for their eventual translational reactivation
upon relief of stress (Hooper and Hilliker, 2013). Interestingly, a previous report has shown
that mRNA-containing granules with the properties of SGs appear in Toxoplasma under
stressful conditions (Lirussi and Matrajt, 2011), suggesting a possible link between global
TR and the maintenance of specific transcripts throughout stressful conditions. It is
possible to speculate that LDH1, as transcript that undergoes sustained TR in bradyzoites,
could be one transcript that is selectively recruited to SGs under stress.
The binding of specific mRNAs by RNA binding proteins that are necessary for
maintaining them throughout sustained TR is a recurrent theme. For example, under
stressful conditions that cause the inactivation of mTOR in mammals, 5’ terminal
oligopyrimidine tract-containing mRNAs are bound by the translational repressors TIA1
and TIAR. These transcripts are withdrawn from active translation and stored in SGs
(Damgaard and Lykke-Anderson, 2011). In Plasmodium the RNA binding proteins DOZI
and PUF2 have been shown to selectively bind transcripts through a sequence-based cisacting element and are essential for their maintenance throughout sustained TR (Mair et
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al., 2006; Miao et al., 2013; Braks et al., 2008). Notably, the Toxoplasma genome is
predicted to contain homologues to these and other regulatory RNA binding proteins. In
Toxoplasma, ALBA1 and ALBA2 proteins are capable of binding mRNAs as well as
translation regulatory machinery and they localize to SGs under stressful conditions (Gissot
et al., 2013).
More recently, Liu and colleagues identified a Toxoplasma homologue of the
translational repressor PUF1 that is upregulated and localized to cytoplasmic granules in
bradyzoites (Liu et al., 2014). PUF1 binds transcripts through the Puf-binding element, a
UUGUN3AU consensus sequence, which is strikingly similar to the sequence starting
within the terminal loop of Hp1 composed of UUGUN3A where the A is predicted to form
a non-canonical pair necessary for its TR-inducing activity (Figure 5). It is therefore very
tempting to speculate on the involvement of PUF1 in the regulation of LDH1 translation in
bradyzoites. Identification of trans-acting factors involved in the sustained TR of LDH1
may yield insight into how other similarly regulated transcripts are maintained in
Toxoplasma bradyzoites.
A large scale conservation of the K45–85 element amongst the Toxoplasma
transcriptome was not found. This is likely because its activity relies on the adoption of
certain conformational characteristics and not on a strict sequence-based conservation.
Recently Joyce and colleagues have published microarray data listing genes that undergo
TR upon induction of the unfolded protein response (Joyce et al., 2013). Unfortunately, it
appears they were unable to identify unifying cis-acting elements present within genes
targeted for sustained TR. This may illustrate either the need for a comparative RNA
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structure approach or a large variety in potential TR-inducing cis-acting elements.
Intriguingly, a survey of the literature studying post-transcriptional gene regulation in
Toxoplasma points to a rich abundance of cis-acting elements in its transcriptome. For
example, a report on the apicoplast-targeted translational elongation factor G has suggested
that its 3’UTR contributes to promoting its translation, suggesting the presence of an
undefined cis-acting element within (Payne et al., 2011). Also the translation of ALBA2
requires a putative element located in its 3’UTR (Gissot et al., 2013). Limited reports,
coupled with the discovery of miRNA and its differential regulation in Toxoplasma (Braun
et al., 2010), strongly suggest that transcript-specific post-transcriptional gene regulation
is important for modulating gene expression through the use of cis-acting elements. This
may be reflective of the need for multiple transcript-specific regulatory mechanisms to
adequately control gene expression in Toxoplasma.
3.4.2

Sustained TR of LDH1 suggests that its regulation is important for bradyzoite and
tachyzoite interconversion
Carbohydrate metabolism in bradyzoites is radically different than in tachyzoites.

Bradyzoites lack the ability to complete the tricarboxylic acid cycle and their
mitochondrion is non-functional (Denton et al., 1996; Toursel et al., 2000) suggesting that
they operate under functionally anaerobic conditions. Since bradyzoites are unable to
complete cellular respiration, glycolysis is used as a major source of energy (Denton et al.,
1996). In the final step of glycolysis under anaerobic conditions, lactate dehydrogenase
catalyses the conversion of pyruvate to lactate and regenerates NAD+ from NADH. In
bradyzoites, this reaction is catalysed by LDH2 which is transcriptionally upregulated to
perform this task (Behnke et al., 2008; Yang and Parmley, 1997). The production of lactate
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is much more active in bradyzoites than in tachyzoites, suggesting that a higher throughput
of this process is necessary for the parasite to meet its energy requirements (Denton et al.,
1996). LDH2 functions efficiently in the presence of the large amounts of pyruvate
assumed to be generated in bradyzoites (Dando et al., 2001). This characteristic is thought
to be essential for the regeneration of NAD+ and the continual drive of glycolysis
throughout anaerobic conditions. In contrast, the function of LDH1 is inhibited by large
doses of pyruvate, suggesting that it is not adapted to the bradyzoite environment (Dando
et al., 2001). Furthermore, two reports have shown that alterations in the expression
profiles and levels of the LDH isoforms can influence the parasite’s ability to differentiate,
suggesting that precise regulation of LDH isoforms must be tightly controlled (Al-Anouti
et al., 2009; Liwak and Ananvoranich, 2009).
In tachyzoites LDH2 is transcriptionally silenced while LDH1 protein expression is
made possible. Perhaps surprisingly, although the tricarboxylic acid cycle is functional, it
has been shown that the conversion of pyruvate to lactate still occurs at substantial levels
in tachyzoites (Denton et al., 1996). As much as 20% of the glucose taken in by tachyzoites
may be converted to lactate (Denton et al., 1996), highlighting the need for a functional
LDH isoform in this stage. As such a large contributor of energy to the parasite, it could
be hypothesized that production of functional LDH1 protein may be an early development
in the transition of bradyzoite to tachyzoite. Upon the relief of stress, the LDH1 transcript
would be released from sustained TR and made translationally competent, allowing for
Toxoplasma to rapidly respond by compensating for the loss of LDH2 through immediate
production of LDH1. Such a mechanism would be faster and more energetically favourable
than newly transcribing the LDH1 gene upon conversion to tachyzoites.
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Conclusion
In this study, we identified a small structural cis-acting element that resides within
the LDH1 5’UTR. To our knowledge, this is the first report offering the experimental
characterization of a specific cis-acting element that contributes to post-transcriptional gene
regulation in Toxoplasma. We show that this element selectively targets the LDH1
transcript for sustained TR and can confer stage-specific expression to an otherwise
constitutively expressed gene in a heterologous context. This activity requires the adoption
of an RNA hairpin structure which may be indicative of an RNA protein binding site. The
selectivity conferred by the K45–85 element strongly suggests that the LDH1 transcript
which is destined for sustained TR is recognized by as of yet unidentified trans-acting
factor(s) in Toxoplasma bradyzoites. We further propose that upon identification by said
factors, the transcript is withdrawn from the pool of actively translated mRNAs and sent
for maintenance and storage.

Upon the relief of stress, it would be translationally

reactivated in order to aid in the reconversion into tachyzoites. By studying similarly
regulated transcripts, it may be able to illuminate pathways, metabolic or otherwise, that
need to be rapidly reactivated upon the relief of stress for the reconversion to tachyzoites.
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CHAPTER IV – The use of RNA aptamer technologies for the affinity purification of
LDH1-interacting partners and examination of short- and long-term features of stressinduced translational repression in Toxoplasma gondii
Introduction
The world’s most successful parasite, the obligate intracellular pathogen Toxoplasma
gondii, infects warm-blooded animals the world over, including up to an estimated one
third of the human population (Turner et al., 2013; Montoya and Liesenfeld, 2004). Key
to its survival and widespread distribution is its ability to react to the many hostile
environments it encounters throughout its sexual and asexual lifecycles (Skariah et al.,
2010). After completing its sexual reproduction in the intestine of the feline, it must survive
in the outdoor environment for months or years until being ingested by a warm-blooded
host (Dubey, 1998; Torrey and Yolken, 2013). Once ingested, it must survive the harsh
extracellular environment it encounters after destroying a previously infected host cell until
it colonizes another (Konrad et al., 2011; Black and Boothroyd, 2000). Once infection is
established in an intermediate host, it must survive the anti-microbial effects of interferon
γ produced by the innate immune system (Suzuki et al., 1988; Schroder et al., 2004). This
is accomplished by converting from the rapidly growing and destructive tachyzoite stage
to the non-replicating and immunologically protected bradyzoite stage which is responsible
for maintaining chronic infection for the life of the host (Skariah et al., 2010).
Similar to other eukaryotes, when subjected to stressful stimuli, Toxoplasma initiates
a robust general translational repression mediated through the phosphorylation of the alpha
subunit of eukaryotic initiation factor 2 (eIF2α; Sullivan et al., 2004). Phosphorylation of
the Ser71 regulatory residue causes eIF2 to have an increased affinity for its nucleotide
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exchange factor, decreasing its turnover rate and inhibiting cap-dependent translation
(Sullivan et al., 2004; Sonenberg and Hinnebusch, 2009). eIF2α phosphorylation is
performed by one of four T. gondii eIF2α kinases (TgIF2K)s, each of which are activated
by different signals (Narasimhan et al., 2008). TgI2K-A is activated in response to the
accumulation of misfolded proteins in its endoplasmic reticulum, TgIF2K-B is induced by
oxidative stress and other cytoplasmic stresses, while TgIF2K-C and TgIF2-D both react
to amino acid starvation, with the former selectively acting within the intracellular
environment and the later exclusively mediating the response when the parasite finds itself
in the extracellular milieu (Narasimhan et al., 2008; Konrad et al., 2013a; Konrad et al.,
2011; Joyce et al., 2010).
Prolonged eIF2α phosphorylation causes the conversion of tachyzoites into
bradyzoites and the translational control demonstrated under stressful conditions has been
suggested to be a key part of the conversion mechanism (Konrad et al., 2013b; Joyce et al.,
2013). While under eIF2α phosphorylation, a subset of transcripts that encode stressresponsive proteins are preferentially translated while the majority dissociate from
polysomes (Joyce et al., 2013). Of this latter group, most appear to be degraded through
standard mRNA turnover (Joyce et al., 2013).

However, a subset of translationally

quiescent transcripts is maintained throughout the prolonged TR response (Yang and
Parmley, 1997; Dendouga et al., 2002; Cleary et al., 2005). This suggests a mechanism
exists by which they are distinguished from those transcripts subject to degradation and
would rely on the use of recognizable cis-acting elements.
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Previously we have proposed that non-translated transcripts that are maintained
throughout the bradyzoite stage are likely recruited to stress granules (SG)s, sites of mRNA
storage that are formed in response to stressful environments (Holmes et al., 2014;
Anderson and Kedersha, 2008). In well studied eukaryotic organisms, SGs have been
found to be formed upon eIF2α phosphorylation and consist of translationally quiescent
mRNAs, machinery involved in cap-dependent translational initiation, and RNA-binding
proteins that bind specific cis-acting elements (Anderson and Kedersha, 2008).
Importantly, SGs have recently been shown to form in both extracellular tachyzoites and
intracellular bradyzoites in Toxoplasma, demonstrating that this stress-response pathway is
conserved in ancient eukaryotes (Lirrusi and Matrajt, 2011; Cherry and Ananvoranich,
2014; Cherry and Ananvoranich, unpublished results).
In our previous work, we used the lactate dehydrogenase 1 (LDH1) transcript as a
study model to determine how specific transcripts are selected to be maintained through
what we termed long-term sustained translational repression. It was determined that LDH1
harbours a cis-acting element, termed the K45–85 element, in its 5’UTR that is responsible
for inhibiting its translation in bradyzoites while allowing the mRNA to be maintained at
similar steady state levels to what is seen in tachyzoites (Holmes et al., 2014). The K45–
85 element necessitates the formation of a small 16 nucleotide RNA hairpin that is
characterized by a central non-canonical C:A base pair. It is well documented that internal
non-canonical base pairings and RNA hairpin loops can be important recognizable features
that mediate the binding of RNA-binding proteins (Hermann and Westhof, 1999; Leontis
and Westhof, 2003). It was therefore hypothesized that upon eIF2α phosphorylation, the
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LDH1 transcript is recruited to SGs through the actions of an unidentified trans-acting
factor (Holmes et al., 2014).
RNA aptamers are small, self-folding RNA segments that specifically bind a
molecule of interest (Mayer, 2009). They have been discovered in naturally-occurring
biological systems or engineered from randomized RNA libraries through successive
rounds of selective amplification of ligand-binding RNAs (Mayer, 2009). RNA aptamers
combined with affinity purification procedures are exceptionally suited to offer an unbiased
approach towards identifying the protein complement that binds a known transcript
(Srisawat and Engelke, 2001; Slobodin and Gerst, 2010).

Since LDH1 has been

demonstrated to be an ideal model of sustained translational repression in bradyzoites
(Holmes et al., 2014), in this study the feasibility of using RNA aptamer technologies in
combination with the LDH1 system were examined. Furthermore, to better understand how
T. gondii manages stress, the LDH1 system was used to better examine the features of
stress-induced translational control.
Materials and methods
4.2.1

Plasmid construction
All polymerase chain reactions (PCR)s performed to generate plasmids were

conducted according to the manufacturer’s instructions (Phusion High Fidelity, Thermo
Scientific, Ontario, Canada). The template and primer pairings for each construct are listed
in Appendix B.
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4.2.1.1 Aptamer constructs
All aptamer-containing constructs generated in this study were based off of the green
fluorescent protein (GFP) reporter system flanked upstream by LDH1-related and / or
tubulin-related sequences and downstream by either LDH1 or SAG1 sequences (Holmes et
al., 2014). The 44 nucleotide minimal S1 aptamer, which selectively binds streptavidin
(Srisawat and Engelke, 2001), was inserted along with an EcoRV endonuclease restriction
site directly downstream of the GFP stop codon by a PCR approach using back to back
primers. After PCR, the products were phosphorylated with T4 polynucleotide kinase
according to the manufacturer’s instructions (Promega, Ontario, Canada) and ligated with
T4 DNA ligase for 1 h at 37°C (BioBasic, Ontario, Canada). After bacterial transformation,
clones were screened for the incorporation of the EcoRV restriction site. This generated
plasmids p53L1-S1 and pT3L1-S1 from p53L1 and pT3L1, which both contain the S1
aptamer and differ from each other only by their use of LDH1 or TUB8 upstream fragments,
respectively (Table 4.1).
Plasmid p53L1-S1 was used to create pT5L1-S1 and pCTRL-S1. To do so, parental
plasmids pT5L1 and pCTRL as well as p53L1-S1 were digested with NsiI and PacI and
gel purified (Hettmann et al., 2000; Holmes et al., 2014). The GFP-S1 fragment generated
from p53L1-S1 was ligated into the opened and GFP deficient pT5L1 and pCTRL vectors
to generate pT5L1-S1 and pCTRL-S1 respectively. These later plasmids are both driven
by a modified tubulin promoter with transcription initiating at the TUB8 5’UTR and also
have SAG1 3’UTRs, similar to the previously established system (Table 4.1; Hettmann et
al., 2000; Holmes et al., 2014). However, in this study plasmids pT5L1-S1 and pCTRL-
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S1 were not used for parasite expression and instead used for further cloning or for the
generation of in vitro synthesized RNA (Appendix B).
Plasmids containing the 68 nucleotide Hepatitis delta virus (HDV) ribozyme were
generated in a similar back-to-back strategy as described above in a two-step process. The
HDV ribozyme, which is capable of self-cleaving directly 5’ of itself (Mercure et al., 1998),
was inserted directly downstream of the S1 aptamer using oligonucleotides that each
incorporated a partial modified HDV genomic strand ribozyme (Been, 2006). This version
of the HDV ribozyme contains an altered P1 stem and a shortened P4 stem, two changes
which have been shown to have negligible impact on its function (Mercure et al., 1998;
Ananvoranich et al., 1999). Once ligated, the oligonucleotides generated a SphI restriction
digest site for screening purposes and, used in conjunction with pT5L1-S1 or pCTRL-S1
in a PCR reaction yielded pT5L1-S1-HDVΔG58 and pCTRL-S1-HDVΔG58, respectively
(Table 4.1). These plasmids encode a catalytically inactive form of the HDV ribozyme
(Been and Perrotta, 1995). In the second step, these plasmids were used as templates to
create pT5L1-S1-HDV and pCTRL-S1-HDV, which each lack a PacI site for screening
and encode a catalytically active ribozyme (Table 4.1).
Plasmids were also designed for use with a different aptamer system derived from
the MS2 bacteriophage (Slobodin and Gerst, 2010). The MS2 aptamer, consisting of two
19 nucleotide RNA hairpins separated by a small spacer, selectively binds the MS2 phage
coat protein (CP), which in turn can be used for affinity purification (Said et al., 2009;
Slobodin and Gerst, 2010). Using a similar back-to-back methodology as described above,
one copy of a MS2 hairpin was incorporated into each oligonucleotide so that they
149

generated plasmids encoding two copies of the MS2 hairpin separated by an XbaI
restriction site directly downstream of the GFP stop codon. These plasmids were named
pT5L1-MS2 and pCTRL-MS2 (Table 4.1).
4.2.1.2 Dual luciferase constructs
Plasmids incorporating the firefly (FF) or Renilla (RN) luciferase coding sequences
were adopted to the previously established LDH1 GFP reporter system (Holmes et al.,
2014). The FF luciferase fragment was obtained by gel purification after digesting plasmid
p3011FF with NsiI and PstI. Vectors pT5L1 and pCTRL were digested with NsiI and PstI
in order to remove the GFP coding sequence, dephosphorylated with calf intestinal
phosphatase according to the manufacturer’s instructions to prevent self-ligation
(Promega), and gel purified. The appropriate fragments were then ligated and, after
transformation, screened for insertion in the correct orientation with EcoRI and PstI. This
generated plasmids pT5FF and pT0FF (Table 4.1).
To serve as an internal control for dual luciferase expression assays, a RN-containing
plasmid was generated and termed pT0RN (Table 4.1). Briefly, the RN coding sequence
was PCR-amplified from pTubRn (Crater et al., 2012), digested with PstI and ligated
within an NsiI / PstI digested and dephosphorylated open pT0FF vector following a similar
procedure as previously mentioned.
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Table 4.1 Names and characteristics of plasmids used in study.
Plasmid name

Promoter

5'UTR

Coding
sequence

Aptamer

3'UTR

Screening site

p53L1-S1
pT3L1-S1
pT5L1-S1
pCTRL-S1
pT5L1-S1HDVΔG58
pCTRL-S1HDVΔG58
pT5L1-S1-HDV
pCTRL-S1HDV
pT5L1-MS2
pCTRL-MS2
pT5FF
pT0FF

LDH1
TUB8
TUB8
TUB8

LDH1
TUB8
TUB8-LDH1
TUB8

GFP
GFP
GFP
GFP

S1
S1
S1
S1

LDH1
LDH1
SAG1
SAG1

EcoRV
EcoRI/EcoRV
EcoRI/EcoRV
EcoRI/EcoRV

TUB8

TUB8-LDH1

GFP

S1-HDVΔG58

SAG1

SphI

TUB8
TUB8

TUB8
TUB8-LDH1

GFP
GFP

S1-HDVΔG58
S1-HDV

SAG1
SAG1

EcoRI/EcoRV
ΔPacI

TUB8
TUB8
TUB8
TUB8
TUB8

TUB8
TUB8-LDH1
TUB8
TUB8-LDH1
TUB8

GFP
GFP
GFP
FF
FF

S1-HDV
2x MS2 loop
2x MS2 loop
N/A
N/A

SAG1
SAG1
SAG1
SAG1
SAG1

ΔPacI
XbaI
XbaI

pT0RN

TUB8

TUB8

RN

N/A

SAG1

4.2.1.3 Bacterial expression vector
For use in subsequent affinity purification, a plasmid was generated so as to
bacterially express a fusion protein consisting of an N-terminal CP, a central GFP, and a
C-terminal streptavidin-binding peptide (SBP). The sequence corresponding to CP-GFPSBP fusion protein was PCR-amplified from a plasmid provided by Dr. Jeffrey Gerst
(Weizmann Institute of Science, Israel). The PCR fragment was digested with BspHI and
XhoI and gel purified. A pET28b vector was digested with NcoI and XhoI, gel purified and
the ligated with the CP-GFP-SBP fragment. The resulting plasmid, pET_CP-GFP-SBP,
was subsequently used to bacterially express C-terminally histidine tagged CP-GFP-SBP.
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4.2.2

Tissue culture and parasite transformation
Routine culture of human foreskin fibroblasts (ATCC: SCRC-1041) was conducted

using DMEM medium (Invitrogen) supplemented with 10% cosmic calf serum (Hyclone,
USA) and 0.5x antibiotic-antimycotic (Invitrogen). Upon reaching confluency at 37°C in
a 5% CO2 atmosphere, fibroblasts were infected with the Toxoplasma gondii PLKΔHX
strain which lacks functional HXGPRT activity (NIH AIDS program, Division of AIDS,
NIAID, cat#2860; Roos et al., 1994; Pfefferkorn and Borotz, 1994). Tachyzoites were
grown in MEM medium (Invitrogen) supplemented with 1% dialysed fetal bovine serum
(Hyclone) and 0.5x antibiotic-antimycotic at 37°C in 5% CO2. Bradyzoites were grown
for 3 days at 37°C in atmospheric CO2 in RPMI medium (Invitrogen) buffered with 50 mM
HEPES at pH 8.2 and supplemented with 5% dialyzed fetal bovine serum and 0.5x
antibiotic-antimycotic. Bradyzoite media was changed daily in order to maintain the
elevated pH.
Stable transgenic lines were generated by an established electroporation protocol
using 20 μg of purified plasmid (Roos et al., 1994). One day after electroporation, the
media was exchanged to include 20 µg/ml mycophenolic acid and 50 µg/ml xanthine for
selection of the HXGPRT cassette included in the plasmid. Clonal isolates were obtained
by serially diluting transformed parasites into 96-well plates.
Dual luciferase assays requiring the transient expression of FF and RN luciferases in
tachyzoites and bradyzoites were performed using 5 μg of FF plasmid (either pT5FF or
pT0FF) and 5 μg of pT0RN. Four hours after electroporation, the media was changed to
fresh tachyzoite or bradyzoite media and the parasites were grown for 24 h or 3 days,
152

respectively. A similar strategy was used to examine extracellular parasites expressing FF
and RN luciferases.

Three million freshly lysed tachyzoites were collected and

electroporated with FF plasmid (either pT5FF or pT0FF) and pT0RN each at 1 μg plasmid
/ 106 parasites. After four hours, the media was exchanged and the parasites were allowed
to grow for 24 hours before collection.
4.2.3

Fluorescent microscopy and relative GFP quantification
Stable transgenic P53L1-S1 or PT3L1-S1 (Table 1) parasites were grown for 24 h

under tachyzoite conditions and for 5 days under bradyzoite conditions on confluent
coverslips. Following fixation in 3% paraformaldehyde, the coverslips were stained in 10
μM Hoechst, rinsed in PBS, and mounted onto slides. Relative GFP quantification was
performed as previously described using the Northern Eclipse software (Image Scanning
Technology, Ontario, Canada) on a Leica DMIRB inverted microscope (Holmes et al.,
2014). Briefly, at least 100 vacuoles per life stage per clonal line (total N ≥ 300) were
analysed by densitometry. Relative bradyzoite fluorescence was expressed as a function
of tachyzoite values, which were normalized to 100%. To assess the statistical significance
of any bradyzoite-specific decrease in GFP expression, a one-tailed z test assuming unequal
variances was performed using the Data Analysis pack available within Microsoft Excel
2007.
4.2.4

Generation of in vitro transcribed RNA fragments
DNA fragments incorporating the T7 RNA polymerase promoter were generated by

PCR using plasmid templates (see Appendix B for appropriate template and
oligonucleotide combinations). Reactions were performed according to the manufacturer’s
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instructions (OneTaq; NEB).

PCR fragments were cleaned by phenol:chloroform

extraction, ethanol precipitated, and resuspended in DEPC-treated water prior to use for in
vitro transcription.
RNA fragments were generated in a standard T7 RNA polymerase reaction mixture
consisting of 50 mM Tris pH8.0, 10 mM MgCl2, 2 mM spermidine, 25 mM NaCl, 2.5 mM
rNTPs, 1 mM DTT, 1 U of pyrophosphatase and 20 U of RNase inhibitor (Thermo
Scientific). Reactions were incubated at 37°C for 3 h after which point 1 U of DNase I
(Promega) was added. The reaction mixture was incubated another 30 minutes to degrade
the DNA template. Synthesized RNA was cleaned by phenol:chloroform extraction,
ethanol precipitated, resuspended in DEPC-treated water and quantified on a NanoDrop
spectrophotometer (Thermo Scientific).
4.2.5

Northern Blot
A DIG-labeled probe corresponding to a 273 bp region of the GFP coding sequence

was generated by PCR using a plasmid template. The reaction was performed according
to the manufacturer’s instructions (OneTaq; NEB) with the exception that the reaction
mixture contained 100 μM dA/G/CTP, 67 μM dTTP, and 33 μM DIG-11-dUTP (Roche;
Eisel et al., 2008). The reaction was run in conjunction with non-labeled dNTP mix and
ran on an acrylamide gel to ensure a gel shift due to labeled nucleotide incorporation. The
probe was phenol:chloroform extracted, ethanol precipitated, and resuspended in DEPCtreated water prior to use.
The northern blot protocol was adopted from the DIG Application Manual for Filter
Hybridization from Roche (Eisel et al., 2008). One microgram of in vitro synthesized RNA
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was run on a 1.5% formaldehyde-agarose gel and transferred overnight to a nylon
membrane. After crosslinking, the blot was pre-warmed at 50°C in 5 ml of hybridization
buffer (Roche) and hybridized overnight at 50 °C with 2 μl of snap-cooled DIG-labeled
probe. The blot was then washed twice in 2X SSC/0.1% SDS (1X SSC: 150 mM NaCl, 15
mM sodium citrate) for 5 minutes at room temperature and twice in 0.1X SSC/0.1%SDS
for 15 minutes at 65°C. Blocking, incubation with α-DIG-alkaline phosphatase (1:10 000),
and exposure were performed according to manufacturer’s instructions (Roche).
4.2.6

S1 aptamer affinity purification
RNA segments containing the S1 aptamer were isolated using a protocol adapted

from Srisawat and Engelke (2001). Fifty micrograms of S1-containing in vitro synthesized
RNA were briefly heated to 75°C and snap-cooled on ice before addition to 25 μl of
streptavidin-agarose beads (Thermo Scientific) in the presence of 200 μl of binding buffer
(50 mM HEPES pH 7.4, 10 mM MgCl2, 100 mM NaCl, 1 mM DTT, 0.1% Triton X-100,
10% glycerol, 20 mM vanadyl ribonucleoside complexes; modified from Srisawat and
Engelke, 2001). The RNA was and allowed to incubate while rotating for 1 h at 4°C. The
agarose resin was pelleted at 1000 rpm for 2 minutes at 4°C on a tabletop centrifuge and
washed in 200 μl binding buffer for 5 minutes a total of ten times. The beads were eluted
in binding buffer supplemented with 5 mM D-biotin (BioBasic) while rotating at 4°C for
30 minutes. The supernatants from each sample were ethanol precipitated in the presence
of 5 μg of linear polyacrylamide carrier and resuspended in DEPC-treated water. Samples
were then reverse transcribed using a GFP-specific primer according to the manufacturer’s
instructions (M-MLV; BioBasic) with the exception of supplementing the reaction mixture
with dNTPs to final concentration of 2 mM. The cDNA was PCR-amplified to generate a
155

324 bp product corresponding to a segment of the GFP coding sequence. See Appendix B
for relevant oligonucleotides.
4.2.7

Affinity purification of bacterially expressed CP-GFP-SBP
The pET_CP-GFP-SBP vector was transformed into BL21 competent cells and

grown overnight in a 2 ml starter culture. A one litre culture was grown to 0.5 OD600 and
induced with 0.2 mM IPTG at room temperature overnight. The bacteria was isolated by
centrifugation and the pellet lysed by sonication in denaturing lysis buffer (50 mM Tris pH
8.0, 300 mM NaCl, 0.1% Triton X-100, 20 mM imidazole, 8 M urea) because it had been
determined by SDS-PAGE that CP-GFP-SBP was restricted to inclusion bodies. The
supernatant was transferred to a Ni-NTA column previously equilibrated in five volumes
of denaturing lysis buffer. Following two washes with denaturing lysis buffer, the CPGFP-SBP protein was allowed to refold on the column using four washes with nondenaturing wash buffer (same recipe omitting urea). CP-GFP-SBP was then eluted in nondenaturing wash buffer supplemented with 250 mM imidazole and analysed by SDS-PAGE
for purity.
4.2.8

Affinity purification of MS2 aptamer from tachyzoite lysates
This procedure was performed with the intention of selectively purifying a transcript

containing the LDH1 5’UTR and the MS2 aptamer from tachyzoite lysate using purified,
bacterially expressed CP-GFP-SBP. Generally, the methodology described below was
adapted from Slobodin and Gerst (2010; 2011) who optimized a system for the recovery of
MS2 aptamer-containing transcripts from mammalian lysate using an inducibly expressed
CP-GFP-SBP. One important modification from the aforementioned method is the use of
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a smaller MS2 aptamer, containing two MS2 loop repeats (Said et al., 2009) instead of
twenty four (Slobodin and Gerst, 2010). Furthermore, buffer compositions were altered
from Slobodin and Gerst (2010) to milder, less stringent buffers to promote MS2 aptamer
binding to recombinantly expressed CP after formaldehyde crosslinking and cell lysis (Said
et al., 2009; Corcoran et al., 2012).
4.2.8.1 Preparation of tachyzoite lysates
Extracellular PT5L1-MS2 tachyzoites were collected from seven 10 cm culture
dishes and pelleted at 2500 rpm for 10 minutes at 4°C. After being washed one time in
PBS, the cell pellet, consisting of approximately 108 parasites, was resuspended in isotonic
crosslinking buffer (20 mM HEPES-KOH pH 7.4, 150 mM KCl, 1.5 mM MgCl2, 1 mM
DTT, 0.1% formaldehyde) and incubated on ice for 10 minutes to crosslink mRNA-protein
complexes.

Crosslinking was stopped through the addition of glycine to a final

concentration of 250 mM and incubation on ice for 10 minutes. The cells were then pelleted
at 6000 rpm for 5 minutes at 4°C on a tabletop centrifuge. After rinsing in isotonic wash
buffer (IWB; isotonic lysis buffer without formaldehyde) the cell pellet was resuspended
in 500 μl hypotonic lysis buffer (20 mM HEPES-KOH pH 7.4, 10 mM KCl, 1.5 mM MgCl2,
1 mM DTT, 0.1% Triton X-100, 20 U/mL RNase inhibitor, 1 μl/ml Pefabloc protease
inhibitor) and lysed through multiple freeze-thaw cycles followed by three short bursts of
sonication on ice. The supernatant was collected and protein concentration was determined
using the RC-DC protein quantification kit (Bio-Rad). Egg white avidin (BioBasic) was
added at 5 μg/mg of lysate and the sample was incubated at 4°C while rotating for 1 h to
block endogenous biotinylated proteins.
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4.2.8.2 Preparation of CP-GFP-SBP-bound streptavidin-agarose beads
All steps were performed at 4°C and all wash and incubation steps were performed
while rotating. Fifty microliters of streptavidin-agarose resin was equilibrated in 500 μl of
IWB and pelleted at 1000 rpm for 2 minutes on a tabletop centrifuge. The beads were then
concurrently bound by 5 μg CP-GFP-SBP and blocked for 90 minutes in isotonic blocking
buffer (IWB supplemented with 2% BSA, 100 μg/ml yeast tRNA, 20 U/ml RNase
inhibitor). To remove excess CP-GFP-SBP and blocking components, the resin was
washed with five 5 minute washes in 500 μl IWB.
4.2.8.3 Affinity purification and western blot analysis
Five milligrams of prepared lysate was incubated with prepared agarose beads in
IWB overnight while rotating at 4°C. The beads were then subjected to five or six 5 minute
washes in 1 ml of IWB. The resin was eluted in 80 μl isotonic elution buffer (IWB
supplemented with 6 mM D-biotin (BioBasic) for 30 minutes while rotating at 4°C. The
formaldehyde crosslinking was then reversed by addition of an equal amount of 2X
crosslink reversal buffer (100 mM Tris pH 7.0, 10 mM EDTA, 20 mM DTT, 2% SDS) and
heated at 65°C for 1 h. Twenty microlitres of the sample was then run on a 10% SDSPAGE acrylamide gel which was then processed by silver staining or western blot. Silver
staining was performed using an established procedure (Shevchenko et al., 1996). After
transferring to a nitrocellulose membrane and blocking in 5% milk, the blot was probed
with α-GFP (1:2500; Rockland) or α-human PABPC3 (1:1000; Applied Biological
Materials). The blot was then incubated in horseradish peroxidase-conjugated α-goat (1:10
000) or α-rabbit (1:20 000) secondary antibodies as appropriate and chemiluminescent
signals were visualized on an Alpha-Imager system.
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4.2.9

Poly(A) tail length analysis
The length of the poly(A) tail of selected transcripts was estimated through a two-

step RT-PCR approach (Murray and Schoenberg, 2008). Total RNA was isolated from
intracellular tachyzoites or bradyzoites using guanidinium isothiocyanate reagent
according to the manufacturer’s instructions (BioBasic), resuspended in DEPC-treated
water and 20 mM vanadyl ribonucleoside complexes, and treated with 1 U DNase for 30
minutes at 37°C. A reverse transcriptase reaction was performed as previously described
(Holmes et al., 2014) using an oligonucleotide designed to bind the poly(A) tail with high
enough annealing temperature to function in subsequent PCR analysis (Murray and
Schoenberg, 2008; Appendix B). PCR was performed using a standard reaction mixture
except only a gene-specific forward primer was added at 0.2 μM. The sequence of the
LDH1 and GRA1 forward primers were designed to anneal 124 nucleotides upstream of the
poly(A) tail as determined by other studies (Appendix B; Yang and Parmley, 1997;
Cesbron-Delauw et al., 1989). The PCR reactions were run on a 10% non-denaturing
acrylamide gel at 200V for 1 h and stained with ethidium bromide prior to visualization
using the Alpha-Imager system.
4.2.10 Dual luciferase assay
4.2.10.1 Stage differentiation trials
After the appropriate growth period, tachyzoite- and bradyzoite-infected fibroblast
monoloayers plates were rinsed briefly with PBS. The monolayers were then scraped and
lysed in 200 μl passive lysis buffer (Promega). After a 15 minute incubation at room
temperature, the lysate was centrifuged for 1 minute at 12 000 rpm on a tabletop centrifuge
and the supernatant was transferred to a new tube. To obtain FF luciferase readings, 20 μl
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of lysate was added to 100 μl FF luciferase buffer (20 mM Tricine, 10 mM MgSO4, 5 mM
DTT, 250 μM Coenzyme A, 250 μM ATP, 200 μM D-luciferin) as previously described
(Crater et al., 2012). RN readings were obtained as previously described (Crater et al.,
2012) using 20 μl of lysate and 100 μl RN luciferase buffer (100 mM K2HPO4/KH2PO4 pH
7.4, 500 mM NaCl, 1 mM EDTA, 0.02% BSA, 10 μM coelentrazine; Liu et al., 1997). All
readings were performed with a 5 second integration time on a 20/20n luminometer (Turner
BioSystems). FF readings were normalized against the RN signal and bradyzoite relative
fluorescent units (RFU)s were expressed as a function of tachyzoite RFUs. A one-tailed
Student t test assuming unequal variances was performed using the Data Analysis pack
available through Microsoft Excel 2007.
4.2.10.2 Extracellular dual luciferase assay
After growing for 24 h under optimal tachyzoite conditions, infected monolayers
were scraped and the parasites were released from the lifted host cells by passing them
twice through a 26 gauge needle. After centrifugation, the parasites were resuspended in
high potassium buffer (25 mM HEPES-KOH pH 7.4, 142 mM KCl, 5 mM NaCl, 5 mM
MgCl2, 2 mM EGTA, 1 mg/ml BSA), which has been shown to cause stress granule
formation in extracellular parasites (Lirussi and Matrajt, 2011). The parasites were then
separated into six equal aliquots and assayed over a time course of three hours for their FF
and RN luciferase activities as previously described (Crater et al., 2012) with the exception
that BSA was omitted from the RN luciferase detection buffer.
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Results and discussion
4.3.1

Adaptation of the S1 aptamer system for affinity purification
The LDH1 5’UTR has previously been shown to be responsible for conferring

sustained translational repression to multiple transcripts when placed in a heterologous
context (Holmes et al., 2014). Since this activity depended on the presence of small
structural element, it was hypothesized that an interaction was occurring between this cisacting element and an unidentified trans-acting factor (Holmes et al., 2014). Previous
reports have suggested four general strategies for the identification of RNA-protein
interactions. In the first method, an RNA-binding protein (RBP) likely to be involved in
the interaction is immunoprecipitated and the association of the RNA in question is
validated through detection techniques such as RT-PCR (Niranjanakumari et al., 2002).
While this method has the advantage of retrieving in vivo RBP-RNA interactions, it
assumes that the RBP is known and only requires validation as an interacting partner, which
is not the case for the LDH1 5’UTR. A second, more RNA-centric method relies on using
a biotinylated version of the cis-acting element as a bait to selectively purify any transacting factors from cell lysate (Rouault et al., 1989). While this method has the advantage
of using a specific sequence to capture RBPs, it can be prone to non-specific binding from
biotinylated moieties or other RBPs and relies on a non-specific elution (Rouault et al.,
1989; Slobodin and Gerst, 2011). Furthermore, this method presents a major technical
challenge in the particular case of Toxoplasma since it is co-cultured with human fibroblasts
and the potential of contaminating human protein in parasite lysates could obscure a
genuine Toxoplasma RBP-RNA interaction. Because of this consideration, an option that
preserves mRNP composition prior to cell lysis was required. This could be achieved by a
161

third option which uses a tagged oligonucleotide to capture the transcript in question
through base pairing interactions (Baltz et al., 2012). While decent specificity can be
achieved with this method, the complementary binding of target and bait would not occur
if the selected region were obscured by RBPs or if it were already involved in double
stranded interactions. The final option considered for retrieval of the LDH1-interacting
trans-acting factor was an affinity purification that relied on the use of an RNA aptamer
(Srisawat and Engelke, 2001; Slobodin and Gerst, 2010). The procedure requires the
aptamer to be encoded within the transcript which could then be used to for retrieval of the
transcript and its protein complement through the aptamer’s affinity for an anchored bait
molecule. This system can achieve high target specificity similar to antibody-antigen
interactions and also is amenable to competitive elution of target molecules which
facilitates downstream analysis (Srisawat and Engelke, 2001, Slobodin and Gerst 2010;
Slobodin and Gerst, 2011).
Because of these benefits, the S1 aptamer system was selected. This 44 nucleotide
aptamer, which has been shown to selectively bind streptavidin with a dissociation constant
of 7.0 x 10-8 M (Srisawat and Engelke, 2001), was engineered into a previously established
reporter system directly after the GFP stop codon (Holmes et al., 2014; Figure 4.1A). To
ensure that the inclusion of the aptamer did not affect stage specific translational repression,
tachyzoites and bradyzoites expressing GFP reporters flanked upstream by either the LDH1
5’UTR or the non-regulated TUB8 5’UTRs were examined for their relative fluorescence
(Figure 4.1B). While the GFP reporter flanked upstream by LDH1 displayed a 51% ± 6%
(P = 0.999, P53L1-S1) bradyzoite-specific decrease in GFP fluorescence, PT3L1-S1
remained unregulated in the bradyzoite stage (Figure 4.1B). This is consistent with
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previously reported results (Holmes et al., 2014) and indicates that the insertion of
sequences directly downstream of the GFP stop codon do not alter the ability of the LDH1
5’UTR to confer sustained translational repression to transcripts in bradyzoites.
To assess whether the S1 aptamer could be used for affinity purification, an in vitro
synthesized RNA fragment consisting of the LDH1 5’UTR, the GFP coding sequence, the
S1 aptamer and the SAG1 3’UTR (5L1-GFP-5L1-3SAG1; Figure 4.1C upper panel) was
made and incubated with streptavidin coated beads.

After washes, the beads were

competitively eluted using biotin, which binds streptavidin with a dissociation constant of
10-14 M and can completely dissociate the aptamer from the beads (Srisawat and Engelke,
2001). An RT-PCR was performed on the eluted fractions and the RNA fragment was not
retrieved (Figure 4.1D, upper panel). Since large amounts of the RNA transcript were
added to the initial binding step, the failure to retrieve it upon elution suggested that the S1
aptamer could not bind the streptavidin beads.
The S1 aptamer was engineered using an in vitro selection process and notably, it is
one member of a family that was generated to selectively bind streptavidin (Srisawat and
Engelke, 2001). While this aptamer family shared some sequence similarity, all members
produced an identical secondary structure (Srisawat and Engelke, 2001; Figure 4.1A).
Furthermore, the authors suggested that the S1 aptamer must adapt the conserved secondary
structure for it to maintain its activity. It was therefore hypothesized that the S1 aptamer
was unable to adopt the proper conformation in the context that it was used here. Using
the MFOLD algorithm (Zuker, 2003), it was found the sequence of the S1 aptamer is
predicted to extensively interact with the SAG1 3’UTR (Figure 4.1C, upper panel). To
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assess if this predicted base pairing interaction was responsible for precluding the proper
S1 conformation, an RNA fragment was generated as before while lacking the SAG1
3’UTR (Figure 4.1C, lower panel). This transcript, which expresses the S1 aptamer on its
3’ terminus, was predicted to allow the aptamer to fold upon itself (Figure 4.1C, lower
panel) and was successfully bound and eluted from the streptavidin beads (Figure 4.1D,
lower panel). This result underscores the reliance of the S1 aptamer on achieving a proper
conformation for its functionality (Srisawat and Engelke, 2001).
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Figure 4.1 The S1 aptamer does not affect regulation but must fold upon itself to bind
streptavidin beads.
(A) Graphical representation of S1-containing GFP reporter plasmids. The S1 aptamer
(Srisawat and Engelke, 2001) is placed directly after the GFP stop codon. Orange
segments are derived from LDH1, green from GFP, purple represents non-regulated
sequences.

(B) Relative GFP fluorescence (RFU) of transformed parasites under

tachyzoite and bradyzoite conditions. Bars show normalized average readings ± standard
error (N ≥ 300) obtained from at least three independent clones per construct. Dark bars,
tachyzoites; light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤
0.001. (C) Predicted secondary structures of the S1 aptamer when placed in the context
of the in vitro synthesized transcripts depicted in the inset. (D) RT-PCR of affinity
purification samples. The washes were grouped in sets of two. L, ladder; FT, flow
through; E1/E2 elutions; RT +/-, cDNA or NoRT control respectively.
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Since the S1 aptamer appeared functional when placed in a 3’ terminal position, a
transcript was engineered to express the HDV ribozyme directly downstream of the S1
aptamer (Figure 4.2A). Ribozymes are RNAs that possess enzymatic activity and this class
self-cleaving viral ribozymes have been extensively used to produce transcripts with
defined 3’ termination sites when appended directly downstream of the desired cleavage
site (Figure 4.2A; Chowrira et al., 1994; Schürer et al., 2002). The HDV ribozyme, which
is derived from the hepatitis delta virus genome, forms a conserved pseudoknot structure
and causes the cleavage of transcripts directly at its 5’ terminus with minimal upstream
sequence requirements (Figure 4.2B; Been, 2006; Chowrira et al., 1994). In contrast to
other ribozymes that generate precise 3’ termini, the HDV ribozyme has a relatively low
requirement for its Mg2+ cofactor (1 mM), suggesting that it is ideally suited for use in
biological systems, where the estimated amount of free Mg2+ in the cell is similar to that
needed for optimal HDV ribozyme activity (Chowrira et al., 1994). Importantly, the HDV
ribozyme has been shown to be tolerant of certain sequence mutations as long as secondary
structure is maintained. For example, nucleotide changes within the P1 stem cause little
effect on cleavage efficiency as long as compensatory mutations are present to preserve
Watson-Crick base paring (Been et al., 1992; Ananvoranich et al., 1998). Likewise,
decreasing the P4 stem from the long wild-type sequence to a shortened stem with a
terminal ultra-stable UUCG tetraloop shows little change in HDV cleavage activity (Figure
4.2B; Been et al., 1992; Mercure et al., 1998). The HDV ribozyme variant used in this
study contains mutations in the P1 stem that maintain Watson-Crick base pairing and has
shortened P4 stem with a UUCG tetraloop, which has been indicated to cause increased
stability to the ribozyme (Mercure et al., 1998).
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In order to assess if inclusion of the HDV ribozyme was able to produce 3’ terminal
S1 aptamers in a transcript, an in vitro transcription reaction was performed to produce the
full length 1426 nucleotide transcript which is composed of the LDH1 5’UTR, GFP coding
sequence, S1 aptamer, HDV ribozyme and SAG1 3’UTR (Figure 4.2A). This full length
transcript was anticipated to be processed by the HDV ribozyme in the presence of MgCl2
to a 1027 nucleotide shortened version that included the LDH1 5’UTR, the GFP coding
sequence and a terminal S1 aptamer (Figure 4.2A). For size comparison, these transcripts
were produced along with a catalytically inactive version of the HDV ribozyme and the full
length transcript without the S1 or HDV ribozyme sequences, consisting of 1296
nucleotides. The inactive ribozyme has a deletion of 1 nucleotide, G58, which removes a
purine-purine pairing that has been shown to be essential for catalytic activity (Figure 4.2B;
Been and Perrotta, 1995). A northern blot of the aforementioned transcripts was performed
to assess HDV processing (Figure 4.2C). Large trails were detected under each of the
samples, likely due to non-specific degradation products or through the accumulation of
products arising from premature transcriptional termination of the T7 RNA polymerase.
While a clearer image could have been obtained had the uppermost bands of each sample
been gel extracted and resuspended in a MgCl2-containing buffer to induce HDV ribozyme
cleavage prior to running the blot, it clearly shows no specific accumulation of cleavage
product in the presence of HDV ribozyme (Figure 4.2C, lane 3). This indicated that the
HDV ribozyme was unable to produce a transcript with a 3’ terminal S1 aptamer in this
context.
Similar to the S1 aptamer, the HDV ribozyme requires the formation of a specific
secondary structure to achieve a functional state. Although these considerations were
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noted, it is likely that the HDV ribozyme was unable to fold properly into its complex
pseudoknot structure. It had been hypothesized that the modified P4 hairpin, containing
the ultra-stable UUCG tetraloop, would help to drive the proper folding of the ribozyme
since this has been reported to confer additional stability to the HDV ribozyme (Been et
al., 1992; Mercure et al., 1998). Contrarily, previous reports have shown that sequences
downstream of the HDV ribozyme can have great positive or negative effect on its
functionality likely through promoting its correct folding or by creating unwanted base
pairing with the ribozyme (Chowrira et al., 1994). Since the use of the S1 aptamer and S1HDV ribozyme methodologies both fell victim to the similar drawback of RNA misfolding,
it was abandoned in favour of a strategy that was less reliant on the adoption of complex
RNA structures.
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Figure 4.2 The HDV ribozyme does not produce S1 terminal transcripts.
(A) Graphical representation of S1-HDV in vitro synthesized transcript and cleavage
product. (B) Diagramme of properly folded HDV ribozyme used in this study. The
stems of the pseudoknot and nucleotide G58 are annotated. (C) Northern blot of in vitro
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blot.
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4.3.2

Adaptation of the MS2 aptamer system for affinity purification
The MS2 loop aptamer consists of a small 19 nucleotide RNA hairpin that

specifically binds that MS2 bacteriophage coat protein (CP) with dissociation constant of
3 x 10-9 M (Said et al., 2009; Slobodin and Gerst, 2010). This interaction has been utilized
for the development of affinity purification methodologies where a CP fusion protein binds
a transcript encoding the MS2 loop aptamer and is then selectively withdrawn from protein
lysate. For example, Slobodin and Gerst (2010) developed a CP fused to GFP and a
streptavidin-binding peptide (SBP; Figure 4.3A). This CP-GFP-SBP was expressed and
shown to co-localize with MS2 loop-containing transcripts in vivo, showing that the GFP
moiety could be used for live cell imaging (Slobodin and Gerst, 2010). Furthermore the
SBP portion was compatible with streptavidin-agarose resin and permitted a clean,
competitive elution in the presence of biotin (Slobodin and Gerst, 2010). However, because
the CP has a propensity to oligomerize in vivo, the authors suggested that it be should only
be expressed while using an inducible system to prevent non-specific binding (Slobodin
and Gerst, 2010). This system was adapted for use in Toxoplasma and the LDH1-GFP
reporter system. However, because of the propensity for CP to oligomerize and because
the MS2 aptamer was incorporated into a GFP cassette (Figure 4.3A), which would make
live-cell transcript visualization impractical, it was decided to bacterially express the CPGFP-SBP capturing molecule.
After incorporation into the pET vector system, a C-terminally histidine tagged CPGFP-SBP was expressed in a bacterial system. As is common for GFP-containing proteins
expressed in E. coli (Peternel et al., 2008), the recombinant protein partitioned to the
insoluble fraction and was therefore solubilized in an 8 M urea buffer and allowed to refold
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on the column. This procedure isolated the CP-GFP-SBP protein at high purity as assessed
by SDS-PAGE analysis (Figure 4.3B, lane P). While the choice to bacterially express the
CP-GFP-SBP had advantages over allowing it to be produced in vivo, it also raised several
important technical issues. For example, while the cellular expression of CP-GFP-SBP has
the advantage of being able to preserve the MS2-CP interaction along with the mRNP
composition through formaldehyde crosslinking (Slobodin and Gerst, 2010; Slobodin and
Gerst, 2011), using a bacterially expressed CP-GFP-SBP instead requires the interaction to
occur post-fixation. Therefore, modifications were made to the recovery procedure that
take this into consideration. For example, gentler lysis, binding, and wash buffers were
modeled after those that were used for MS2 aptamer affinity purification using a bacterially
expressed CP (Said et al., 2009; Corcoran et al., 2012).
After crosslinking in formaldehyde, approximately 108 extracellular tachyzoites
expressing the MS2-tagged GFP transcript were lysed in a gentle hypotonic lysis buffer,
yielding a total of 5 mg total protein. Notably, this amount of total protein has been
recommended as the minimum amount to use for this procedure as using input amounts
significantly lower than this may not yield sufficient protein for downstream western blot
analysis (Slobodin and Gerst, 2011). After blocking endogenous biotin moieties with
avidin, the protein lysate was applied to a streptavidin-agarose resin that was pre-bound
with CP-GFP-SBP. The resin was washed five or six times and eluted with biotin. When
the samples from the affinity purification procedure were run on an SDS-PAGE gel, a
single 48 kDa protein, likely corresponding to the CP-GFP-SBP targeting molecule, was
observed in the eluate (Figure 4.3B). A silver staining procedure had been performed with
the hopes that other protein bands would be seen and could be identified using a mass
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spectrometry approach (Figure 4.3B). However, since only the CP-GFP-SBP band was
observed, it was thought that perhaps any other isolated proteins were under the detection
limit for silver staining. After repeating the affinity purification procedure either in the
presence of absence of CP-GFP-SBP, a western blot was performed (Figure 4.3C). Probing
with α-GFP revealed a 26 kDa band corresponding to the free GFP produced by the MS2tagged transcript in the parasite lysate as well as a 48 kDa band in the eluted fraction
corresponding to the CP-GFP-SBP fusion (Figure 4.3C). This indicates that successful
binding and elution of the CP-GFP-SBP targeting molecule to the streptavidin-agarose
resin was achieved through its SBP moiety. In order to assess if the MS2-transcript was
able to be purified using this methodology, the western was probed for PABP with the
thought that since it is a ubiquitous RBP, it should be retrieved upon successful affinity
purification of any MS2-tagged transcript. Multiple Toxoplasma-reactive bands were seen
in the parasite lysate when the blot was probed with α-human PABPC3 (Figure 4.3D).
However, no PABPC3-reactive protein was observed in the eluted sample, consistent with
the possibility that the CP-GFP-SBP targeting molecule was unable to capture the MS2containing transcript (Figure 4.3D).

In addition, after reversing the formaldehyde

crosslinking from the same eluted sample, RT-PCR analysis was performed, however no
products corresponding to the GFP amplicon were seen (data not shown). Although care
was made to minimize the risk, technical issues such as post-lysis RNA degradation cannot
be completely discounted. However, it is likely that the MS2-CP interaction did not occur.
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Figure 4.3 CP-GFP-SBP binds streptavidin but not the MS2 aptamer.
(A) Cartoon representation of the materials used. Bacterially expressed CP-GFP-SBP
fusion protein (green) should bind streptavidin-agarose resin (white) and the MS2
aptamer (pink). The MS2 aptamer is encoded directly after GFP in a reporter construct.
(B) Silver stained SDS-PAGE of affinity purification trial using PT5L1-MS2 parasites.
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Lanes are indicated as before; OE, over-exposed elution.
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Two important issues could have disfavoured the binding of the MS2 loop aptamer
by the CP. First, since the bacterially expressed CP-GFP-SBP was insoluble, it was
solubilized and denatured through the use of 8 M urea. While the protein was subsequently
allowed to refold, it is very possible that the CP was unable to adopt its proper
conformation. This issue likely could have been avoided had the central GFP portion been
removed from the CP-GFP-SBP fusion since GFP is known to aggregate into insoluble
bacterial inclusion bodies (Peternel et al., 2008). Alternatively, a mutant CP that is
defective in oligomerization exists (Said et al., 2009) and could have been used for
expression of the fusion within Toxoplasma, with the hope that the MS2-CP interaction
would have occurred under more natural conditions in the cell.
The second major issue that could have prevented MS2 binding echoes the problems
encountered with the S1 aptamer approach, namely that the MS2 aptamer may not have
folded into the necessary conformation to permit CP binding. The MS2 aptamer is a small,
19 nucleotide RNA hairpin that has a weak predicted free energy (ΔG = -6.80 kcal/mol;
Said et al., 2009; Zuker, 2003). This indicates that its stability is relatively low and
therefore an individual hairpin is prone to be influenced surrounding upstream and flanking
sequences. To combat this issue, multiple units of the MS2 aptamer are typically expressed
in tandem. For example, like this study, Said et al. (2009) expressed two MS2 hairpins in
tandem while twenty four were used by Slobodin and Gerst (2010). By using such a large
copy number of the MS2 hairpin (Slobodin and Gerst, 2010), it is likely that at least some
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of the MS2 units could be shielded from the non-specific base pairing that would disrupt
their activity.
In contrast, this study consistently used a minimalist approach when inserting
sequences within the GFP reporter system with the goal of minimizing potential unintended
consequences caused by the introduction of large sequence insertions. For example, instead
of using the full length 84 nucleotide S1 aptamer (Srisawat and Engelke, 2001), the minimal
sequence was used. Similarly, instead of opting to use a large copy number of MS2
hairpins, only two were used. While these minimal elements have been described as
successful in purification procedures (Srisawat and Engelke, 2001; Said et al., 2009), they
were not here. The primary difference between this study and others using minimal
aptamer motifs is that in those cases the aptamers were rationally placed while accounting
for the secondary structure of its surroundings. For example, in a proof of concept
experiment using the S1 aptamer for the purification of RNaseP components, the S1
aptamer was placed at the end of a previously established stem loop (Srisawat and Engelke,
2001). This positioning likely encouraged the aptamer to form a self-folding domain since
both upstream and downstream flanking sequences formed a stable, well defined RNA stem
(Srisawat and Engelke, 2001).
In the future, such a strategy could be used for inserting an aptamer within the GFP
reporter system and would likely yield more positive results. This could be accomplished
in a number of ways. First, an aptamer could be inserted within a naturally occurring or an
engineered stable hairpin, mimicking its previous use in RNase P (Srisawat and Engelke,
2001). Alternatively, multiple tandem copies of an aptamer could be used (Slobodin and
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Gerst, 2010). However, to improve the folding efficiency of individual aptamers, these
could be placed between two engineered long and stable RNA hairpins. Conceptually,
these external hairpins would self-anneal and promote the internal sequences to act as a
self-folding RNA domain.
4.3.3

The LDH1 poly(A) tail is not shortened during sustained translational repression
Controlling the length of a transcript’s poly(A) tail is a common mechanism for

modulating its translational competency (Godwin et al., 2013). The poly(A) tail serves as
a substrate for poly(A) binding protein (PABP) which in turn interacts with eIF4G, causing
an increase in translation and circularization of the transcript in what has been termed the
closed loop model of translation (Sonenberg and Hinnebusch, 2009). In contrast, a
common theme amongst translationally repressed transcripts is their deadenylation which
can either lead to their degradation or, if the poly(A) tail is kept very short, their sustained
translational repression (Godwin et al., 2013). Since this mechanism is widely conserved
and the LDH1 transcript is maintained in a translationally quiescent state in bradyzoites
(Yang and Parmley, 1997; Holmes et al., 2014), changes in the polyadenylation state of the
LDH1 transcript were examined in order to gain an insight into its stage-specific regulation.
An RT-PCR approach was undertaken to estimate the poly(A) tail length of LDH1
and, for comparative purposes, the constitutively expressed GRA1 transcript in intracellular
tachyzoites and bradyzoites (Figure 4.4A; Murray and Schoenberg, 2008; Cesbron-Delauw
et al., 1989). In this procedure, a modified oligo-dT primer is used as a substrate in a
reverse transcriptase reaction for the synthesis of cDNA from polyadenylated mRNA
(Figure 4.4A; Murray and Schoenberg, 2008). Next, a transcript-specific forward primer
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is added and a conventional PCR is performed. The sizes of the resulting products represent
a range spanning the length of the poly(A) tail (Murray and Schoenberg, 2008). Following
this procedure, it was apparent that tachyzoites and bradyzoites produce an LDH1 transcript
with similar poly(A) tail lengths (Figure 4.4B). After subtracting the 124 nucleotides
resulting from the sequence upstream of the polyadenylation start site, the LDH1 poly(A)
tail is estimated to vary between 25 and 200 nucleotides in both life stages. While it may
seem as though a smaller poly(A) tail is favoured in both tachyzoites and bradyzoites due
to its intensity on the gel (Figure 4.4B), it is important to note that PCR has a propensity
for favouring the production of small amplicons over larger ones. Similar results were
obtained for the non-regulated GRA1 in tachyzoites and bradyzoites (Figure 4.4B).
However, the primary product appears significantly smaller than the predicted 124 bp
minimal product based on the previous reporting of the polyadenylation site (CesbronDelauw et al., 1989), suggesting that the GRA1 3’UTR contains multiple polyadenylation
sites.
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Figure 4.4 The LDH1 poly(A) is not shortened in bradyzoites.
(A) Cartoon representation showing the methodology of the poly(A) tail length
estimation assay. Primer PAT-Rv binds within the poly(A) tail through an oligo-dT
region and is used to synthesize cDNA. A PCR is then performed upon the addition of
a gene-specific primer. (B) Acrylamide gel showing the poly(A) tail lengths of LDH1
and GRA1 transcripts in tachyzoites and bradyzoites. The sizes of the ladder bands are
indicated in bp on the side on the gel. Note: for size estimation, 124 bp corresponding
to sequences upstream of the polyadenylation site must be subtracted.
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While the finding that the LDH1 poly(A) tail is unregulated during sustained
translational repression runs contrary to most other investigated systems, a similar result
has been found in the apicomplexan parasite Plasmodium (Braks et al., 2008). Similar to
LDH1, the transcripts of P25 and P28 are maintained in a translationally quiescent state in
female gametocytes. Upon fertilization, these transcripts are released and translated.
Interestingly, northern blot analysis of these transcripts revealed that their poly(A) is
maintained in an elongated state while repressed (Braks et al., 2008). Together, these
results suggest that, contrary to well-studied metazoans whose transcripts undergo
deadenylation while silenced and awaiting developmental progression, apicomplexans are
not regulated in this manner. Importantly, a BLAST search against the Toxoplasma
genome using the Xenopus cytoplasmic polyadenylation binding element protein, which is
commonly involved in poly(A) tail shortening (Godwin et al., 2013), revealed no hits
suggesting that this common regulatory mechanism may be absent. Furthermore, the long
poly(A) observed in repressed transcripts in apicomplexan parasites raises interesting
questions regarding the involvement of PABP.
One of the most well studied proteins involved in stage-dependent translational
repression in Plasmodium is the DEAD-box helicase DOZI, which is a homolog of yeast
DHH1. DOZI is required for sustained translational repression of P25 and P28 in female
gametocytes (Mair et al., 2006). A study examining DOZI-associated factors involved in
translational repression identified a variety classic proteins involved in translational
repression, including the Plasmodium homolog of BRUNO and a number of ALBA
proteins as well as PABP, which was the protein identified with the highest abundance
(Mair et al., 2010).

While it could easily be expected that this association with
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translationally repressed transcripts has little biological significance aside from the obvious
poly(A) binding activity, the apicomplexan PABP has several features that could merit
investigation.
When encountered with conditions of cellular stress, a generalized translational
repression is induced while a small subset of transcripts, corresponding primarily to stressresponsive gene products, are preferentially translated (Joyce et al., 2013). Intriguingly,
PABP is preferentially translated under these conditions along with bradyzoite-specific
transcription factors and translational repressors such as the Toxoplasma homolog of PUF1
(Joyce et al., 2013). This is a particularly interesting finding considering that translation is
stunted and most transcripts are thought to be rapidly degraded under these conditions
(Joyce et al., 2013). One might instead expect that the large scale transcript degradation
hypothesized to occur upon stressful insult would yield an abundant source of available
PABP to serve any immediate needs under stress.
Also, PABP has been shown to interact with the Toxoplasma ABLA proteins, which
form mRNA granules under stress and are involved in translational control (Gissot et al.,
2013). Furthermore, polyadenylated mRNA has been found to aggregate into stress
granules upon stressful insult (Lirussi and Matrajt, 2011). Presumably, PABP would be
similarly located. Intriguingly, a chance BLAST search of Toxoplasma using the stress
granule marker TIA1 protein as a query revealed PABP as the top hit with an expected
value of 2e-25. In metazoans, TIA1 is regarded as an important protein involved in the
aggregation of stress granules through its C-terminal prion-like domain (Anderson and
Kedersha, 2008).

Interestingly, unlike the metazoan PABPs, Toxoplasma PABP is
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predicted to contain a nearly 200 amino acid prion-like domain near its C-terminus
(Lancaster et al., 2014). These PABP features along with the observation that repressed
transcripts display long poly(A) tails may suggest that it acts as a stress granule aggregator
under stressful conditions.
4.3.4

Transcript-specific translational repression is not an immediate event
The transition of tachyzoites to bradyzoites is known to occur in response to cellular

stresses that cause the phosphorylation of eIF2α (Narasimhan et al., 2008). This causes a
generalized translational repression which is maintained throughout the bradyzoite life
stage (Narasimhan et al., 2008). Recently it has been shown using a GFP reporter system
that the LDH1 5’UTR is responsible for conferring a sustained translational repression to
its transcript through a cis-acting element and that if this element was missing or mutated,
repression was relieved in bradyzoites (Holmes et al., 2014). This indicates that in addition
to the generalized translational repression mediated through eIF2α phosphorylation,
transcript-specific mechanisms are also important for mediating long term translational
control.

While not mutually exclusive with the generalized model of translational

repression, this raises the question as to whether the transcript-specific regulation of LDH1
is an early event, occurring rapidly after stressful insult or a gradual long-term process. If
it were to occur rapidly, it would be expected that LDH1 would be repressed upon stressful
insult relative to a transcript that remains unregulated in bradyzoites. In contrast, if
transcript-specific repression were a gradual process, LDH1 would show similar expression
relative to a control transcript that remains constitutively expressed in bradyzoites.
Determining the relative speed at which LDH1 is repressed would allow for insight into
transcript-specific translational repression in Toxoplasma.
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In order to answer this question, the previously described GFP reporter system was
converted to a dual luciferase system. Notably, GFP is a very stable protein with an
estimated half-life of 26 h (Kitsera et al., 2007), making it unsuitable for studying rapid
changes in post-transcriptional gene regulation. In contrast, firefly (FF) and Renilla (RN)
luciferases have half-lives of approximately 3 hours making them more ideal for the study
of rapid changes in gene expression (Leclerc et al., 2000). Therefore, the GFP coding
sequence was exchanged for the corresponding FF and RN sequences in order to create
plasmids that would express FF in a regulated (PT5FF) and unregulated manner (PT0FF)
while RN would be under the control of unregulated upstream and downstream sequences
(PT0RN) according to previously established conventions (Figure 4.5A; Holmes et al.,
2014).

Importantly, when assessed for their relative expression in tachyzoites and

bradyzoites, repression was restricted to PT5FF in bradyzoites, indicating that the exchange
of GFP for FF does not affect regulation (Figure 4.5B).
In order to assess the rapidity with which LDH1 encounters transcript-specific
repression, extracellular parasites were subjected to a high potassium buffer and their
relative FF expression was assessed over a time course assay (Figure 4.5C). This buffer
mimics the host’s cytoplasmic ionic composition and would typically be seen as the parasite
leaves its parasitophorus vacuole upon egress (Lirrusi and Matrajt, 2011). Also, this buffer
has previously been reported to cause a robust stress in the parasite, inducing eIF2α
phosphorylation and the aggregation of mRNAs into stress granules (Lirussi and Matrajt,
2011; Gissot et al., 2013). Interestingly, both PT5FF and PT0FF showed a similar decay
over a three hour time period (Figure 4.5C). When normalized against the PT0RN internal
control, it becomes apparent that PT5FF and PT0FF are expressed at similar relative levels
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relative to one another throughout the selected time points (Figure 4.5D). This indicates
that transcripts containing the LDH1 5’UTR are not preferentially repressed after initial
stressful insult and in contrast suggests that a period of generalized translational repression
is induced upon stressful insult.

These observations are consistent with the model

postulated by Joyce and colleagues whereby a stressful insult causes rapid eIF2α
phosphorylation and a generalized translational repression that affects the wide majority of
transcripts independently of repressive cis-acting elements like that seen in LDH1 (Joyce
et al., 2013; Holmes et al., 2014). Furthermore, these results clearly indicate that the
translational control observed in extracellular tachyzoites is different than that seen in fully
developed bradyzoites since PT0FF and PCTRL are regulated differently in the two
stressful situations despite both being characterized as sustaining eIF2α phosphorylation
(Figure 4.5B, Holmes et al., 2014; Narasimhan et al., 2008; Joyce et al., 2010).
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Figure 4.5 The LDH1 5’UTR does not confer immediate translational repression in
extracellular parasites.
(A) Cartoon representation of plasmids used for the dual luciferase assay. Purple
segments represent TUB8 or SAG1 sequences; orange, the LDH1 5’UTR; yellow and
blue FF and RN coding sequences, respectively. (B) Relative expression of FF luciferase
normalized against RN levels in tachyzoites and bradyzoites. Bars represent mean ±
standard deviation.

Yellow bars, unregulated PT0FF; orange, PT5FF; dark bars,

tachyzoites; light bars, bradyzoites; asterisk, bradyzoite-specific decrease where P ≤
0.001. (C) FF luciferase shows a time-dependent decay. Data points ± standard
deviation (N = 3) expressed as a function of the initial timepoint. These data points are
not normalized against RN luciferase. Orange, PT5FF; yellow, PT0FF. (D) Dual
luciferase assay with data from (C) normalized against internal PT0RN control. Bars
indicated mean ± standard deviation (N = 3).
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Interestingly, although all stressful stimuli tested to date seem to result in the same
central response of eIF2α phosphorylation and translational repression, the biological
outcomes to the parasite can be quite different depending on the circumstances. For
example, exposure to the extracellular environment activates the GCN2-like TgIF2K-D
kinase, causing eIF2α phosphorylation and a generalized translational repression at the step
of translational initiation which in turn induces the aggregation of transcripts into stress
granules (Konrad et al., 2011; Lirussi and Matrajt, 2011). Furthermore, both eIF2α
phosphorylation and formation of stress granules are essential for sustained viability of
extracellular parasites indicating that this can act as a coordinated survival mechanism
(Konrad et al., 2011; Lirussi and Matrajt, 2011). In contrast, intracellular tachyzoites
undergoing amino acid starvation see eIF2α phosphorylation mediated through TgIF2K-C
(Konrad et al., 2013a). However this stimulus leads to the autophagic loss of the parasite’s
unique mitochondrion and inevitable cell death (Ghosh et al., 2011). Finally, a collection
of other stimuli that induce cytoplasmic or endoplasmic reticulum stress activate TgIF2KB and -A respectively and cause the conversion to bradyzoites, which are marked by
mitochondrial dysfunction and the production of stress-responsive transcripts (Narasimhan
et al., 2008; Toursel et al., 2000; Behnke et al., 2008).
Conclusion
It is therefore apparent that while many different stressful stimuli can initiate
translational repression, care should be taken when substituting one study model for
another. This has a direct consequence on the question of whether or not to revisit an
aptamer-based affinity purification approach for the identification of the putative transacting factor involved in the sustained translational repression of LDH1. While important
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lessons have been learned regarding aptamer selection and potential placement within a
transcript, the current technological limitations require a recommended minimum of 5 mg
total protein lysate from which to begin such an experiment with any hopes of achieving
an identification by western blot (Slobodin and Gerst, 2011). In this study, attaining that
amount of protein required seven 10 cm culture plates yielding 108 extracellular
tachyzoites. Bradyzoites grow at several orders of magnitude less than tachyzoites and the
purification procedures currently available are far less efficient for the former than the
latter. It would therefore make it highly impractical and would be ill advised to follow a
similar attempt in the future.
In contrast, the study of the fate of the LDH1 transcript in bradyzoites and
extracellular tachyzoites has the potential to yield great insight into post-transcriptional
gene regulation in Toxoplasma. Results shown here demonstrate that LDH1, and likely
other transcripts, are not regulated in their poly(A) tail length while translationally
repressed. Also, sustained translational repression of LDH1 is not an immediate event and
likely occurs in bradyzoites specifically. This could be achieved if a translational repressor
were to be produced or activated specifically in bradyzoites. Conceptually, this transacting factor would be responsible for binding and inducing, either directly or indirectly,
the sustained translational quiescence of LDH1 and other transcripts.

186

Works Cited
Ananvoranich S, Lafontaine DA, Perreault JP. (1999). Mutational analysis of the
antigenomic trans-acting delta ribozyme: the alterations of the middle nucleotides located
on the P1 stem. Nucleic Acids Research. 27(6): 1473-9.
Anderson P, Kedersha N. (2008). Stress granules: the Tao of RNA triage. Trends in
Biochemical Sciences. 33(3): 141-50.
Baltz AG, Munschauer M, Schwanhäusser B, Vasile A, Murakawa Y, Schueler M, Youngs
N, Penfold-Brown D, Drew K, Milek M, Wyler E, Bonneau R, Selbach M, Dieterich C,
Landthaler M. (2012). The mRNA-bound proteome and its global occupancy profile on
protein-coding transcripts. Molecular Cell. 46(5): 674-90.
Been MD. (2006). HDV ribozymes. Current Topics in Microbiology and Immunology.
307: 47-65.
Been MD, Perrotta AT. (1995). Optimal self-cleavage activity of the hepatitis delta virus
RNA is dependent on a homopurine base pair in the ribozyme core. RNA. 1(10): 1061-70.
Been MD, Perrotta AT, Rosenstein SP. (1992). Secondary structure of the self-cleaving
RNA of hepatitis delta virus: applications to catalytic RNA design. Biochemistry. 31(47):
11843-52.
Behnke MS, Radke JB, Smith AT, Sullivan WJ Jr, White MW. (2008). The transcription
of bradyzoite genes in Toxoplasma gondii is controlled by autonomous promoter elements.
Molecular Microbiology. 68(6): 1502-18.
Black MW, Boothroyd JC. (2000). Lytic cycle of Toxoplasma gondii. Microbiology and
Molecular Biology Reviews. 64(3): 607-23.
Braks JA, Mair GR, Franke-Fayard B, Janse CJ, Waters AP. (2008). A conserved U-rich
RNA region implicated in regulation of translation in Plasmodium female gametocytes.
Nucleic Acids Research. 36(4): 1176-86.

187

Cesbron-Delauw MF, Guy B, Torpier G, Pierce RJ, Lenzen G, Cesbron JY, Charif H,
Lepage P, Darcy F, Lecocq JP, Capron A. (1989). Molecular characterization of a 23kilodalton major antigen secreted by Toxoplasma gondii. Proceedings of the National
Academy of Sciences USA. 86(19): 7537-41.
Cherry AA, Ananvoranich S. (2014). Characterization of a homolog of DEAD-box RNA
helicases in Toxoplasma gondii as a marker of cytoplasmic mRNP stress granules. Gene.
543(1): 34-44.
Chowrira BM, Pavco PA, McSwiggen JA. (1994). In vitro and in vivo comparison of
hammerhead, hairpin, and hepatitis delta virus self-processing ribozyme cassettes. Journal
of Biological Chemistry. 269(41): 25856-64.
Cleary MD, Meiering CD, Jan E, Guymon R, Boothroyd JC. (2005). Biosynthetic labeling
of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of
mRNA synthesis and decay. Nature Biotechnology. 23(2): 232-7.
Corcoran CP, Rieder R, Podkaminski D, Hofmann B, Vogel J. (2012). Use of aptamer
tagging to identify in vivo protein binding partners of small regulatory RNAs. Methods in
Molecular Biology. 905: 177-200.
Crater AK, Cherry A, Holmes M, Kadri D, Ananvoranich, S. (2012). Evaluation of the
ability of short and long double-stranded RNAs to induce homologous gene silencing in
the protozoan parasite, Toxoplasma gondii. American Journal of Biomedical Science. 4(1):
1-13.
Dendouga N, Callebaut I, Tomavo S. (2002). A novel DNA repair enzyme containing RNA
recognition, G-patch and specific splicing factor 45-like motifs in the protozoan parasite
Toxoplasma gondii. European Journal of Biochemistry. 269(14): 3393-401.
Dubey JP, Lindsay DS, Speer CA. (1998). Structures of Toxoplasma gondii tachyzoites,
bradyzoites, and sporozoites and biology and development of tissue cysts. Clinical
Microbiology Reviews. 11(2): 267-99.

188

Eisel D, Seth O, Grünewald-Janho S, Kruchen B, Rüger B. (2008). DIG application manual
for filter hybridization. Roche Diagnostics GmbH.
Ghosh D, Walton JL, Roepe PD, Sinai AP. (2011). Autophagy is a cell death mechanism
in Toxoplasma gondii. Cellular Microbiology. 14(4): 589-607.
Gissot M, Walker R, Delhaye S, Alayi TD, Huot L, Hot D, Callebaut I, Schaeffer-Reiss C,
Dorsselaer AV, Tomavo S. (2013). Toxoplasma gondii Alba proteins are involved in
translational control of gene expression. Journal of Molecular Biology. 425(8): 1287-301.
Godwin AR, Kojima S, Green CB, Wilusz J. (2013). Kiss your tail goodbye: the role of
PARN, Nocturnin, and Angel deadenylases in mRNA biology. Biochimica et Biophysica
Acta. 1829(6-7): 571-9.
Hermann T, Westhof E. (1999). Non-Watson-Crick base pairs in RNA-protein recognition.
Chemistry and Biology. 6(12): R335-43.
Hettmann C, Herm A, Geiter A, Frank B, Schwarz E, Soldati T, Soldati D. (2000). A dibasic
motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma
membrane localization. Molecular Biology of the Cell. 11(4): 1385-1400.
Holmes M, Itaas V, Ananvoranich S. (2014). Sustained translational repression of lactate
dehydrogenase 1 in Toxoplasma gondii bradyzoites is conferred by a small regulatory RNA
hairpin. FEBS Journal. 281(22): 5077-91.
Joyce BR, Queener SF, Wek RC, Sullivan WJ Jr. Phosphorylation of eukaryotic initiation
factor-2α promotes the extracellular survival of obligate intracellular parasite Toxoplasma
gondii. (2010). Proceedings of the National Academy of Sciences USA. 107(40): 17200-5.
Joyce BR, Tampaki Z, Kim K, Wek RC, Sullivan WJ Jr. (2013). The unfolded protein
response in the protozoan parasite Toxoplasma gondii features translational and
transcriptional control. Eukaryotic Cell. 12(7): 979-89.
Kitsera N, Khobta A, Epe B. (2007). Destabilized green fluorescent protein detects rapid
removal of transcription blocks after genotoxic exposure. Biotechniques. 43(2): 222-7.
189

Konrad C, Queener SF, Wek RC, Sullivan WJ Jr. (2013b). Inhibitors of eIF2α
dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
Antimicrobial Agents and Chemotherapy. 57(4): 1815-22.
Konrad C, Wek RC, Sullivan WJ Jr. (2011). A GCN2-like eukaryotic initiation factor 2
kinase increases the viability of extracellular Toxoplasma gondii parasites. Eukaryotic Cell.
10(11): 1403-12.
Konrad C, Wek RC, Sullivan WJ Jr. (2013a). GCN2-like eIF2α kinase manages the amino
acid starvation response in Toxoplasma gondii. International Journal for Parasitology.
44(2): 139-46.
Lancaster AK, Nutter-Upham A, Lindquist S, King OD. (2014). PLAAC: a web and
command-line application to identify proteins with prion-like amino acid composition.
Bioinformatics. 30(17): 2501-2.
Leclerc GM, Boockfor FR, Faught WJ, Frawley LS. (2000). Development of a destabilized
firefly luciferase enzyme for measurement of gene expression. Biotechniques. 29(3): 590601.
Leontis NB, Westhof E. (2003). Analysis of RNA motifs. Current Opinion in Structural
Biology. 13(3): 300-8.
Lirussi D, Matrajt M. (2011). RNA granules present only in extracellular Toxoplasma
gondii increase parasite viability. International Journal of Biological Sciences. 7(7): 960-7.
Liu J, O’Kane DJ, Escher A. (1997). Secretion of functional Renilla reniformis luciferase
by mammalian cells. Gene. 203(2): 141-8.
Mair GR, Braks JA, Garver LS, Wiegant JC, Hall N, Dirks RW, Khan SM, Dimopoulos G,
Janse CJ, Waters AP. (2006). Regulation of sexual development of Plasmodium by
translational repression. Science. 313(5787): 667-9.
Mair GR, Lasonder E, Garver LS, Franke-Fayard BM, Carret CK, Wiegant JC, Dirks RW,
Dimopoulos G, Janse CJ, Waters AP. (2010). Universal features of post-transcriptional
190

gene regulation are critical for Plasmodium zygote development. PLoS Pathogens. 6(2):
e1000767.
Mayer G. (2009). The chemical biology of aptamers. Angewandte Chemie International
Edition in English. 48(15): 2672-89.
Mercure S, Lafontaine D, Ananvoranich S, Perreault JP. (1998). Kinetic analysis of delta
ribozyme cleavage. Biochemistry. 37(48): 16975-82.
Montoya JG, Liesenfeld O. (2004). Toxoplasmosis. Lancet. 363(9425): 1965-76.
Murray EL, Schoenberg DR. (2008). Assays for determining poly(A) tail length and the
polarity of mRNA decay in mammalian cells. Methods in Enzymology. 448: 483-504.
Narasimhan J, Joyce BR, Naguleswaran A, Smith AT, Livingston MR, Dixon SE, Coppens
I, Wek RC, Sullivan WJ Jr. (2008). Translation regulation by eukaryotic initiation factor-2
kinases in the development of latent cysts in Toxoplasma gondii. Journal of Biological
Chemistry. 283(24): 16591-601.
Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA. (2002). Reversible crosslinking combined with immunoprecipitation to study RNA-protein interactions in vivo.
Methods. 26(2): 182-90.
Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. (2008). Engineering inclusion
bodies for non denaturing extraction of functional proteins. Microbial Cell Factories. 7:34.
Pfefferkorn ER, Borotz SE. (1994). Toxoplasma gondii: characterization of a mutant
resistant to 6-thioxanthine. Experimental Parasitology. 79(3): 374-82.
Rouault TA, Hentze MW, Haile DJ, Harford JB, Klausner RD. (1989). The iron-responsive
element binding protein: a method for the affinity purification of a regulatory RNA-binding
protein. Proceedings of the National Academy of Science USA. 86(15): 5768-72.
Roos DS, Donald RG, Morrissette NS, Moulton AL. (1994). Molecular tools for genetic
dissection of the protozoan parasite Toxoplasma gondii. Methods in Cell Biology. 45: 2763.
191

Said N, Rieder R, Hurwitz R, Deckert J, Urlaub H, Vogel J. (2009). In vivo expression and
purification of aptamer-tagged small RNA regulators. Nucleic Acids Research. 37(20):
e133.
Schroder K, Hertzog PJ, Ravasi T, Hume DA. (2004). Interferon-gamma: an overview of
signals, mechanisms and functions. Journal of Leukocyte Biology. 75(2): 163-89.
Schürer H, Lang K, Schuster J, Mörl M. (2002). A universal method to produce in vitro
transcripts with homogeneous 3' ends. Nucleic Acids Research. 30(12): e56.
Shevchenko A, Wilm M, Vorm O, Mann M. (1996). Mass spectrometric sequencing of
proteins silver-stained polyacrylamide gels. Analytical Chemistry. 68(5): 850-8.
Skariah S, McIntyre MK, Mordue DG. (2010). Toxoplasma gondii: determinants of
tachyzoite to bradyzoite conversion. Parasitology Research. 107(2): 253-60.
Slobodin B, Gerst JE. (2010). A novel mRNA affinity purification technique for the
identification of interacting proteins and transcripts in ribonucleoprotein complexes. RNA.
16(11): 2277-90.
Slobodin B, Gerst JE. (2011). RaPID: an aptamer-based mRNA affinity purification
technique for the identification of RNA and protein factors present in ribonucleoprotein
complexes. Methods in Molecular Biology. 714: 387-406.
Sonenberg N, Hinnebusch AG. (2009). Regulation of translation initiation in eukaryotes:
mechanisms and biological targets. Cell. 136(4): 731-45.
Srisawat C, Engelke DR. (2001). Streptavidin aptamers: affinity tags for the study of RNAs
and ribonucleoproteins. RNA. 7(4): 632-41.
Sullivan WJ Jr, Narasimhan J, Bhatti MM, Wek RC. (2004). Parasite-specific eIF2
(eukaryotic initiation factor-2) kinase required for stress-induced translation control. The
Biochemical Journal. 380(Pt 2): 523-31.
Suzuki Y, Orellana MA, Schreiber RD, Remington JS. (1988). Interferon-gamma: the
major mediator of resistance against Toxoplasma gondii. Science. 240(4851): 516-8.
192

Torrey EF, Yolken RH. (2013). Toxoplasma oocysts as a public health problem. Trends in
Parasitology. 29(8): 380-4.
Toursel C, Dzierszinski F, Bernigaud A, Mortuaire M, Tomavo S. (2000). Molecular
cloning, organellar targeting and developmental expression of mitochondrial chaperone
HSP60 in Toxoplasma gondii. Molecular and Biochemical Parasitology. 111(2): 319-32.
Turner M, Lenhart S, Rosenthal B, Zhao X. (2013). Modeling effective transmission
pathways and control of the world's most successful parasite. Theoretical Population
Biology. 86: 50-61.
Yang S, Parmley SF. (1997). Toxoplasma gondii expresses two distinct lactate
dehydrogenase homologous genes during its life cycle in intermediate hosts. Gene. 184(1):
1-12.
Zuker M. (2003). Mfold web server for nucleic acid folding and hybridization prediction.
Nucleic Acids Research. 31(13): 3406-15.

193

CHAPTER V – General discussion
The emerging role of securinine as an inducer of differentiation
As an important component of traditional Chinese medicines, securinine has long to
know to possess biological activities and one of the most characterized is its action as an
antagonist of the GABA receptor (Raj and Luczkiewicz, 2008). Because it is capable of
acting on the central nervous system of the host, displays anti-cancer activity, and causes
the conversion of tachyzoites into bradyzoites, it has been proposed that securinine shows
potential as an anti-toxoplasmosis in cancer patients (Raj and Luczkiewicz, 2008; Rana et
al., 2010; Holmes et al., 2011). However the mechanism of action remains undescribed in
Toxoplasma. Since the publication of our results, research into the anti-cancer effects of
securinine has continued and yielded some very interesting results regarding its activities
and potential mechanism(s) of action.
It has been revealed that securinine causes the cell cycle arrest of leukemia, colon,
and breast cancer cells in the G1 phase, reducing their growth and proliferation (Gupta et
al., 2011; Xia et al., 2011; Li et al., 2014). Furthermore, securinine has been shown to be
a potent inducer of monocytic differentiation in leukemia cells and this activity is
independent of its GABA antagonistic activities but involves DNA damage (Gupta et al.,
2011). Interestingly, bradyzoites are characterized by a cell cycle arrest in the G1 phase
and the induction of differentiation (Radke et al., 2003). Furthermore, these activities occur
in the same range (IC50 = 10 μM) that securinine has been shown to inhibit Toxoplasma
growth and induce differentiation to bradyzoites (Gupta et al., 2011; Holmes et al., 2011).
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Investigations into the molecular targets of securinine have discovered a few novel
possibilities for its mechanism of action. In Plasmodium, securinine has been found to bind
and allosterically increase the activity of the essential enzyme dUTPase and decrease
parasite replication (Vu et al., 2013). dUTPase catalyses the conversion of dUTP to dUMP,
an essential step in the production of dTTP and has been described as a potential drug target
for apicomplexan parasites (Quesada-Soriano et al., 2010). However, it is important to
note that a decrease, not an increase, of dUTPase activity has been linked to inhibition of
parasite growth (Quesada-Soriano et al., 2010). Although securinine has been shown to
activate Plasmodium dUTPase and cause inhibition of parasite growth, no mechanistic
relationship between the two activities has been suggested or investigated (Vu et al., 2013).
In contrast, one of the biological targets of securinine in mammalian cells may have
interesting applications for future investigations into Toxoplasma differentiation.
Securinine has been shown to bind and inhibit protein disulfide isomerase (PDI) in
mammalian cells (Hoffstrom et al., 2010). PDI is an important chaperone protein involved
in mediating the correct folding of proteins in the endoplasmic reticulum by ensuring the
correct formation of disulfide bridges (Obukuro et al., 2013). Its inhibition either through
nitrosylation or by securinine has been shown to cause an accumulation of unfolded
proteins in the ER lumen (Obukuro et al., 2013). Notably, this accumulation is known to
activate the PERK-like eIF2α kinase TgIF2K-A, causing a generalized translational
repression and bradyzoite differentiation in Toxoplasma (Narasimhan et al., 2008).
Furthermore, production of nitric oxide (NO), which nitrosylates and inactivates PDI, is
known to be upregulated by macrophages during infection and be necessary for bradyzoite
differentiation in vivo, suggesting that an unexplored link between PDI and differentiation
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may exist (Obukuro et al., 2013; Bohne et al., 1994). It is therefore tempting to speculate
that inactivation of PDI by securinine is conserved in Toxoplasma. While NO has been
thought to cause bradyzoite differentiation through inhibition of mitochondrial enzymes
(Bohne et al., 1994; Tomavo and Boothroyd, 1995), it may also have an unexplored role in
PDI inactivation and ER stress induction in bradyzoites. If future investigations were to
find securinine binds and inhibits Toxoplasma PDI, which maintains 55% sequence
similarity with its human counterpart, it could be used to specifically probe the involvement
of PDI in mediating bradyzoite differentiation.
A unifying model of transcript-specific translational repression and bradyzoite
development
There is overwhelming evidence that sustained cellular stress causes the
differentiation of tachyzoites to bradyzoites. Furthermore, a generalized translational
repression plays a vital role in this process. Taken together, recent results in stress-induced
translational repression combined with insights into transcript-specific translational
repression can be combined into a cohesive model. This model integrates translational
repression and bradyzoite differentiation with mRNP granule accumulation and selective
transcript storage and maintenance within the context of developmental progression in
Toxoplasma.
Upon stressful insult, such as oxidative stress, the accumulation of nitrogen reactive
species or unfolded proteins in the lumen of the endoplasmic reticulum, one of the four
encoded eIF2α kinases is activated in Toxoplasma (Narasimhan et al., 2008). eIF2α is
phosphorylated, reducing the turnover of eIF2-GFP and availability of charged ternary
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complex inhibiting translational initiation (Sullivan et al., 2004; Sonenberg and
Hinnebusch, 2009). Translating ribosomes complete elongation but after termination, are
not able to re-initiate due to the lack of available charged ternary complex (Anderson and
Kedersha, 2008). Transcripts stalled in the translational initiation stage accumulate in the
cytoplasm (Anderson and Kedersha, 2008). As in metazoans, these stalled transcripts
would accumulate into cytoplasmic granules known as stress granules (Anderson and
Kedersha, 2008). This has been observed in extracellular parasites but has only been
indirectly observed in intracellular parasites using RNA-binding proteins (RBP)s as
markers of aggregation (Lirussi and Matrajt, 2011; Gissot et al., 2013; Cherry and
Ananvoranich, 2014). Since stressful insult causes the immediate translational repression
of transcripts that would remain unregulated in bradyzoites (Figure 4.5C,D) it could be
hypothesized that most transcripts are recruited to stress granules without regard for their
selection, at least in the short term. This could be mediated through a ubiquitous RBP with
aggregation-like properties. While in metazoans this function is performed by the prionlike TIA1 (Anderson and Kedersha, 2008), in Toxoplasma it may be mediated by PABP
which is predicted to have a prion-like domain, is a classical marker of stress granules, and
has been shown to be involved in translational repression complexes in Plasmodium
(Section 4.3.3; Anderson and Kedersha, 2008; Mair et al., 2010; Gissot et al., 2013).
Stress granules, which have been described as loosely aggregated complexes that
remain in equilibrium with the translational machinery, help to withdraw the stalled
transcripts from the limited translational pool (Stoecklin and Kedersha, 2013; Yamasaki
and Kedersha, 2008). This withdrawal is thought to allow the translational machinery to
favour stress-responsive transcripts for translation (Yamasaki and Kedersha, 2008). At
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least some of these transcripts contain specific cis-acting elements that aid them to be
preferentially translated under stress (Joyce et al., 2013). These transcripts include PABP,
the translational repressor PUF1, and a variety of bradyzoite-specific AP2 transcription
factors (Joyce et al., 2013). It therefore follows that their production is important for the
conversion of tachyzoites into bradyzoites.
Notably, tachyzoite to bradyzoite conversion is a lengthy process, dependent on cell
cycle progression, and it is common to see parasites expressing both tachyzoite and
bradyzoite-specific markers as their cell division slows (Radke et al., 2003). This indicates
that the parasite goes through a transitional period, where a balance exists between
“tachyzoite” and “bradyzoite” protein synthesis. This balance is likely shifted towards
“bradyzoite” production through two complementary mechanisms.

First, the stress-

induced expression of PABP and PUF1 (Joyce et al., 2013), and perhaps other transcriptspecific translational repressor proteins, would increase the stability of mRNP aggregation
through their ability to bind cis-acting elements in specifically repressed transcripts, such
as that of LDH1. This would decrease the amount of competition that these “tachyzoite”
transcripts would be able to provide against stress-responsive “bradyzoite” transcripts.
Transcript-specific translational repressors are known to be important for the long-term
aggregation and translational inactivation of stage-specific transcripts and the inclusion of
transcript-specific translational repressors in granules has been characterized as a late stage
of mRNP aggregation, signaling a maturation of the stress granules (Anderson and
Kedersha, 2008). This has been observed in apicomplexan parasites. For example in
Plasmodium, PUF2 is essential for the long-term storage of transcripts that are
transcriptionally silent in sporozoites and female gametocytes and has granular distribution
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(Gomes-Santos et al., 2011; Miao et al., 2013). Furthermore, PUF1 and the translational
regulator ALBA proteins show granular distribution in bradyzoites (Liu et al., 2014; Gissot
et al., 2013).
In the second complementary mechanism, the production of stress-induced AP2
transcription factors initiates a cascade of downstream bradyzoite-specific transcription
(Behnke et al., 2010; Behnke et al., 2008). This would increase the relative proportion of
“bradyzoite” transcripts that could compete for the translational machinery against the
disadvantaged “tachyzoite” transcripts that are assembled in weakly associated stress
granules. Taken together these two mechanisms would form a positive feedback loop
where the increase in “bradyzoite” transcripts leads to more “bradyzoite” proteins,
presumably including more transcript-specific translational repressors.

In turn, this

increases the specificity and stability of mRNP aggregates, causing their maturation from
loosely assembled stress granules into more stable germ-like granules, decreasing their
ability to compete for translational machinery and causing more efficient bradyzoite protein
production.

Coupled with the inevitable degradation and removal of “tachyzoite”

transcripts whose genomic loci are no longer transcribed, this mechanism would be
consistent with a model of progressive bradyzoite differentiation. Interestingly, it has been
shown that the expression of bradyzoite-induced transcripts shifts gradually over the period
of days until reaching maturation, consistent with this hypothesis (Cleary et al., 2002).
Upon reaching a certain state bradyzoite maturation, the pressure on the translational
machinery may decrease. Although eIF2α phosphorylation is maintained throughout the
bradyzoite stage (Narasimhan et al., 2008; Konrad et al., 2013), transcripts that are
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translationally quiescent during the initial stages of a stressful insult become translationally
permissive in bradyzoites (Section 4.3.4). This suggests that as mRNP storage granules
stabilize and the transcription of tachyzoite genes ceases, the subset of transcripts that are
able to translated under the conditions of generalized translational repression expands
somewhat. Again this is supported by the observation that the transcription of bradyzoite
genes occurs gradually as the parasite matures (Cleary et al., 2002).
Finally, the process of bradyzoite to tachyzoite transition likely works in a manner
similar to the above hypothesized mechanism of bradyzoite conversion.

Similar to

bradyzoite differentiation, the reactivation of bradyzoites to tachyzoites has been shown to
be a gradual process, with the first signs of tachyzoite antigens being produced in
approximately 18 hours after reactivation is induced (Radke et al., 2003). This would be
consistent with a model whereby upon the relief of stress, eIF2α phosphorylation decreases,
likely causing an uptick in translation (Konrad et al., 2013). Essential tachyzoite transcripts
that were tightly stored in germ-like storage granules would gradually emerge from
repression and enter the translational pool. The products of these stored transcripts would
then drive metabolic and transcriptional changes, causing a cascade that amplifies the
conversion from bradyzoite to tachyzoite. This hypothesis is consistent with previous
research performed in Plasmodium where the premature release of transcripts from storage
granules in salivary gland sporozoites, some of which are transcription factors, causes the
premature progression into liver stage parasites (Gomes-Santos et al., 2011).

200

Potential components and characteristics of sustained translational repression
The above stated hypothesis supposes heavily on the existence of mRNA-containing
germ-like granules in Toxoplasma bradyzoites.

While these have not been directly

observed to date, they are likely to exist since proteins involved in translational repression
have displayed granular localization in bradyzoites (Liu et al., 2014; Gissot et al., 2013;
Cherry and Ananvoranich, unpublished results). Furthermore these observations echo the
composition of mRNA-containing germ-like granules found in the salivary gland
sporozoite and female gametocyte stages of Plasmodium development (Gomes-Santos et
al., 2011; Mair et al., 2010). It therefore follows that the components of germ-like granules
in bradyzoites would be similar to what is found in their Plasmodium cousins.
Transcripts that undergo sustained translational repression are likely sequestered in
germ-like granules. This would most assuredly include LDH1, and likely other transcripts
that have been suggested to be post-transcriptionally silenced in bradyzoites such as the
RNA-binding TgDRE and the canonical tachyzoite marker SAG1 (Yang and Parmley,
1997; Dendouga et al., 2002; Cleary et al., 2005). Undoubtedly, other transcripts would
be sequestered to these granules and would likely have the general function of being
important for early tachyzoite survival; prime candidates would be tachyzoite-specific
transcription factors, similar to what has been described in Plasmodium (Gomes-Santos et
al., 2011).

Verification of transcripts recruited into germ-like granules could be

accomplished by a fluorescent in situ hybridization approach.
Since transcripts require specific cis-acting elements for sustained translational
repression in bradyzoites, translational repressor proteins that bind specific sequences are
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also likely to be included in germ-like granules. Examples in Toxoplasma likely include
PUF1 and ALBA proteins, all of which show granular distribution in bradyzoites (Liu et
al., 2014, Gissot et al., 2013). Again this echoes findings in Plasmodium and metazoans
(Mair et al., 2010; Voronina et al., 2007). These proteins would be responsible for the
sustained translational repression of specific transcripts through the use of cis-acting
elements. For example, in vitro assays show that Toxoplasma PUF1 binds the consensus
PUF binding element from repressed Plasmodium transcripts (Liu et al., 2014). This
consensus bears a striking resemblance to the unpaired nucleotides within the small
regulatory hairpin in the LDH1 5’UTR (Holmes et al., 2014) and the verification of this
interaction through in vitro binding assays and in vivo functional assays is an obvious
progression of this work.
The final component of germ-like granules in bradyzoites would be proteins involved
in the storage and maintenance of transcripts. Potential examples include the DEAD-box
helicase homolog of Plasmodium DOZI and PABP. In Toxoplasma, this helicase displays
granular distribution in bradyzoites and is capable of rescuing a temperature sensitive yeast
DHH1 mutant indicating that it likely fulfills the same function in stress response (Cherry
and Ananvoranich, unpublished results; Cherry and Ananvoranich, 2014). Furthermore,
DOZI has been shown to be essential to the maintenance of germ-like granules in
Plasmodium (Mair et al., 2006).

In contrast to metazoans, translationally repressed

transcripts in Toxoplasma and Plasmodium maintain long poly(A) tails (Godwin et al.,
2013; Figure 4.4; Braks et al., 2008), indicating that PABP is likely a major component of
mature germ-like granules. PABP has indeed been found as a major component of DOZIassociated granules in Plasmodium and other potential protein candidates contained within
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bradyzoite germ-like granules likely mirror those found within similar granules in
Plasmodium (Mair et al., 2010). Future studies, which could be facilitated with the novel
application of CRISPR/Cas9 technology to Toxoplasma (Shen et al., 2014; Sidik et al.,
2014), could be directed towards their localization and stress-related functions.
Conclusions and Significance
This work has focused on two areas, the first of which is the discovery of antiToxoplasma compounds. The serendipitous finding that securinine is an inducer of
bradyzoite conversion may signal that it has applications in future studies regarding stressresponse and differentiation. Furthermore, since it is a biologically active molecule that
has been successfully used in animals and humans, it may be possible to use securinine, or
a derivative thereof as a medicinal tool for treating or preventing recurrent toxoplasmosis.
Notably, this work the first and only to show that securinine can induce cellular
differentiation outside of metazoans.
The second area of research focuses on outlining the features of transcript-specific
translational repression in bradyzoites. These studies show that transcripts are selected for
long-term sustained translational repression through the use of cis-acting elements. This
suggests the involvement of a yet to be identified trans-acting factor that specifically
recognizes the transcript. This work is the first to functionally characterize a cis-acting
element involved in post-transcriptional regulation in Toxoplasma.
This work also shows that differences exist between metazoan and apicomplexan
sustained translational repression, namely through maintenance of the poly(A) tail. Finally,
the observation that transcripts undergo a tight translational repression after initial stressful
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insult that is later not as strict in mature bradyzoites suggests that the mechanisms
regulating translational control change throughout bradyzoite development.
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APPENDICES
Appendix A. List of oligonucleotides used in Chapter 3
Primer combinations used to create each construct are listed. Inserted restriction sites
are underlined. Red nucleotides represent mutated or inserted nucleotides.
Template
name

Product

NAME

SEQUENCE

Full length flank
gDNA

p5L1, p53L1

KpnI_ups-600LDH1
HindIII_dws-600LDH1

gDNA

p3L1, p53L1

PACI_3UTRups780LDH1
BamHI_3UTPdws780LDH1

cccggtaCCTGCTGTGCGAATG
TGTC
aagcTTGCTGACTAAAAATGA
GC
cccttaattaaGCGTTGGCAAAAC
AGG
aaaggatCCTCTATGTATCATGG
GCC

Deletions
pT5L1

pT5L1Δ2-24

ss_del25_06_5UTRL1
as_del25_06_5UTRL1

pT5L1

pT5L1Δ26-65

ss_del20_04_5UTRL1
as_del20_05_5UTRL1

pT5L1

pT5L1Δ47-65

pT5L1

pT5L1Δ66-105

ss_del20_04_5UTRL1
as_del40_C_5UTRL1=as_del2
0_04_5UTRL1
ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1

pT5L1Δ86-105

as_del40_B_5UTRL1
ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1

pT5L1

as_del20_02_5UTRL1
pT5L1

pT5L1Δ106-132

ss_del27-5URL1
as_del27_5UTRL1

GCTTCGATTTCCAAACGCGA
TTTATTC
GCTGGGAACGCGAATTCAA
GAAAAAATG
GCTAGACTAACCGGTGCACT
TTTGCAC
GCTAAATCAAAAAAATCTG
GTCGAGTGTG
GCTAGACTAACCGGTGCACT
TTTGCAC
GCTAAATCGCGTTTGGAAAT
CGAAAATC
GCTTTCGCAGACAACATCTG
GCAGCCTcc
GCTACAAGGCGGATTGGAA
TAAATCG
GCTTTCGCAGACAACATCTG
GCAGCCTcc
GCTAAAAGTGCACCGGTTA
GTCTGCTA
GCT CAT TTT TAG TCA GCA
AGC TTA ATT C
GCTGTCTTGCGTACACGTGC
AAAAGTGC

Keep Series
pT5L1

step1:
pT5L1

pT5L1:K106-151

pT5L1:K45-85

ss_del40_B_5UTRL1=ss_del2
0_02_5UTRL1
as_del25_06_5UTRL1

GCTTTCGCAGACAACATCTG
GCAGCCTcc
GCTGGGAACGCGAATTCAA
GAAAAAATG

ss_del27-5URL1

gctcatttttagtcagcaagcttaattc
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as_del20_02_5UTRL1
step2:
pT5L1Δ8
6-132

ss_del40_C_5UTRL1=ss_del2
0_05_5UTRL1

GRA plasmids
pGRA:CTRL,pG
PLKΔHX RA:K45-85

GCTAAAAGTGCACCGGTTA
GTCTGCTA

as_del25_06_5UTRL1

GCTATTCCAATCCGCCTTGT
AGCAGACTA
GCTGGGAACGCGAATTCAA
GAAAAAATG

gra1_upstrm_fw

aaaGGTACCaaaacctcgaggctgctag
t

gra1_upstrm_rv

aaaGAATTCcttgcttgatttcttcaaag

K45-85 mutations
pT5L1

pT5L1:Hp1D

MH_Fw_KB_P2dis
MH_Rv_KB_P2same

pT5L1

pT5L1:Hp1R

MH_Fw_KB_P2dis
MH_Rv_KB_P2res

pT5L1

pT5L1:Hp1R-UA

MH_Fw_KB_P2dis
Rb_KB_P2res_Uabp

pT5L1

pT5L1:Hp2D

MH_Fw_KB_P3same
MH_Rv_KB_P3dis

pT5L1

pT5L1:Hp2R

MH_Fw_KB_P3res
MH_Rv_KB_P3dis

qRT-PCR
RNA (RT
reaction)
cDNA

cDNA
ldh1

25T_oligo
LDH1_sense

cDNA

gfp

LDH1_RTPCR_RV2
qPCR_GFP_FW

bag1

qPCR_BAG_FW

gapdh

qPCR_BAG_RV
qPCR_GAPDH_Fw

TTTTTTTTTTTTTTTTTTTTTT
TTT
ATGGCACCCGCACTTGT
AGGTCACATGGCTCAGGTCA
A
CAAGACCCGCCACAACATC
CTCTTTTCGTTGGGATCTTTC
G
AGGCTGAGTCACGACAAAA
ATG
GCCGTCTCGAACAACATATC
G
GGTGTTCCGTGCTGCGAT

qPCR_GAPDH_Rv

GCCTTTCCGCCGACAAT

qPCR_GFP_RV
cDNA

cDNA

CGAGCTCTAACCGGTGCACT
TTTAGC
ATCAAGGCGGATTGGAATA
G
CGAGCTCTAACCGGTGCACT
TTTAGC
TACAAGCGGGCATGCAATA
GCGCT
CGAGCTCTAACCGGTGCACT
TTTAGC
TACAAGCGAGCATGCAATA
GCGCTGGGAA
ACTTTTAGCGCTCATTTTTA
G
CCAGCTGTTAGTCTGCTACA
AGGC
ACTTTTACCGGTACCTTTTT
AG
CCAGCTGTTAGTCTGCTACA
AGGC
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Appendix B. List of oligonucletodies used in Chapter 4
Primer combinations used to create each construct are listed. Inserted restriction sites
are underlined. Red nucleotides represent aptamer / ribozyme sequences.
Template name

Product

NAME

SEQUENCE

Aptamer constructs
p53L1

p53L1-S1

pT3L1

pT3L1-S1

pT5L1-S1

pT5L1-S1HDVΔG58

PacI_3UTRups
780LDH1
S1_stop_GFP_
MH
PacI_3UTRups
780LDH1
S1_stop_GFP_
MH
3enddRz3SAG
_Sense

pCTRL-S1HDVΔG58

5enddRzS1aptAntisense
3enddRz3SAG
_Sense

pT5L1-S1

pT5L1-S1HDVΔG58

pT5L1-S1-HDV

pT5L1-S1HDVΔG58

pCTRL-S1HDV

pT5L1

pT5L1-MS2

pCTRL

pCTRL-MS2

5enddRzS1aptAntisense
Fw_delPacI3SAG
HDV rv repair
Fw_delPacI3SAG
HDV rv repair
MS2-SAG1
3’UTR sense
MS2-GFP
antisense
MS2-SAG1
3’UTR sense
MS2-GFP
antisense

cccttaattaaGCGTTGGCAAAACAGG
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat
cccttaattaaGCGTTGGCAAAACAGG
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat
catgcttcggcatgcgaatgggac tta att aat cac cgt
tgt gc
TTGCCCACTAGCCGCCAGCGAGGAG
GCTGGGACCATGGCTAGC gat atc ccg
gcc cgc gac ta
catgcttcggcatgcgaatgggac tta att aat cac cgt
tgt gc
TTGCCCACTAGCCGCCAGCGAGGAG
GCTGGGACCATGGCTAGC gat atc ccg
gcc cgc gac ta
TTAAgTAATCACCGTTGTGC
gtcccattcgCcatgccgaag
TTAAgTAATCACCGTTGTGC
gtcccattcgCcatgccgaag
AGA CAGACACCATCAGGGTCTG
TTA ATT AAT CAC CGT TGT GC
AGA CGTACCCTGATGGTGTACG TTA
AGC ACC ATC TGC AGC TT
AGA CAGACACCATCAGGGTCTG
TTA ATT AAT CAC CGT TGT GC
AGA CGTACCCTGATGGTGTACG TTA
AGC ACC ATC TGC AGC TT

CP-GFP-SBP bacterial expression construct
pUG-MS2CPCP-GFP-SBP
GFP-SBP
fragment
BspHI_CP_Fw

ccc tca tga atg ctt cta act tta ctc agt

XhoI_SBP_Rv

ggg ctc gag tgg ttc tct ctg tcc ttg ag

PstI_Rncds_F
w
PStI_Rncds_R
v

AAA CTG CAG ATG GCT TCC AAG
GTG TAC GA
AAA CTG CAG TTA CTG CTC GTT
CTT CAG CA

Dual luciferase assay construct
pTubRN_NoB

RN fragment

In vitro transcription fragments
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T7-5L1-GFPS1-3SAG1

MH_T7LDH1
5UTR

pT5L1-S1

T7-5L1-GFP-S1

3UTRSAG1
MH_T7LDH1
5UTR
S1_stop_GFP_
MH

pT5L1-S1HDVΔG58

T7-5L1-GFPS1-HDVΔG583SAG1

pT5L1-S1-HDV

T7-5L1-GFPS1-HDV3SAG1

MH_T7LDH1
5UTR

pT5L1

T7-5L1-GFP3SAG1

3UTRSAG1
MH_T7LDH1
5UTR

pT5L1-MS2

T7-5L1-GFPMS2-SAG1

3UTRSAG1
MH_T7LDH1
5UTR

pT5L1-S1

MH_T7LDH1
5UTR
3UTRSAG1

RT-PCR
T7-5L1-GFP-S1 /
T7-5L1-GFP-S13SAG1
GFP cDNA

GFP cDNA
GFP fragment

TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
GGATCCCCCTCGGGGGGGCAAGAAT
TG
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
atatcccggcccgcgactatcttacgcacttgcatgattctgg
tcggttaagcaccatctgcagctttgtat
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
GGATCCCCCTCGGGGGGGCAAGAAT
TG

3UTRSAG1

TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
GGATCCCCCTCGGGGGGGCAAGAAT
TG
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
GGATCCCCCTCGGGGGGGCAAGAAT
TG
TAATACGACTCACTATAGGGACACT
CGACCAGATTTTTTTGATTTTCGAT
GGATCCCCCTCGGGGGGGCAAGAAT
TG

3GFP1940
5GFPMYC

GCCATGTGTAATCCCAGC
ATGCAGGAGCAGAAGCTC

3GFP1491

GTCGTGCCGCTTCATATG

5GFP1667

GAATACAACTACAACTCC

3GFP1940

GCCATGTGTAATCCCAGC

Northern probe
pT5L1

DIG-GFP probe

PAT assay
RNA
cDNA

cDNA
LDH1poly(A)_tail

PAT_Rv
LDH1_PAT_F
w

cDNA

GRA1poly(A)_tail

PAT_Rv
GRA1_PAT_F
w
PAT_Rv

GTG TGT GTG TGT GTC TCT TTT TTT
TTT T
TTG TCC ACT GTC ATG TCG AAA AC
GTG TGT GTG TGT GTC TCT TTT TTT
TTT T
GGT GGT TGT TGC TCA GTT CAA TT
GTG TGT GTG TGT GTC TCT TTT TTT
TTT T
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